,class_name,class_description,domain_name,domain_label,domain_description,field_core,field_definition,field_implementationNotes,field_label,field_mappingInstructions,field_name,field_ordinal,field_prompt,field_questionText,field_simpleDatatype,field_codelistSubmissionValues
0,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
1,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on CRFs that are shipped to each site. EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
2,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTM DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
3,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Agent,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGCAT,4,Procedure Agent Category; NULL,What is the category for the [procedure/assessment agent]?,Char,
4,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the AGCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer.,Subcategory for Agent,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGSCAT,5,Procedure Agent Subcategory; NULL,What is the subcategory for the [procedure/assessment agent]?,Char,
5,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether any procedure/assessment agent(s) were administered.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Procedure Agent Taken,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,AGYN,6,Any procedure agents,[Were/Was] there any [procedure/assessment agent(s)] taken/administered?,Char,['NY']
6,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile procedure agent records with AEs and/or MH. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",AG Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,AGSPID,7,[Sponsor defined],[Sponsor defined question],Char,
7,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,Verbatim name of procedure/assessment agent administered.,"In most cases, the verbatim drug names or treatment will be coded to a standard dictionary (e.g., WHODrug) after the data have been collected on the CRF. For the collection of verbatim procedure agents, the recommendation is to ask sites to provide the full trade or proprietary name since it is more exact than the generic. The full trade name provides the base generic and the appropriate salt for that particular drug. In addition, for coding purposes it helps with ATC classification system code selection. For example, Tylenol with codeine #1 has a different ATC code than Tylenol with codeine #3.",Reported Agent Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGTRT,8,[Procedure/Assessment Agent],What was the [procedure/assessment agent] [name/term]?,Char,
8,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that a specific procedure/assessment agent or group of agents is prespecified on a CRF.,"For prespecified interventions, a hidden field on a CRF defaulted to ""Y"", or added during the SDTM dataset creation. If a study collects both prespecified and free-text interventions, the value of AGPRESP should be ""Y"" for all prespecified interventions and null for interventions reported as free text.",AG Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGPRESP,9,,,Char,['NY']
9,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication whether the given procedure/assessment agent or group of agents was administered when information about the occurrence of a specific procedure/assessment agent is solicited.,AGOCCUR is used to report the occurrence of a prespecified procedure agent. AGOCCUR is not used for spontaneously free-text reported procedure agent(s). The site should be able to indicate that the response was not asked or answered.,AG Occurrence,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. If the response was not asked or answered, populate the SDTMIG variable AGSTAT with ""NOT DONE"".",AGOCCUR,10,[AGTRT],[Has/Was] the subject (been) administered the [procedure/assessment agent]?,Char,['NY']
10,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dose of procedure/assessment agent (e.g., --TRT ) given at one time represented as a numeric value.","Used when the dose/amount administered has only numeric entries. If non-numeric entries are possible, use the CDASH field AGDSTXT.",AG Dose per Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGDOSE,11,[Dose/Amount] (per administration),What was the individual dose per administration of the [procedure/assessment agent]?,Num,
11,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dose of procedure/assessment agent administered per instance.,"Defining this data collection field as a dose text field allows for flexibility in capturing dose entries as numbers, text or ranges. The data collected in this dose text-format field should be separated or mapped to either SDTMIG AGDOSE (if numeric) or AGDOSTXT (if text).",Procedure Agents Dose Description,"This does not map directly to an SDTMIG variable. Numeric values map to AGDOSE in SDTM. Non-numeric values (e.g., 200-400) map to AGDOSTXT in SDTM.",AGDSTXT,12,Dose,What was the individual dose of the [procedure/assessment agent]?,Char,
12,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The unit associated with the procedure/assessment agent.,"When sponsors collect data for amount of dose administered (i.e., Dose, Total Daily Dose), the unit must be collected as well (if applicable).",AG Dose Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGDOSU,13,(Dose) Unit,What is the unit (for the dose of the [procedure/assessment agent])?,Char,"['UNIT', 'CMDOSU']"
13,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The pharmaceutical dosage form in which the AGTRT is physically presented.,"Some drugs have multiple forms and this field may be needed to code the drug to an ATC level. However, in general, this level of detail should not be necessary except for procedure agents of interest.",AG Dose Form,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGDOSFRM,14,Dose Form,What was the dose form of the [procedure/assessment agent]?,Char,"['FRM', 'CMDOSFRM']"
14,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The number of doses administered during a specific interval.,"The frequency of the procedure agent. When collected, the recommendation is to collect dosing information in separate fields (e.g., AGDOSE, AGDOSEU, AGDOSFRQ) for specific and consistent data collection and to enable programmatically utilizing these data.",AG Dosing Frequency per Interval,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGDOSFRQ,15,Frequency,What was the frequency of the [procedure/assessment agent]?,Char,"['FREQ', 'CMDOSFRQ']"
15,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The route of administration of the procedure/assessment agent.,"This additional information may be important to collect on the CRF when the sponsor wants to capture a procedure agent's route of administration, for purposes such as coding, and the procedure agent may have more than 1 route. Some companies may use route in coding procedure agents to be able to choose a precise preferred name and ATC code.",AG Route of Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGROUTE,16,Route,What was the route of administration of the [procedure/assessment agent]?,Char,"['ROUTE', 'CMROUTE']"
16,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The start date when the procedure/assessment agent was first administered, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The assumption is that sponsors should either have a start date or will indicate that the procedure agent was started before, during or after the study period. The preferred method is to collect a complete start date. Partial dates (e.g., providing year only) for procedure agent started a considerable amount of time prior to the start of study are acceptable.",Procedure Agent Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable AGSTDTC in ISO 8601 format.",AGSTDAT,17,Start Date,What was the procedure/assessment agent] start date?,Char,
17,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The time the procedure/assessment agent was started, represented in an ambiguous time format (e.g., h:mm:ss).","Recommend collecting the time a procedure agent was started only when a protocol or data collection scenarios supports it. Typically, a start time is not collected unless the subject is under the direct care of the site at the time a procedure agent administered or the subject records the start time in a diary. See Section 3.7, Mapping Relative Times from Collection to Submissions, and the SDTMIG for more information.",Procedure Agent Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable AGSTDTC in ISO 8601 format.",AGSTTIM,18,Start Time,What was the [procedure/assessment agent] start time?,Char,
18,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Indication the procedure/assessment agent was administered prior to [AGSTTPT] or prior to the date in DM.RFSTDTC.,"Sponsors may collect this information rather than start dates. See Section 3.7, Mapping Relative Times from Collection to Submissions, and the SDTMIG for more information.",Prior Procedure Agents,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTMIG relative timing variable such as AGSTRF or AGSTRTPT. When populating AGSTRF or AGSTRTPT, if the value of the CDASH field AGPRIOR is ""Y"", a value from the CDISC CT (STENRF) may be used. When AGPRIOR refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC), the SDTMIG variable AGSTRF should be populated. When AGPRIOR is compared to another time point, the SDTMIG variables AGSTRTPT and AGSTTPT should be used. Note: AGSTRTPT must be in reference to the time-point anchor described in AGSTTPT.",AGPRIOR,19,Prior to [AGSTTPT]; prior to study,Was the [procedure/assessment agent] administered prior to AGSTTPT? Was the procedure/assessment agent given prior to study start?,Char,['NY']
19,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Indication the procedure/assessment agent is ongoing when no end date is provided.,"This box should be checked to indicate that the procedure agent has not stopped at the time of data collection. It is expected that every recorded procedure agent should have either an end date or be checked as ongoing, but not both. However, in cases where ongoing procedure agents are not permitted, it may not be necessary to include an Ongoing field in the CRF. See Section 3.7, Mapping Relative Times from Collection to Submissions, for more information about collecting relative date/time; see the SDTMIG for information about mapping relative times.",Ongoing Procedure Agents,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTMIG relative timing variable such as AGENRF or AGENRTPT. When populating AGENRF, if the value of AGONGO is ""Y"", the values of ""DURING"", ""AFTER"" or ""DURING/AFTER"" may be used. When populating AGENRTPT, if the value of AGONGO is ""Y"", the value of ""ONGOING"" may be used. When AGONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC), the SDTMIG variable AGENRF should be populated. When AGONGO is used in conjunction with another time point, the SDTMIG variables AGENRTPT and AGENTPT should be used. Note: AGENRTPT must be in reference to the time-point anchor described in AGENTPT.",AGONGO,20,Ongoing (as of [the study-specific time point or period]),Was the [procedure/assessment agent] ongoing (as of the [study-specific time point or period])?,Char,['NY']
20,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The date the procedure/assessment agent was stopped/ended, represented in an unambiguous date format (e.g. DD-MON-YYYY).","The assumption is that sponsors should either have an end date or will indicate that the procedure agent was ongoing at the time of collection or at the end of the study. However, in cases where the end date can be determined from dates collected elsewhere in the CRF it is not necessary to include an end date in the CRF. For example, if all procedure agents are administered only once during a trial, the end date will be the same as the start date.",Procedure Agents End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CMENDTC in ISO 8601 format.",AGENDAT,21,End Date,What was the [procedure/assessment agent's] end date?,Char,
21,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The time the concomitant medication/treatment/therapy was started, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a procedure agent was ended only when a protocol or data collection scenarios require it or the subject records the end time in a diary. Typically, an end time is not collected unless the subject is under the direct care of the site at the time a procedure agent is stopped.",Procedure Agents End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable AGENDTC in ISO 8601 format.",AGENTIM,22,End Time,What was the [procedure/assessment agent's] end time?,Char,
22,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dictionary or sponsor-defined standardized text description of the topic variable (AGTRT) or the modified topic variable (AGMODIFY), if applicable.","This is typically not a data collection field that will appear on the CRF. If the sponsor chooses to code the procedure, the sponsor will populate this through the coding process. If PRPRESP is used, and the information about a specific standardized procedure name is being solicited, the data from AGTRT may map directly to the SDTMIG AGDECOD variable.",Standardized Agent Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGDECOD,23,,,Char,
23,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The class for the agent, often obtained from a coding dictionary.",This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This would generally be the class used for analysis.,AG Agent Class,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGCLAS,24,,,Char,
24,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",AG,Procedure Agents,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The assigned dictionary code for the class of agent.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This would generally be the class code used for analysis.,AG Agent Class Code,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AGCLASCD,25,,,Num,
25,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
26,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: For single-site studies, this is typically preprinted in the header of each CRF page. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
27,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. \n EDC: The subject identifiers may be system-generated. \n This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
28,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Medication,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMCAT,4,(Concomitant) [Medication/Treatment/Therapy Category]; NULL,What is the category for the (concomitant) [medication/treatment/therapy]?,Char,
29,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the CMCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer.,Subcategory for Medication,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMSCAT,5,(Concomitant) [Medication/Treatment/Therapy subcategory]; NULL,What is the subcategory for the (concomitant) [medication/treatment/therapy]?,Char,
30,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether any (concomitant) medications/treatments/therapies were taken/given.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Concomitant Medications Taken,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,CMYN,6,Any (Concomitant) [Medication(s)/Treatment(s)/Therapy(ies)],Were/Was any (concomitant) [medication(s)/treatment(s)/therapy(ies)] taken?,Char,['NY']
31,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile concomitant medication/treatment records with AEs and/or MH. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",CM Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,CMSPID,7,[Sponsor defined],[Sponsor-defined question],Char,
32,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,Verbatim medication name or treatments (include only treatments with data collection characteristics similar to medications).,"In most cases, the verbatim drug names or treatment will be coded to a standard dictionary (e.g., WHODrug) after data have been collected on the CRF. For the collection of verbatim drug name or treatments, the recommendation is for sites to provide the full trade or proprietary name, which is more exact than the generic. The full trade name provides the base generic and the appropriate salt for that particular drug. In addition, for coding purposes, it helps with ATC selection (e.g., Tylenol with codeine #1 has a different ATC code than Tylenol with codeine #3). This field can be used for either prior or concomitant medication/treatments.","Reported Name of Drug, Med, or Therapy",Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMTRT,8,(Concomitant) [Medication/Treatment/Therapy],What was the (concomitant) [medication/treatment/therapy] (name/term)?,Char,
33,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that a specific intervention or a group of interventions is prespecified on a CRF.,"For prespecified interventions, this is a hidden field on a CRF defaulted to ""Y"", or added during the SDTM dataset creation. If a study collects both prespecified and free-text interventions, the value of CMPRESP should be ""Y"" for all prespecified interventions and null for interventions reported as free text.",CM Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMPRESP,9,,,Char,['NY']
34,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication whether the prespecified medication/treatment/therapy (CMTRT) or the group of medications/treatments/therapies was administered when information about the occurrence of a specific intervention was solicited.,CMOCCUR is used to report the occurrence of a prespecified medication/treatment. CMOCCUR is not used for spontaneously free-text reported concomitant medication/treatments. The site should be able to indicate that the question was not asked or answered.,CM Occurrence,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. If the question was not asked or answered, populate the SDTMIG variable CMSTAT with ""NOT DONE"".",CMOCCUR,10,[Specific (Concomitant) [Medication/Treatment/Therapy],Did the subject take [prespecified (concomitant) medication/treatment/therapy/dose]?; Has the subject taken [prespecified (concomitant) medication/treatment/therapy/dose]?,Char,['NY']
35,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Medication ingredients.,"This may be collected in addition to the medication/treatment name. Collecting this provides more detailed information when coding to a medication dictionary like WHODrug Dictionary Enhanced Format C, which codes to the ingredient level for many trade-name medications. For example, depending on the country where it is manufactured, the active ingredients in the medication dolmen may be different: In Spain, acetylsalicylic acid, ascorbic acid, codeine phosphate; in Italy and Czech Republic, tenoxicam; in Estonia and Latvia, dexketoprofen trometamol.",Concomitant Meds Active Ingredients,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,CMINGRD,11,Active Ingredients,What were the active ingredients?,Char,
36,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The condition, disease, symptom, or disorder that the concomitant (non-study) medication/treatment/therapy was used to address or investigate (e.g., why the medication/treatment/therapy was taken or administered).","This is not the pharmacological/therapeutic classification of an agent (e.g., antibiotic, analgesic), but rather the reason for its administration to the subject. This additional information is collected on the CRF when sponsors want to capture the reason(s) a subject took a medication/treatment. This information could be used as deemed appropriate for coding; analysis (e.g., in the classification of medications); reconciling medications/treatments taken by a subject with provided medical history; and/or AEs/SAEs, as part of the data clean-up and monitoring process.",CM Indication,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMINDC,12,Indication,For what indication was the (concomitant) [medication/treatment/therapy] taken?,Char,
37,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Identifier for the adverse event that is the indication for this medication/treatment/therapy.,The intent is to establish a link between the medication/treatment and the AE that was reported. CMAENO can be used to identify a relationship between records in CM dataset and records in the AE dataset. See the SDTMIG for information on RELREC.,Related Adverse Event ID,"This does not map directly to an SDTMIG variable. For SDTM submission datasets, may be used to create RELREC to link this record with a record in the AE domain.",CMAENO,13,Adverse Event Identifier,What was the identifier for the adverse event(s) for which the (concomitant) [medication/treatment/therapy] was taken?,Char,
38,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Identifier for the medical history condition that is the indication for this medication/treatment/therapy.,The intent is to establish a link between the medical history condition and the medication/treatment taken for the condition. CMMHNO can be used to identify a relationship between records in the CM dataset and records in the MH dataset. See the SDTMIG for information on RELREC.,Related Medical History Event ID,"This does not map directly to an SDTMIG variable. For SDTM submission datasets, may be used to create RELREC to link this record with a record in the MH domain.",CMMHNO,14,Medical History Event Identifier,What was the identifier for the medical history event(s) for which the (concomitant) [medication/treatment/therapy] was taken?,Char,
39,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dose of medication/treatment (e.g., --TRT ) given at one time, represented as a numeric value.","Used when the dose/amount taken/administered/consumed has only numeric entries. If non-numeric entries are possible, use the CDASH field CMDSTXT.",CM Dose per Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMDOSE,15,[Dose/Amount] (per administration),What was the individual dose (of the concomitant [medication/treatment/therapy] per administration)?,Num,
40,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dose of medication/treatment taken per administration.,"Defining this data collection field as a dose text field allows for flexibility in capturing dose entries as numbers, text, or ranges. The data collected in this text-format field should be separated or mapped to either SDTMIG CMDOSE if numeric or CMDOSTXT if text.",Concomitant Meds Dose Description,"This does not map directly to an SDTMIG variable. Numeric values map to CMDOSE in SDTM. Non-numeric values (e.g., ""200-400"") map to CMDOSTXT in SDTM.",CMDSTXT,16,Dose,What was the individual dose of the (concomitant) [medication/treatment/therapy]?,Char,
41,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The total amount of CMTRT taken over a day, using the units in CMDOSU.","For use when only total daily dose is collected on the CRF. For general medications/treatments, it is not recommended to use Total Daily Dose. Instead, this can be calculated from other fields (e.g., Units, Dose, Frequency).",CM Total Daily Dose,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMDOSTOT,17,Total Daily Dose,What was the total daily dose of the (concomitant) [medication/treatment/therapy]?,Num,
42,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The unit associated with the concomitant medication/treatment/therapy taken (e.g., mg in ""2 mg 3 times per day"").","When sponsors collect data for amount of dose taken (i.e., Dose, Total Daily Dose), Unit must be collected as well (if applicable).",CM Dose Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMDOSU,18,(Dose) Unit,What is the unit (for the dose of concomitant [medication/treatment/therapy])?,Char,"['UNIT', 'CMDOSU']"
43,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The pharmaceutical dosage form in which the CMTRT is physically presented.,"Some drugs have multiple forms; this field may be needed to code the drug to an ATC level. However, in general, this level of detail should not be necessary except for medications/treatments of interest.",CM Dose Form,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMDOSFRM,19,Dose Form,What was the dose form of the (concomitant) [medication/treatment/therapy]?,Char,"['FRM', 'CMDOSFRM']"
44,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The number of doses given/administered/taken during a specific interval.,"The frequency of the concomitant medication/treatment. When collected, the recommendation is to collect dosing information in separate fields (e.g., CMDOSE, CMDOSEU, CMDOSFRQ) for specific and consistent data collection and to enable programmatically using these data.",CM Dosing Frequency per Interval,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMDOSFRQ,20,Frequency,What was the frequency of the (concomitant) [medication/treatment/therapy]?,Char,"['FREQ', 'CMDOSFRQ']"
45,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The route of administration of the concomitant medication/treatment/therapy.,"This additional information may be important to collect on the CRF when the sponsor wants to capture a medication's/treatment's route of administration, for purposes such as coding; also, the medication/treatment may have more than 1 route. Some companies may use route in coding medications/treatments, to be able to choose a precise preferred name and ATC code.",CM Route of Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMROUTE,21,Route,What was the route of administration of the (concomitant) [medication/treatment/therapy]?,Char,"['ROUTE', 'CMROUTE']"
46,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The start date is when the concomitant medication/treatment/therapy was first taken, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The assumption is that sponsors should either have a Start Date or will indicate that the medication or therapy was started before, during, or after the study period. The preferred method is to collect a complete Start Date. Partial dates (e.g., providing year only) for medications/treatment started a considerable amount of time prior to the start of study are acceptable.",Concomitant Meds Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable CMSTDTC in ISO 8601 format.",CMSTDAT,22,Start Date,What was the (concomitant) [medication/treatment/therapy/dose] start date?,Char,
47,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The time the concomitant medication/treatment/therapy was started, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a concomitant medication/treatment was started only when a protocol or data collection scenarios supports it. Typically, a start time is not collected unless the subject is under the direct care of the site at the time a concomitant medication/treatment administered or the subject records the start time in a diary.",Concomitant Meds Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable CMSTDTC in ISO 8601 format.",CMSTTIM,23,Start Time,What was the (concomitant) [medication/treatment/therapy/dose] start time?,Char,
48,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Indication the concomitant medication/treatment/therapy was given or taken prior to [CMSTTPT] or prior to the date in DM.RFSTDTC.,"Sponsors may collect this information rather than start dates. See Section 3.7, Mapping Relative Times from Collection to Submissions, and the SDTMIG for more information.",Prior Concomitant Meds,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTM relative timing variable such as CMSTRF or CMSTRTPT. When populating CMSTRF, or CMSTRTPT, if the value of the CDASH field CMPRIOR is ""Y"" a value from the CDISC CT (STENRF) may be used. When CMPRIOR refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC), the SDTM variable CMSTRF should be populated. When CMPRIOR is compared to another time point, the SDTM variables CMSTRTPT and CMSTTPT should be used. Note: CMSTRTPT must refer to the time-point anchor described in CMSTTPT.",CMPRIOR,24,Prior to [CMSTTPT]; Prior to Study,Was the (concomitant) [medication/treatment/therapy] given/taken prior to [CMSTTPT]?; Was the (concomitant) [medication/treatment/therapy] given/taken prior to study start?,Char,['NY']
49,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Indication the concomitant medication/treatment/therapy is ongoing when no end date is provided.,"This box should be checked to indicate that the concomitant medication/treatment has not stopped at the time of data collection. It is expected that every recorded medication/treatment should have either an end date or be checked as ongoing, but not both. However, in cases where ongoing concomitant medications/treatments are not permitted, it may not be necessary to include an Ongoing field in the CRF. See Section 3.7, Mapping Relative Times from Collection to Submission, for more information about collecting relative date/time; see the SDTMIG for information about mapping relative times.",Ongoing Concomitant Meds,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable (e.g., CMENRF, CMENRTPT). When populating CMENRF, if the value of CMONGO is ""Y"", the values of ""DURING"", ""AFTER"", or ""DURING/AFTER"" may be used. When populating CMENRTPT, if the value of CMONGO is ""Y"", the value of ""ONGOING"" may be used. When CMONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTM variable CMENRF should be populated. When CMONGO is used in conjunction with another time point, the SDTM variables CMENRTPT and CMENTPT should be used. Note: CMENRTPT must refer to a time-point anchor described in CMENTPT.",CMONGO,25,Ongoing (as of [the study-specific time point or period]),Was the (concomitant) [medication/treatment/therapy] ongoing (as of [the study-specific time point or period])?,Char,['NY']
50,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The date that the subject ended/stopped taking the concomitant medication/treatment/therapy, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The assumption is that sponsors should either have an End Date or will indicate that the medication or therapy was ongoing at the time of collection or at the end of the study. However, in cases where the end date can be determined from dates collected elsewhere in the CRF it is not necessary to include an End Date field on the CRF. For example, if all concomitant medications/treatments are administered only once during a trial, the end date will be the same as the start date.",Concomitant Meds End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CMENDTC in ISO 8601 format.",CMENDAT,26,End Date,What was the (concomitant) [medication/treatment/therapy/dose] end date?,Char,
51,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The time when the subject ended/stopped taking the concomitant medication/treatment/therapy, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a concomitant medication or treatment was ended only when a protocol or data collection scenario requires it or the subject records the end time in a diary. Typically, an end time is not collected unless the subject is under the direct care of the site at the time a concomitant medication/treatment is stopped.",Concomitant Meds End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CMENDTC in ISO 8601 format.",CMENTIM,27,End Time,What was the [medication/treatment/therapy/dose] end time?,Char,
52,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The reason the treatment was discontinued.,"Although frequently used for prior meds, this can be used for any intervention at any timepoint. \n When the dosing of a treatment is recorded over multiple successive records, this variable is applicable only for the (chronologically) last record for the treatment.",Reason for Treatment Discontinuation,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMRSDISC,28,Reason for discontinuation of concomitant medication/treatment,What was the reason the (concomitant) [medication/treatment/therapy/ --TRT] was [discontinued/stopped/ended]?,Char,
53,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dictionary or sponsor-defined standardized text description of the topic variable, CMTRT, or the modified topic variable (CMMODIFY), if applicable.","This field does not typically appear on the CRF. Sponsors will populate this through the coding process. Equivalent to the generic drug name in published (e.g., WHODrug, SNOMED, ICD9) or sponsor-defined dictionaries.",Standardized Medication Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMDECOD,29,,,Char,
54,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The class for the intervention (often obtained from a coding dictionary).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This would generally be the class used for analysis.,CM Medication Class,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMCLAS,30,,,Char,
55,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The assigned dictionary code for the class for the intervention.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This would generally be the class code used for analysis.,CM Medication Class Code,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CMCLASCD,31,,,Num,
56,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary text description of the first level of hierarchy within the Anatomical Therapeutic Chemical (ATC) classification system; indicates the anatomical main group.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 1 Description,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC1"" and SUPPCM.QLABEL=""ATC Level 1 Description"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables (NSVs) in SDTM domains.",CMATC1,32,,,Char,
57,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary code denoting the first level of hierarchy within the ATC classification system; indicates the anatomical main group.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 1 Code,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM =""CMATC1CD"" and SUPPCM.QLABEL=""ATC Level 1 Code"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",CMATC1CD,33,,,Num,
58,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary text description for the second level of hierarchy within the ATC classification system; indicates the therapeutic main group.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 2 Description,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC2"" and SUPPCM.QLABEL=""ATC Level 2 Description"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",CMATC2,34,,,Char,
59,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary code denoting the second level of hierarchy within the ATC classification system; indicates the therapeutic main group.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 2 Code,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC2CD"" and SUPPCM.QLABEL=""ATC Level 2 Code"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",CMATC2CD,35,,,Num,
60,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary text description of the third level of hierarchy within the ATC classification system; indicates the therapeutic/pharmacological subgroup.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 3 Description,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC3"" and SUPPCM.QLABEL=""ATC Level 3 Description"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",CMATC3,36,,,Char,
61,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary code denoting the third level of hierarchy within the ATC classification system; indicates the therapeutic/pharmacological subgroup.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 3 Code,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC3CD"" and SUPPCM.QLABEL=""ATC Level 3 Code"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",CMATC3CD,37,,,Num,
62,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary text description of the fourth level of hierarchy within the ATC classification system; indicates the chemical/therapeutic/pharmacological subgroup.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 4 Description,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC4"" and SUPPCM.QLABEL=""ATC Level 4 Description"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",CMATC4,38,,,Char,
63,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary code denoting the fourth level of hierarchy within the ATC classification system; indicates the chemical/therapeutic/pharmacological subgroup.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 4 Code,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC4CD"" and SUPPCM.QLABEL=""ATC Level 4 Code"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",CMATC4CD,39,,,Num,
64,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary text description of the fifth level of hierarchy within the ATC classification system; indicates the chemical substance.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 5 Description,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC5"" and SUPPCM.QLABEL=""ATC Level 5 Description"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",CMATC5,40,,,Char,
65,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",CM,Concomitant/Prior Medications,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Dictionary code denoting the fifth level of hierarchy within the ATC classification system; indicates the chemical substance.,This field does not typically appear on the CRF. This is populated through the sponsor's coding process.,ATC Level 5 Code,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPCM dataset as the value of SUPPCM.QVAL where SUPPCM.QNAM=""CMATC5CD"" and SUPPCM.QLABEL=""ATC Level 5 Code"". Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",CMATC5CD,41,,,Num,
66,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
67,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
68,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. \n EDC: The subject identifiers may be system generated. \n This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
69,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Name of the trial epoch with which this element of the arm is associated.,"If the same information is collected more than once in different periods/parts of a study (e.g., Disposition), EPOCH may be needed to differentiate them. Typically, the trial epoch will be preprinted on the CRF as the title of the page. See SDTMIG for further information regarding EPOCH.",Epoch,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EPOCH,4,[Epoch](Period/Phase/Sponsor-defined phrase),What is the trial epoch?,Char,['EPOCH']
70,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the subject took the study medication/ treatment.,"The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank. The ECYN is meant to indicate that the exposure as collected form should be completed or inserted into the case book. ECOCCUR would be used when the actual drug name is preprinted on the CRF. While these might be equivalent in a single-drug study, there are differences in how they would be used in most trials. Therefore, it does not map into the SDTM variable ECOCCUR; ECOCCUR indicates whether the subject was actually administered treatment/medication. If actual treatment data is available (ECYN =""Y""), ECOCCUR may be populated based on whether subject was actually administered treatment/medication.",Any Study Treatment Taken,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,ECYN,5,Any Study Treatments,Were any[study treatment/dose] taken?,Char,['NY']
71,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column heading.",Category of Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECCAT,6,[Study Treatment Category]; NULL,What is the category of the [study treatment/dose]?,Char,
72,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the ECCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. ECSCAT can only be used if there is an ECCAT and it must be a subcategorization of ECCAT.,Subcategory of Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECSCAT,7,[Study Treatment Subcategory]; NULL,What is the subcategory of the [study treatment/dose]?,Char,
73,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Name of the intervention or treatment known to the subject and/or administrator.,"ECTRT is the name of the intervention or treatment known to the subject and/or administrator and it is the SDTM topic variable. It is a required variable in SDTM and must have a value in CDASH or a plan to populate it in the SDTM submission datasets (i.e., collected or populated from other sources). If, in a masked study, treatment is collected and known as tablet A to the subject or administrator, then ECTRT=""TABLET A"". If, in a masked study, the treatment is not known by a synonym and the data are to be exchanged between sponsors, partners, and/or regulatory agency(s), then assign ECTRT the value of ""MASKED"".",Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECTRT,8,[Study Treatment/Investigational Product Name],What was the [study treatment/investigational product] name?,Char,
74,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that a specific intervention or a group of interventions is prespecified on a CRF.,"For prespecified interventions, a hidden field on a CRF defaulted to ""Y"", or added during the SDTM dataset creation. If a study collects both prespecified and free-text interventions, the value of ECPRESP should be ""Y"" for all prespecified interventions and null for interventions reported as free text.",Exposure as Collected Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECPRESP,9,,,Char,['NY']
75,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication whether the study treatment was administered when information about the occurrence of a specific intervention was solicited.,ECOCCUR is used to indicate whether the subject was actually administered treatment/medication. ECOCCUR should not be used to indicate that the question was not asked or answered.,Exposure as Collected Occurrence,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. Not applicable when ECMOOD is ""Scheduled"".",ECOCCUR,10,[Study Medication/Treatment],Was [study treatment/dose] administered?; Has the subject taken [study treatment/dose]?,Char,['NY']
76,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An explanation for why a scheduled study treatment administration did or did not occur.,"The reason the study treatment was or was not taken may be chosen from a sponsor-defined codelist (e.g., SUBJECT MISTAKE, SUBJECT REFUSED) or entered as free text. When --REASOC is used, --OCCUR must also be populated in the SDTM dataset with a value of ""Y"" or ""N"".",Exposure Reason for Occur Value,"This information could be submitted in a SUPPEC dataset as the value of SUPPEC.QVAL where SUPPEC.QNAM=""ECREASOC"" and SUPPEC.QLABEL =""Reason for Occur Value"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables (NSVs) in SDTM domains.",ECREASOC,11,Reason (Not) Taken,What was the reason that the [study treatment/dose] was (not) taken?,Char,
77,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Mode or condition of the record specifying whether the intervention (activity) is intended to happen or has happened.,"""SCHEDULED"" is for collected subject-level intended dose records. ""PERFORMED"" is for collected subject-level actual dose records. ""Planned"" or ""Scheduled"" can be preprinted as the CRF name or section header, as applicable. If collecting both the scheduled and performed dosing in the same horizontal record, the sponsor may choose to append ""_SCHEDULED"" to the ECDOSE/ECDOSTXT variable name to delineate the scheduled dose from the performed dose. The performed dose would just be collected with ECDOSE/ECDOSTXT and ECDOSU.",Exposure as Collected Mood,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. When implemented, ECMOOD must be populated for all records.",ECMOOD,12,Scheduled/Performed,Does this record describe scheduled [study treatment/dose] or performed [study treatment/dose]?,Char,['BRDGMOOD']
78,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"An internal or external identifier (e.g., kit number, bottle label, vial identifier).","This packaging identifier (e.g., kit number, bottle label, vial identifier) may be collected in different ways (e.g., affixing label onto CRF, scanning a bar code). For some study dosing regimens that require greater granularity for treatment identifiers, sponsors may need to use additional variables.",Exposure as Collected Reference ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECREFID,13,[Study Treatment] Label Identifier,What is the[study treatment/dose] label identifier?,Char,
79,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Lot number of the ECTRT product.,"The lot number identifies the manufacturing batch of the study treatment. In open-label studies, the reference number on the study treatment container may represent an actual lot number and should be submitted using ECLOT. This variable may be populated during the process of creating the SDTM submission datasets. Do not collect other identification variables in this field.",Lot Number,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECLOT,14,Lot Number,What was the lot number of the[study treatment/dose] used?,Char,
80,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that the subject has abstained from food/water for the specified amount of time.,"Because some study treatments may have a food effect, it is important to know whether the dose was taken after the subject had fasted.",Exposure as Collected Fasting Status,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. Would only be populated when ECMOOD=""PERFORMED"".",ECFAST,15,Fasting,Was the subject fasting?,Char,['NY']
81,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The dosage form in which the ECTRT is physically presented.,This must be collected if it cannot be determined from other sources or if there are multiple options for the same study treatment.,Exposure as Collected Dose Form,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECDOSFRM,16,Dose Form,What was the dose form of the [study treatment/dose]?,Char,"['FRM', 'EXDOSFRM']"
82,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,"The start date of study treatment, intended or actual, represented in an unambiguous date format (e.g., DD-MON-YYYY).","Date when constant dosing interval of the study treatment started or single administration occurred. When collecting the date for an individual dose, the word ""start"" may be omitted from the Question Text and Prompt. When ECMOOD is collected and ECMOOD is ""SCHEDULED"", use ""intended"" in the question text and prompt. When ECMOOD is collected and ECMOOD is ""PERFORMED"", use ""actual"" in the question text and prompt.",Exposure as Collected Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable ECSTDTC in ISO 8601 format.",ECSTDAT,17,(Start) Date,What was the ([intended/planned/actual]) ([study treatment/dose]) (start) date?,Char,
83,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The start time of study treatment, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a medication was started only when a protocol or data collection scenarios requires it. When collecting the time for an individual dose, the word ""start"" may be omitted from the question text and prompt.",Exposure as Collected Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable ECSTDTC in ISO 8601 format.",ECSTTIM,18,(Start) Time,What was the ([intended/planned/actual]) ([study treatment/dose]) (start) time?,Char,
84,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The end date of study treatment, represented in an unambiguous date format (e.g., DD-MON-YYYY).","Date when study treatment period stopped.If start date and end date are not expected to be the same date, the collection of the end date is required. If the study design indicates that the start and end are on the same day, the collection of the end date is not required because it can be assigned to be equal to the start date.",Exposure as Collected End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable ECENDTC in ISO 8601 format.",ECENDAT,19,(End) Date,What was the ([intended/planned/actual]) ([study treatment/dose]) (end) date?,Char,
85,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The end time of study treatment, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a medication was ended when a protocol or data collection scenarios requires it. For infusions, the end time of the infusion is typically needed.",Exposure as Collected End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable ECENDTC in ISO 8601 format.",ECENTIM,20,(End) Time,What was the ([intended/planned/actual]) ([study treatment/dose]) (end) time?,Char,
86,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The dose of study medication taken (per administration).,"Dose or amount taken for single administration of study treatment or per constant dosing interval recorded. Dose must be collected if it cannot be determined via other methods (e.g., from diary data, drug accountability data, protocol). Care should be taken when mapping ECDSTXT. The data collected in this dose text-format field should be separated or mapped to either ECDOSE if numeric or ECDOSTXT if text.",Exposure as Collected Dose Description,This does not map directly to an SDTMIG variable. The data collected in this dose text-format field should be mapped to either ECDOSE if numeric or ECDOSTXT if text.,ECDSTXT,21,Dose,What was the dose (per administration) (of [study treatment/dose])?,Char,
87,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The unit for intended dose (per administration) for ECDOSE, ECDOSTOT, or ECDOSTXT.","Unit of dose or amount taken per constant dosing interval recorded. Dose unit must be collected if it cannot be determined via other methods (e.g., from protocol, randomization data). The unit should be preprinted on the CRF or a field provided on the CRF to capture it. A CDASH Subset Controlled Terminology Codelist Name is available for dose and volume units. In blinded trials, the collected unit may be tablet, capsule, etc., since the actual unit is also blinded.",Exposure as Collected Dose Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECDOSU,22,Units,What were the units for the dose?,Char,"['UNIT', 'EXDOSU']"
88,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The number of doses given/administered/taken during a specific interval.,"This may be collected if it cannot be determined from other sources or if there are multiple options. When possible, the options for dose/amount frequency are preprinted on the CRF. When collected, the recommendation is to collect dosing information in separate fields (e.g., ECDOSE, ECDOSEU, ECDOSFRQ) for specific and consistent data collection and to enable programmatically using these data.",EC Dosing Frequency per Interval,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECDOSFRQ,23,Frequency,What was the frequency of [study treatment/dose] dosing?,Char,"['FREQ', 'EXDOSFRQ']"
89,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The route of administration of the study treatment.,"This may be collected if it cannot be determined via other methods (e.g., from protocol) or if there are multiple options.",EC Route of Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECROUTE,24,Route,What was the route of administration (of the [study treatment/dose])?,Char,"['ROUTE', 'EXROUTE']"
90,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Text description of the intended schedule or regimen for the Intervention.,"The regimen information (e.g., TWO WEEKS ON, TWO WEEKS OFF) may further clarify the dose administration and dose frequency. This may be preprinted or collected. The sponsor may wish to create a codelist to collect this data consistently.",Intended Dose Regimen,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECDOSRGM,25,Intended Dose Regimen,What was the intended dose regimen?,Char,
91,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the dose was adjusted.,"Typically, the intent/purpose of collecting this field is to help with data cleaning and monitoring, as it provides a definitive response regarding any dose changes. It provides verification that the associated field on the CRF (ECADJ) was deliberately left blank. However, the sponsor may collect whether the dose was adjusted, without collecting the reason for the change. When using ECMOOD, this field should not be used.",Dose Adjusted,"When ECADJ is collected, does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED. When ECADJ is not collected, the sponsor may submit this variable in SUPPEC.",ECDOSADJ,26,(Dose) Adjusted,Was the dose adjusted?,Char,['NY']
92,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Description of or explanation for why a dose of the study treatment was adjusted.,"Captures the reason the dose was changed or modified. The reason may be chosen from a sponsor-defined list (e.g., adverse event, insufficient response) or entered as free text. May be used for variations from protocol-specified doses, or changes from expected doses. Used only when an adjustment is represented in EX dataset.",Reason for Dose Adjustment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECADJ,27,Reason Adjusted,What was the reason the dose was adjusted?,Char,
93,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the exposure was interrupted.,"The intent/purpose of collecting this field is to help with data cleaning and monitoring when the actual duration of the exposure is collected using the CDASH field ECCINTD. In some situations, if the actual duration of the interruption is not collected or not derived, this information could be submitted in a SUPPEC.QVAL dataset where SUPPEC.QNAM = ""ECITRPYN"" and SUPPEC.QLABEL = ""Exposure Interrupted"".",EC Exposure Interrupted,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED..,ECITRPYN,28,[(Study) Treatment / Dose] Interrupted,Was the [(study) treatment/dose] interrupted?,Char,['NY']
94,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The collected duration of the treatment interruption.,"This field is used to collect the duration of treatment interruption. In some situations, the duration of the interruption may not be collected but calculated from the treatment start and end times recorded elsewhere in the CRF.",EC Interruption Duration,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEC dataset as the value of SUPPEC.QVAL where SUPPEC.QNAM=""ECITRPD"" and SUPPEC.QLABEL= ""Interruption Duration"". Concatenate the collected treatment interruption duration and the duration unit components and create ECITRPD using ISO 8601 Period format. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",ECCINTD,29,(Interruption) Duration,What was the duration of the treatment interruption?,Char,
95,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit for the collected duration of treatment interruption.,The unit should be collected as a qualifier to the number for duration.,EC Interruption Duration Units,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEC dataset as the value of SUPPEC.QVAL where SUPPEC.QNAM = ""ECITRPD"" and SUPPEC.QLABEL= ""Interruption Duration"". Concatenate the collected treatment interruption duration and the duration unit components and create ECITRPD using ISO 8601 Period format. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",ECCINTDU,30,(Interruption Duration) Unit,What was the interruption duration unit?,Char,"['UNIT', 'EXINTPU']"
96,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A description of the anatomical location of administration.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location where the study treatment was administered. LAT, DIR, PORTOT are used to further describe the anatomical location.",EC Location of Dose Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECLOC,31,Anatomical Location,What was the anatomical location of the ([study treatment/dose]) administration?,Char,['LOC']
97,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier for anatomical location, further detailing side of the body for the study treatment administration.",Further details the laterality of the location where the study treatment was administered. This may be preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Exposure as Collected Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECLAT,32,Side,What was the side of the anatomical location of the ([study treatment/dose]) administration?,Char,['LAT']
98,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Exposure as Collected Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECDIR,33,Directionality,What was the directionality of the anatomical location of the ([study treatment/dose]) administration?,Char,['DIR']
99,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The amount of the prepared product (treatment + vehicle) administered or given.,Administration amount that was given to the subject. \n Note: Should not be the diluent amount alone. The ECTRTV field may be collected if it cannot be determined from other sources.,EC Vehicle Amount,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTM variable ECTRTV may also be populated during the process of creating the SDTM submission datasets.,ECVAMT,34,Total Amount (Drug + Vehicle),What was the total amount (Drug + Vehicle) (of [study treatment/dose]) administered?,Num,
100,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit of measurement for the prepared product (treatment + vehicle).,Unit of the administration amount,EC Vehicle Amount Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,ECVAMTU,35,Unit,What was the unit for the amount (of [study treatment/dose]) administered?,Char,['UNIT']
101,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The flow rate for the total amount of drug + vehicle administered to the subject.,The infusion rate can be used to derive dose.,Exposure as Collected Infusion Rate,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEC dataset as the value of SUPPEC.QVAL where SUPPEC.QNAM=""ECFLRT"" and SUPPEC.QLABEL= ""Infusion Rate"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",ECFLRT,36,Infusion Rate,What was the [study treatment/dose] infusion rate?,Num,
102,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit of measure for the flow rate for the total amount of drug + vehicle administered to the subject.,Unit of the infusion rate,Exposure as Collected Infusion Rate Unit,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEC dataset as the value of SUPPEC.QVAL where SUPPEC.QNAM=""ECFLRTU"" and SUPPEC.QLABEL= ""Infusion Rate Unit"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",ECFLRTU,37,Infusion Rate Unit,What was the unit for the ([study treatment/dose]) infusion rate?,Char,"['UNIT', 'EXFLRTU']"
103,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"A text description of the planned time point when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a field that requires the site to enter text. If the form is laid out as a grid, then words such as ""Planned Time Point"" can be included as the column heading.",EC Planned Time Point Name,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. See the SDTMIG for additional information on representing time points. The SDTMIG time-point anchors ECTPTREF (text description) and ECRFTDTC (date/time) may be needed, as well as SDTMIG variables ECTPTNUM, ECELTM.",ECTPT,38,[Planned Time Point Name],What was the planned time point for [study treatment/dose]?,Char,
104,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EC,Exposure as Collected,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the subject completed the intended regimen.,"Depending on how the study treatment details are collected on the CRF/eCRF, it may be possible to derive those data if the regimen data are collected.",Completed Treatment,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEC dataset as the value of SUPPEC.QVAL where SUPPEC.QNAM = ""ECTRTCMP"" and SUPPEC.QLABEL =""Completed Treatment"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",ECTRTCMP,39,Completed Treatment,Did the subject complete the full course of [study treatment/dose]?,Char,['NY']
105,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
106,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
107,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
108,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Name of the trial epoch with which this element of the arm is associated.,"If the same information is collected more than once in different periods/parts of a study (e.g., Disposition), EPOCH may be needed to differentiate them. Typically, the trial epoch will be preprinted on the CRF as the title of the page. See the SDTMIG for further information regarding EPOCH.",Epoch,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EPOCH,4,[Epoch](Period/Phase/Sponsor-defined phrase),What is the trial epoch?,Char,['EPOCH']
109,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the subject took study medication/treatment.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank. The EXYN variable is a cleaning or EDC convention meant to indicate that the exposure form should be completed or inserted into the case book.,Any Study Treatment Taken,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,EXYN,5,Any Study Treatments,Were any[study treatment/dose] taken?,Char,['NY']
110,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category of Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXCAT,6,[Study Treatment Category]; NULL,What is the category of the [study treatment/dose] ?,Char,
111,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the EXCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. EXSCAT can only be used if there is an EXCAT and it must be a subcategorization of EXCAT.,Subcategory of Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXSCAT,7,[Study Treatment Subcategory]; NULL,What is the subcategory of the [study treatment/dose] ?,Char,
112,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Name of the study treatment or intervention given per single administration or during the constant dosing interval for the observation.,"EXTRT captures the name of the investigational treatment. This is typically collected for open label studies and populated for blinded studies during the SDTM-based dataset creation. Because EXTRT is the SDTMIG topic variable, it is a required variable in SDTM and must have a value in CDASH or a plan to populate it in the SDTM submission datasets (i.e., collected or populated from other sources).",Name of Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXTRT,8,[Study Treatment/Investigational Product Name],What was the [study treatment/investigational product] name?,Char,
113,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"An internal or external identifier (e.g., kit number, bottle label, vial identifier).","This packaging identifier (e.g., kit number, bottle label, vial identifier) may be collected in different ways (e.g., affixing label onto CRF, scanning a bar code). For some study dosing regimens, greater granularity for treatment identifiers may be needed.",Exposure Reference ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXREFID,9,Treatment Label Identifier,What is the [study treatment/dose] label identifier?,Char,
114,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Lot number of the EXTRT product.,"The lot number identifies the manufacturing batch of the study treatment. In open-label studies, the reference number on the study treatment container may represent an actual lot number and is submitted using EXLOT. This variable may be populated during the process of creating the SDTM submission datasets. Do not collect other identification variables in this field.",Lot Number,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXLOT,10,Lot Number,What was the lot number of the[study treatment/dose] used?,Char,
115,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that the subject has abstained from food/water for the specified amount of time.,"Because some study treatments may have a food effect, it is important to know whether the dose was taken after the subject had fasted.",Exposure Fasting Status,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXFAST,11,Fasting,Was the subject fasting?,Char,['NY']
116,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The dosage form in which the EXTRT is physically presented.,This must be collected if it cannot be determined from other sources or if there are multiple options.,Exposure Dose Form,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXDOSFRM,12,Dose Form,What was the dose form of the [study treatment/dose] ?,Char,"['FRM', 'EXDOSFRM']"
117,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,"The start date of study treatment, represented in an unambiguous date format (e.g., DD-MON-YYYY).","Date when the constant dosing interval of the study treatment started or single administration occurred. When collecting the date for an individual dose, the word ""start"" may be omitted from the question text and prompt.",Exposure Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable EXSTDTC in ISO 8601 format.",EXSTDAT,13,(Start) Date,What was the ([intended/planned/actual]) ([study treatment/dose]) (start) date?,Char,
118,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The start time of the study treatment, represented in an unambiguous time format (e.g., hh:mm:ss).",Recommend collecting the time a medication was started only when a protocol or data collection scenario requires it.,Exposure Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable EXSTDTC in ISO 8601 format.",EXSTTIM,14,(Start) Time,What was the ([intended/planned/actual]) ([study treatment/dose]) (start) time?,Char,
119,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The end date of study treatment, represented in an unambiguous date format (e.g., DD-MON-YYYY).","If start date and end date are not expected to be on the same date, the end date is required. If the study design indicates that the start and end date are on the same day, the end date is not required because it can be assigned to be equal to the start date.",Exposure End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable EXENDTC in ISO 8601 format.",EXENDAT,15,(End) Date,What was the ([intended/planned/actual]) ([study treatment/dose]) (end) date?,Char,
120,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The end time of treatment, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a medication was ended when a protocol or data collection scenario requires it. For infusions, the end time of the infusion is typically needed.",Exposure End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable EXENDTC in ISO 8601 format.",EXENTIM,16,(End) Time,What was the ([intended/planned/actual]) ([study treatment/dose]) (end) time?,Char,
121,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Dose (per administration).,"Dose or amount taken for single administration of study treatment or per constant dosing interval recorded. Dose must be collected if it cannot be determined via other methods (e.g., from diary data, drug accountability data, protocol). The data collected in this dose text-format field should be mapped to either SDTMIG variable EXDOSE (if numeric) or EXDOSTXT (if text).",Exposure Dose Description,"This does not map directly to an SDTMIG variable. Numeric values map to EXDOSE in SDTM. Non-numeric values (e.g., 200-400) map to EXDOSTXT in SDTM.",EXDSTXT,17,Dose,What was the dose [per administration] (of [study treatment/dose]) ?,Char,
122,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The unit for intended dose (per administration) for EXDOSE, EXDOSTOT, or EXDOSTXT.","Unit of dose or amount taken per constant dosing interval recorded. Dose unit must be collected if it cannot be determined via other methods (e.g., from protocol, randomization data). The unit should be preprinted on the CRF or a field provided on the CRF to capture it. A CDASH Subset Controlled Terminology Codelist Name is available for general dose and volume units.",Exposure Dose Unit,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXDOSU,18,Unit,What was the unit for the dose?,Char,['UNIT']
123,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The number of doses given/administered/taken during a specific interval.,"This may be collected if it cannot be determined from other sources or if there are multiple options. When possible, the options for dose/amount frequency are preprinted on the CRF. When collected, the recommendation is to collect dosing information in separate fields (e.g., ECDOSE, ECDOSEU, ECDOSFRQ) for specific and consistent data collection and to enable programmatically using these data.",Exposure Dosing Frequency per Interval,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXDOSFRQ,19,Frequency,What was the frequency of[study treatment/dose] dosing?,Char,['FREQ']
124,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The route of administration of the study treatment.,"This may be collected if it cannot be determined via other methods (e.g., from protocol) or if there are multiple options.",Exposure Route of Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXROUTE,20,Route,What was the route of administration (of the [study treatment/dose] )?,Char,"['ROUTE', 'EXROUTE']"
125,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The text description of the intended schedule or regimen for the Intervention.,"The regimen information may further clarify the dose administration and dose frequency (e.g., TWO WEEKS ON, TWO WEEKS OFF). This may be preprinted or collected. The sponsor may wish to create a codelist to collect this data consistently.",Intended Dose Regimen,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXDOSRGM,21,Intended Dose Regimen,What was the intended dose regimen (of the [study treatment/dose] )?,Char,
126,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the dose was adjusted.,"Typically, the intent/purpose of collecting this field is to help with data cleaning and monitoring, as it provides a definitive response regarding any dose changes. It provides verification that the associate field on the CRF (EXADJ) was deliberately left blank. However, the sponsor may collect whether the dose was adjusted, without collecting the reason for the change.",Dose Adjusted,"When EXADJ is collected, does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED. When EXADJ is not collected, the sponsor may submit this variable as a SUPPQ.",EXDOSADJ,22,(Dose) Adjusted,Was the dose adjusted?,Char,['NY']
127,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Description of or explanation for why a dose of the study treatment was adjusted.,"Captures the reason the dose was changed or modified. The reason may be chosen from a sponsor-defined list (e.g., adverse event, insufficient response) or entered as free text. May be used for variations from protocol-specified doses or changes from expected doses.",Reason for Dose Adjustment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXADJ,23,Reason Adjusted,What was the reason the dose was adjusted (from planned)?,Char,
128,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the exposure was interrupted.,"The intent/purpose of collecting this field is to help with data cleaning and monitoring when the actual duration of the exposure is collected using the CDASH field EXCINTD. In some situations, if the actual duration of the interruption is not collected, or not derived, this information could be submitted in a SUPPEX.QVAL dataset where SUPPEX.QNAM = ""EXITRPYN"" and SUPPEX.QLABEL = ""Exposure Interrupted"".",EX Exposure Interrupted,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,EXITRPYN,24,[(Study) Treatment / Dose] Interrupted,Was the [ (study) treatment/dose] interrupted?,Char,['NY']
129,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The collected duration of the treatment interruption.,"In some situations, the duration of the interruption may be calculated from the administration start and end times recorded elsewhere in the CRF.",Exposure Interruption Duration,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEX dataset as the value of SUPPEX.QVAL where SUPPEX.QNAM=""EXITRPD"" and SUPPEX.QLABEL= ""Interruption Duration"". Concatenate the collected treatment interruption duration and the duration unit components and create EXITRPD using ISO 8601 Period format. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",EXCINTD,25,(Interruption) Duration,"If the dose was interrupted, how long was the interruption?",Char,
130,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit for the collected duration of treatment interruption.,The unit should be collected and converted into ISO 8601 period format.,Exposure Interruption Duration Units,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEX dataset as the value of SUPPEX.QVAL where SUPPEX.QNAM = ""EXITRPD"" and SUPPEX.QLABEL= ""Interruption Duration"". Concatenate the collected treatment interruption duration and the duration unit components and create EXITRPDusing ISO 8601 Period format. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",EXCINTDU,26,(Interruption Duration) Unit,"If the dose was interrupted, what were the units for the interruption duration?",Char,"['UNIT', 'EXINTPU']"
131,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A description of the anatomical location of administration.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location where the study treatment was administered. LAT, DIR, PORTOT are used to further describe the anatomical location.",Exposure Location of Dose Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXLOC,27,Anatomical Location,What was the anatomical location of the ([study treatment/dose] ) administration?,Char,['LOC']
132,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The amount of the prepared product (treatment + vehicle) administered or given.,Administration amount that was given to the subject. Note: should not be the diluent amount alone. The ECTRTV field may be collected if it cannot be determined from other sources.,Exposure Vehicle Amount,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTM variable ECTRTV may also be populated during the process of creating the SDTM submission datasets.,EXVAMT,28,Total Amount,What was the total amount (Drug + Vehicle)(of [study treatment/dose] ) administered?,Num,
133,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit of measure for the prepared product (treatment + vehicle).,Unit of the administration amount. A CDASH Subset Controlled Terminology Codelist Name is available for dose and volume units.,Exposure Vehicle Amount Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXVAMTU,29,Unit,What was the unit for the amount (of [study treatment/dose] ) administered?,Char,"['UNIT', 'EXVOLTU']"
134,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The flow rate for the total amount of drug + vehicle administered to the subject.,The infusion rate can be used to derive dose.,Exposure Infusion Rate,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEX dataset as the value of SUPPEX.QVAL where SUPPEX.QNAM = ""EXFLRT"" and SUPPEX.QLABEL= ""Infusion Rate"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",EXFLRT,30,Infusion Rate,What was the [study treatment/dose] infusion rate?,Num,
135,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit of measure for the flow rate for the total amount of drug + vehicle administered to the subject.,Unit of the infusion rate,Exposure Infusion Rate Unit,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEX dataset as the value of SUPPEX.QVAL where SUPPEX.QNAM =""EXFLRTU"" and SUPPEX.QLABEL=""Infusion Rate Unit"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",EXFLRTU,31,(Infusion Rate) Unit,What were the units for the [study treatment/dose] infusion rate?,Char,"['UNIT', 'EXFLRTU']"
136,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"A text description of the planned time point when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a field that requires the site to enter text. If the form is laid out as a grid, then words such as ""Planned Time Point"" can be included in the column heading.",Exposure Planned Time Point Name,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. See the SDTMIG for additional information on representing time points. The SDTMIG time-point anchors EXTPTREF (text description) and EXRFTDTC (date/time) may be needed, as well as SDTMIG variables EXTPTNUM, EXELTM.",EXTPT,32,[Planned Time Point Name],What was the planned time point for [study treatment/dose] ?,Char,
137,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Indication of whether the subject completed the intended regimen.,"Depending on how the study treatment details are collected via the CRF/eCRF, it may be possible to derive those data if the regimen data are collected.",Completed Treatment,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPEX dataset as the value of SUPPEX.QVAL where SUPPEX.QNAM = ""EXTRTCMP"" and SUPPEX.QLABEL="" Completed Treatment"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",EXTRTCMP,33,Completed Treatment,Did the subject complete the full course of [study treatment/dose] ?,Char,['NY']
138,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier for anatomical location, further detailing side of the body for the study treatment administration.",Further details the laterality of the location where the study treatment was administered. This may be preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Exposure Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXLAT,34,Side,What was the side of the anatomical location of the ([study treatment/dose] ) administration?,Char,['LAT']
139,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",EX,Exposure,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Exposure Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,EXDIR,35,Directionality,What was the directionality of the anatomical location of the ([study treatment/dose] ) administration?,Char,['DIR']
140,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
141,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
142,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
143,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading, or a preprinted category value on the CRF and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Meal,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLCAT,4,[Meal/Food Product] Category]; NULL,What is the category for the [meal/food product]?,Char,
144,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the MLCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer.,Subcategory for Meal,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLSCAT,5,[Meal/Food Product] Subcategory]; NULL,What is the subcategory for the [meal/food product]?,Char,
145,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether any meal or food product were consumed or administered. \n \n \n,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Meal Taken,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,MLYN,6,Any [meal/food product] [taken/consumed/administered] ?,[Were/Was] any [meal/food product] [taken/consumed/administered] ?,Char,['NY']
146,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile meal/food product records with AEs and/or MH. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",ML Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,MLSPID,7,[Sponsor defined],[Sponsor-defined question],Char,
147,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,"The reported name of the food, beverage or combination of food or beverage consumed at one time. \n","Sponsors may use the name of a food or the name of the combination of foods (e.g., breakfast, low-fat meal, breakfast bar, water). \n",Name of Meal or Food Product,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLTRT,8,[Meal],What was the [meal/food product/sponsor-defined] (name)?,Char,
148,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that a specific intervention or a group of interventions is prespecified on a CRF.,"For prespecified interventions, a hidden field on a CRF defaulted to ""Y"", or added during the SDTM dataset creation. If a study collects both prespecified and free-text interventions, the value of MLPRESP should be ""Y"" for all prespecified interventions and null for interventions reported as free text.",ML Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLPRESP,9,,,Char,['NY']
149,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the prespecified meal or food product were taken/consumed/administered when information about the occurrence of the specific intervention was solicited.,MLOCCUR is used to report the occurrence of a prespecified meal/ food product. MLOCCUR is not used for spontaneously reported free-text meals/food products. The site should be able to indicate that the response was not asked or answered.,ML Occurrence,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. If the question was not asked or answered, populate the SDTMIG variable MLSTAT with ""NOT DONE"".",MLOCCUR,10,[MLTRT],Did the subject take [MLTRT]?; Has the subject [taken/consumed/administered] [MLTRT]?,Char,['NY']
150,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An explanation for why the scheduled intervention did or did not occur.,"The reason MLTRT occurred may be chosen from a sponsor-defined codelist or entered as free text. When --REASOC is used, --OCCUR must also be populated in the SDTM dataset. This variable should not be used to represent that the item was not answered, not done, not completed, or unknown. The variables MLSTAT /MLREASND should be used instead.",Reason for Occur Value,"This information could be submitted in a SUPPML dataset as the value of SUPPML.QVAL where SUPPML.QNAM = ""MLREASOC"" and SUPPML.QLABEL =""Reason for Occur Value"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",MLREASOC,11,Reason for Occur Value,What was the reason that the [MLTRT] was (not) consumed/taken/done/administered]?,Char,
151,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The reason that the meal/food product was used.,"This is the condition, disease, symptom, or disorder for which the meal or food product is taken, consumed, or administered This additional information is collected on the CRF when sponsors want to capture the reason(s) why a subject took a meal/product.",ML Reason,"This information could be submitted in a SUPPML dataset as the value of SUPPML.QVAL where SUPPML.QNAM = ""MLREAS"" and SUPPML.QLABEL =""Reason for the Intervention"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",MLREAS,12,Reason,What was the reason for the [meal/food product] [[taken/consumed/administered]?,Char,
152,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Identifier for the clinical event event that is the indication for this meal or food product.,The intent is to establish a link between the meal/food product and a clinical event that was reported. MLCENO can be used to identify a relationship between records in ML dataset and records in the CE dataset. See the SDTMIG for information on RELREC.,Related Clinical Event ID,"This does not map directly to an SDTMIG variable. For the SDTM submission datasets, may be used to create RELREC to link this record with a record in the CE domain.",MLCENO,13,Clinical Event Identifier,What was the identifier for the clinical event s) for which the (meal/food product] was [taken/consumed/administered],Char,
153,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The quantity/amount of the meal or food product (e.g., --TRT) taken/consumed/administered represented as a numeric value.","Used when the quantity taken/administered/consumed has only numeric entries. If non-numeric entries are possible, use the CDASH field MLDSTXT.",Dose,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLDOSE,14,[Quantity/Amount] (given at one time),What was the quantity/amount (of the) ([meal/food product]) [taken/consumed/administered]?,Num,
154,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The quantity/amount of the meal or food product (e.g., --TRT) taken/consumed/administered represented as a numeric or text value.","Defining this data collection field as a text field allows for flexibility in capturing entries as numbers, text, or ranges. The data collected in this text-format field should be separated or mapped to either SDTMIG MLDOSE (if numeric) or MLDOSTXT (if text).",Dose Description,"This does not map directly to an SDTMIG variable. Numeric values map to MLDOSE in SDTM. Non-numeric values (e.g., 200-400) map to MLDOSTXT in SDTM.",MLDSTXT,15,Dose,What was quantity/amount (of the) ([meal/food product]) [taken/consumed/administered]?,Char,
155,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,The unit associated with the quantity/amount of the the meal /food product taken/consumed/administered.,"When sponsors collect data for amount /quantity of meal/food product taken (i.e., Dose, Total Daily Dose), the unit must be collected as well (if applicable).",Dose Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLDOSU,16,(Quantity/Amount) Unit,What is the unit for the quantity/amount of the [meal/food product]?,Char,"['UNIT', 'CMDOSU']"
156,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The start date when the meal or food product was first taken/consumed/administered, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The assumption is that sponsors should either have a start date or will indicate that the meal or food product was started before, during, or after the study period. The preferred method is to collect a complete start date. Partial dates (e.g., providing year only) for meal/food product started a considerable amount of time prior to the start of study are acceptable.",Meal Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable MLSTDTC in ISO 8601 format.",MLSTDAT,17,(Start) Date,What was the (start) date the [meal/food product] was first [taken/consumed/administered]?,Char,
157,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The time the meal or food product was started, represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a meal/food product was started only when a protocol or data collection scenarios supports it. Typically, a start time is not collected unless the subject is under the direct care of the site at the time a meal/food product or the subject records the start time in a diary. See Section 3.7, Mapping Relative Times from Collection to Submissions, and the SDTMIG for more information.",Meal Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable MLSTDTC in ISO 8601 format.",MLSTTIM,18,Start Time,What was the [meal/food product] start time?,Char,
158,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The date that the subject ended/stopped taking/consuming/administering the meal or food product product represented in an unambiguous date format (e.g., DD-MON-YYYY).","The assumption is that sponsors should either have an end date or will indicate that the meal or food product was ongoing at the time of collection or at the end of the study. However, in cases where the end date can be determined from dates collected elsewhere in the CRF it is not necessary to include an end date in the CRF.",Meal End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable MLENDTC in ISO 8601 format.",MLENDAT,19,End Date,What was the [meal/food product] end date?,Char,
159,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The time when the subject ended/stopped taking the meal or food product represented in an unambiguous time format (e.g., hh:mm:ss).","Recommend collecting the time a meal/food product was ended only when a protocol or data collection scenarios require it or the subject records the start time in a diary. Typically, a end time is not collected unless the subject is under the direct care of the site at the time a meal/food product or the subject records the end time in a diary. See Section 3.7, Mapping Relative Times from Collection to Submissions, and the SDTMIG for more information.",Meal End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable MLENDTC in ISO 8601 format.",MLENTIM,20,End Time,What was the [meal/food product] end time?,Char,
160,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dictionary or sponsor-defined standardized text description of the topic variable (MLTRT) or the modified topic variable (MLMODIFY), if applicable.",This field does not typically appear on the CRF. Sponsors will populate this through the coding process. Equivalent to a standardized name in a published or sponsor-defined dictionaries.,Standardized Meal Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLDECOD,21,,,Char,
161,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",ML,Meal Data,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"If the value for MLTRT is modified for coding purposes, then the modified text is placed here.",This is not a data collection field that will appear on the CRF itself. Sponsors will populate this through the coding process.,Modified Reported Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MLMODIFY,22,,,Char,
162,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or the EDC system. This field can be included into the database or created during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
163,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
164,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
165,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the subject had any procedures performed.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Procedures Performed,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,PRYN,4,Any Procedures,"Were any surgical, therapeutic, or diagnostic procedures performed?",Char,['NY']
166,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Procedure Category,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRCAT,5,[Procedure Category]; NULL,What was the category of the procedure?,Char,
167,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the PRCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. PRSCAT can only be used if there is a PRCAT and it must be a subcategorization of PRCAT.,Procedure Subcategory,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRSCAT,6,[Procedure Subcategory]; NULL,What was the subcategory of the procedure?,Char,
168,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, This is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile procedure records with medical history and/or with AEs. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Procedure Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,PRSPID,7,[Sponsor defined],[Sponsor-defined question],Char,
169,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,"The verbatim surgical, therapeutic, or diagnostic procedure's name.","In most cases, the verbatim procedure names or therapy will be coded to a standard dictionary (e.g., MedDRA, SNOMED) after the data have been collected on the CRF.",Reported Name of Procedure,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRTRT,8,[Procedure Name]; (Specify) Other,What was the procedure name?,Char,
170,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dictionary or sponsor-defined standardized text description of PRTRT, or the modified topic variable (PRMODIFY), if applicable.","This is typically not a data collection field that will appear on the CRF. If the sponsor chooses to code the procedure, the sponsor will populate this through the coding process. If PRPRESP is used, and the information about a specific standardized procedure name is being solicited, the data from PRTRT may map directly to the SDTMIG PRDECOD variable.",Standardized Procedure Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRDECOD,9,[Standardized Procedure Name],,Char,['PROCEDUR']
171,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"If the value for PRTRT is modified for coding purposes, then the modified text is placed here.","This is not a data collection field that will appear on the CRF. If the sponsor chooses to code the procedure, the sponsor will populate this through the coding process.",Modified Procedure Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRMODIFY,10,,,Char,
172,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that a specific intervention or a group of interventions is prespecified on a CRF.,"For prespecified interventions, a hidden field on a CRF defaulted to ""Y"", or added during the SDTM dataset creation. If a study collects both prespecified and free-text interventions, the value of PRPRESP should be ""Y"" for all prespecified interventions and null for interventions reported as free text.",Procedure Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRPRESP,11,,,Char,['NY']
173,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether a prespecified procedure (PRTRT) happened when information about the occurrence of a specific intervention is solicited.,PROCCUR is used to report the occurrence of a prespecified procedure or a group of procedures. PROCCUR is not used for spontaneously free text-reported procedures. The site should be able to indicate that the response was not asked or answered.,Procedure Occurrence,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. If the response was not asked or answered, populate the SDTMIG variable PRSTAT with ""NOT DONE"".",PROCCUR,12,[PRDECOD/PRTRT] Performed,Was [PRDECOD/PRTRT] performed?; Has the subject had [PRDECOD/PRTRT]?,Char,['NY']
174,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An explanation for why a scheduled procedure did or did not occur.,"The reason the scheduled procedure was or was not performed may be chosen from a sponsor-defined codelist (e.g., SUBJECT REFUSED) or entered as free text. When --REASOC is used, --OCCUR must also be populated in the SDTM dataset with a value of ""Y"" or ""N"".",Procedure Reason for Occur Value,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRREASOC,13,Reason for Occur Value,What was the reason that the procedure did or not occur?,Char,
175,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An explanation for why the data are not available.,"The reason the data are not available may be chosen from a sponsor-defined list (e.g., broken equipment, subject refused) or entered as free text. When PRREASND is used, the SDTMIG variable PRSTAT should also be populated in the SDTM-based dataset. The value ""NOT DONE"" here indicates that the subject was not questioned/data was not collected. It does not mean that the subject did not have the procedure.",Procedure Reason Not Done,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRREASND,14,Reason not done,What was the reason not done?,Char,
176,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Indication the procedure occurred prior to [PRSTTPT] or prior to the date in DM.RFSTDTC.,"See Section 3.7, Mapping Relative Times from Collection to Submissions , and and the SDTMIG for more information about mapping relative times. .",Prior Procedure,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTM relative timing variable such as PRSTRF or PRSTRTPT. When populating PRSTRF, or PRSTRTPT, if the value of the CDASH field PRPRIOR is ""Y"" a value from the CDISC CT (STENRF) may be used. When PRPRIOR refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTM variable PRSTRF should be populated. When PRPRIOR is compared to another time point, the SDTM variables PRSTRTPT and PRSTTPT should be used. Note: PRSTRTPT must refer to the time-point anchor described in PRSTTPT.",PRPRIOR,15,Prior to [PRSTTPT]; Prior to study,Was the procedure performed prior to [PRSTTPT]?; Was the procedure performed prior to study start?,Char,['NY']
177,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The date or start date of when the procedure started or was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The preferred method is to collect a complete Start Date. Partial dates (e.g., providing year only) for procedures started a considerable amount of time prior to the start of study are acceptable.",Procedure Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable PRSTDTC in ISO 8601 format.",PRSTDAT,16,(Start) Date,What was the procedure (start) date ?,Char,
178,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Indication the procedure is ongoing when no end date is provided.,"Completed to indicate that the procedure has not stopped at the time point defined by the study. The purpose of collecting this field is to help with data cleaning and monitoring; this field provides further confirmation that the End Date was deliberately left blank. See Section 3.7, Mapping Relative Times from Collection to Submissions , and and SDTMIG for more information about mapping relative times.",Ongoing Procedure,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable such as PRENRF or PRENRTPT. When populating PRENRF, if the value of PRONGO is ""Y"", the value of ""DURING"", ""AFTER"" or ""DURING/AFTER"" may be used. When populating PRENRTPT, if the value of PRONGO is ""Y"", the value of ""ONGOING"" may be used. When PRONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTM variable PRENRF should be populated. When PRONGO is used in conjunction with another time point, the SDTM variables PRENRTPT and PRENTPT should be used. Note: PRENRTPT must refer to a time point anchor described in PRENTPT.",PRONGO,17,Ongoing (as of the [study-specific timepoint or period]),Was the procedure ongoing (as of the [study-specific timepoint or period])?,Char,['NY']
179,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,"The end date of the procedure, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The assumption is that sponsors should either have an end date or will indicate that the procedure was ongoing at the time of collection or at the end of the study. However, in cases where the end date can be determined from dates collected elsewhere in the CRF it is not necessary to include an end date in the CRF. For example, if the procedure is started and stopped within the same day, the end date will be the same as the start date.",Procedure End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTM variable PRENDTC in ISO 8601 format.",PRENDAT,18,(End) Date,What was the procedure (end) date?,Char,
180,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The condition, disease, symptom, or disorder that the procedure was used to address or investigate (e.g., why the therapy was taken or administered, why the procedure was performed).","This additional information is collected on the CRF when the sponsor wants to capture the reason(s) why a procedure was performed. This information can then be used as deemed appropriate for coding, analysis (e.g., in the classification of procedures), for reconciling the procedures performed on a subject with their provided medical history, and/or AEs/SAEs as part of the data clean-up and monitoring process.",Procedure Indication,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRINDC,19,Indication,For what indication was the [PRTRT] performed?,Char,
181,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Identifier for the adverse event that is the indication for this procedure.,The intent is to establish a link between the adverse event and the procedure performed for the adverse event. PRAENO can be used to identify a relationship between records in the PR dataset and records in the AE dataset. See the SDTMIG for information on RELREC.,Related Adverse Event ID,"This does not map directly to an SDTMIG variable. For the SDTM submission datasets, may be used to create RELREC to link this record with a record in the AE domain.",PRAENO,20,Related Adverse Event Identifier,What was the identifier for the adverse event(s) for which the procedure was performed?,Char,
182,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Identifier for the medical history event that is the indication for this procedure.,The intent is to establish a link between the medical history condition and the procedure undergone for the medical history condition. PRMHNO can be used to identify a relationship between records in the PR dataset and records in the MH dataset. See the SDTMIG for information on RELREC.,Related Medical History Event ID,"This does not map directly to an SDTMIG variable. For the SDTM submission datasets, may be used to create RELREC to link this record with a record in the MH domain.",PRMHNO,21,Related Medical History Event Identifier,What was the identifier for the medical history event(s) for which the procedure was performed?,Char,
183,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dose/amount administered during the procedure.,"Defining this data collection field as a dose text field allows for flexibility in capturing dose entries as numbers, text or ranges. The data collected in this dose text-format field should be separated or mapped to either SDTMIG PRDOSE if numeric or PRDOSTXT if text.",Procedure Dose Description,"This does not map directly to an SDTMIG variable. Numeric values map to PRDOSE in SDTM. Non-numeric values (e.g., 200-400) map to PRDOSTXT in SDTM.",PRDSTXT,22,[Dose/Amount],What was the [dose/amount] of [PRTRT] (per administration/for the procedure)?,Char,
184,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The unit for intended dose/amount for PRDOSE, PRDOSTOT, or PRDOSTXT.","When sponsors collect data for amount of PRTRT performed or administered, the unit should be collected as well (as applicable).",Procedure Dose Unit,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRDOSU,23,Unit,What was the unit?,Char,['UNIT']
185,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The number/amount of the procedure that was given/administered/taken during a specific interval.,This may be collected if it cannot be determined from other sources or if there are multiple options. Usually expressed as the number of procedures given per a specific interval.,Procedure Frequency per Interval,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRDOSFRQ,24,Frequency,What was the frequency of [PRTRT]?,Char,['FREQ']
186,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The route of administration of the procedure.,This additional information may be important to collect on the CRF when the sponsor would want to capture a procedure's route of administration for comparative analysis purposes.,Procedure Route of Administration,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRROUTE,25,Route,What was the route of administration of the procedure?,Char,['ROUTE']
187,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"A description of the anatomical location of an procedure (e.g., location of a biopsy).","Collected when the sponsor needs to identify the specific anatomical location (e.g., Liver for the Biopsy). LAT, DIR, PORTOT are used to further describe the anatomical location.",Location of Procedure,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRLOC,26,Anatomical Location,What was the anatomical location where the procedure was performed?,Char,['LOC']
188,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier for anatomical location, further detailing side of the body for the procedure administration.",Further details the laterality of the location where the procedure was administered/taken. This may be preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Procedure Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRLAT,27,Side,What was the side of the anatomical location of the administration?,Char,['LAT']
189,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Procedure Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRDIR,28,Directionality,What was the directionality of the anatomical location of the procedure?,Char,['DIR']
190,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Procedure Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRPORTOT,29,Portion or Totality,What was the portion or totality of the anatomical location that was treated?,Char,['PORTOT']
191,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that the subject has abstained from food/water for the specified amount of time.,This information is collected when the procedure may be affected by whether the subject was fasting. This may not be relevant for all procedures.,Procedure Fasting Status,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRFAST,30,Fasting,Was the subject fasting?,Char,['NY']
192,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The text description of the (intended) schedule or regimen for the procedure.,"The regimen information may further clarify the dose administration and dose frequency (e.g., TWO WEEKS ON, TWO WEEKS OFF). This may be prespecified or collected. The sponsor may wish to create a codelist to collect this data consistently.",Procedure Intended Dose Regimen,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRDOSRGM,31,Intended Procedure Regimen,What was the intended procedure regimen?,Char,
193,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the procedure dose/amount was adjusted.,"Typically, the intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that the associate field on the CRF (PRADJ) was deliberately left blank. However, the sponsor may collect whether the procedure dose/amount was adjusted, without collecting the reason for the change.",Procedure Adjusted,"When PRADJ is collected, does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED. When PRADJ is not collected, the sponsor may submit this variable as a SUPPQ.",PRDOSADJ,32,(Dose) Adjusted,Was the procedure dose adjusted?,Char,['NY']
194,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Description of or explanation for why a procedure dose/amount was adjusted.,"Captures the reason the PRTRT dose was changed or modified. The reason may be chosen from a sponsor-defined list (e.g., adverse event, insufficient response) or entered as free text.",Reason for Procedure Adjustment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,PRADJ,33,Reason Adjusted,What was the reason the procedure dose was adjusted?,Char,
195,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Indication of whether the subject completed the intended regimen.,"Depending on how the PTTRT dose details are collected via the CRF/eCRF, it may be possible to derive those data if the regimen data are collected.",Completed Procedure,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM= ""PRTRTCMP"" and SUPPPR.QLABEL=""Treatment Completed"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",PRTRTCMP,34,Completed [PR Intervention Topic],Did the subject complete the full course of the [PRTRT]?,Char,['NY']
196,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether the procedure was interrupted.,"Provides a definitive response regarding any procedure interruption. The intent/purpose of collecting this field is to help with data cleaning and monitoring when the duration of the interruption is collected. In some situations, if the actual duration of the interruption is not collected, or not derived, this information could be submitted in a SUPPPR dataset.",Procedure Interrupted,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,PRITRPYN,35,Procedure Interrupted,Was the procedure interrupted?,Char,['NY']
197,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An explanation for why the intervention was interrupted.,This CDASH field is use to collected the reason why an intervention was interrupted. The sponsor may define controlled terminology.,Reason Procedure Interrupted,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRITRPRS"" and SUPPPR.QLABEL =""Reason Intervention Interrupted"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",PRITRPRS,36,Reason Procedure Interrupted,Why was the procedure interrupted?,Char,
198,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The collected duration of the procedure interruption.,"This field is used to collect the duration of procedure interruption. In some situations, the duration of the interruption may not be collected but calculated from the procedure start and end times recorded elsewhere in the CRF.",Procedure Interruption Duration,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRITRPD"" and SUPPPR.QLABEL= ""Interruption Duration"". Concatenate the collected procedure interruption duration and the duration unit components and create PRITRPD using ISO 8601 Period format. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",PRCINTD,37,(Interruption) Duration,What was the duration of the procedure interruption?,Char,
199,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The unit for the collected duration of the procedure interruption.,The unit should be collected as a qualifier to the number for duration.,Procedure Interruption Duration Units,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRITRPD"" and SUPPPR.QLABEL= ""Interruption Duration"". Concatenate the collected procedure interruption duration and the duration unit components and create PRITRPD using ISO 8601 Period format. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",PRCINTDU,38,(Interruption Duration) Unit,What was the interruption duration unit?,Char,['UNIT']
200,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived text description of the lowest level term.,"This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for coding. Another dictionary can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure Lowest Level Term,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRLLT"" and SUPPPR.QLABEL=""Lower Level Term"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRLLT,39,,,Char,
201,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived code for the lowest level term.,"This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure Lowest Level Term Code,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRLLTCD"" and SUPPPR.QLABEL=""Lower Level Term Code"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRLLTCD,40,,,Num,
202,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived code for the preferred term.,"This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure Preferred Term Code,"This information could be submitted in a SUPPPR.QVAL dataset where SUPPPR.QNAM=""PRPTCD"" and SUPPPR.QLABEL= ""Preferred Term Code Lower Level Term Code"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVsin SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRPTCD,41,,,Num,
203,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived text description of the high level term for the primary system organ class (SOC).,"This is not a data collection field that would appear on the CRF. Sponsors populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure High Level Term,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRHLT"" and SUPPPR.QLABEL=""High Level Term"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRHLT,42,,,Char,
204,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived code for the high level term for the primary system organ class (SOC).,"This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure High Level Term Code,"This information could be submitted in a SUPPPR.QVAL dataset where SUPPPR.QNAM=""PRHLTCD"" and SUPPPR.QLABEL=""High Level Term Code"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",PRHLTCD,43,,,Num,
205,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived text description of the high level group term for the primary system organ class (SOC).,"This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure High Level Group Term,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM=""PRHLTGT"" and SUPPPR.QLABEL=""High Level Group Term"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRHLGT,44,,,Char,
206,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived code for the high level group term for the primary system organ class (SOC).,"This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",Procedure High Level Group Term Code,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM= ""PRHLTGTCD"" and SUPPPR.QLABEL=""High Level Group Term Code"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRHLGTCD,45,,,Num,
207,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived text description of the primary system organ class (SOC).,"This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",PR Primary System Organ Class,"This information could be submitted in a SUPPPR.QVAL dataset where SUPPPR.QNAM=""PRSOC"" and SUPPPR.QLABEL=""Primary System Organ Class"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",PRSOC,46,,,Char,
208,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",PR,Procedures,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The dictionary-derived code for the primary system organ class (SOC).,"This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Rationale for adding coding variables to CDASH is to provide a more complete data management package. This variable could be used in the PR domain for MedDRA coding. Other dictionaries can be used and the appropriate coding elements added, if appropriate, in the SUPPPR.QVAL dataset.",PR Primary System Organ Class Code,"This information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM= ""PRSOCCD"" and SUPPPR.QLABEL=""Primary System Organ Class Code"". Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains. Sponsors should include an Origin column in the SUPPQ dataset to indicate that the data was ""ASSIGNED"".",PRSOCCD,47,,,Num,
209,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
210,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
211,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
212,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",HR,"The type of substance (e.g., TOBACCO, ALCOHOL, CAFFEINE or CIGARETTES, CIGARS, COFFEE).","Sponsors may require different types of substance-use data (e.g., illicit drug use, cigarettes); the value for category may be preprinted on the CRF as a label for the prompt for Substance Use. If a more detailed type of substance appears on the CRF (e.g., CIGARETTES, CIGARS rather than TOBACCO), SUCAT should be TOBACCO and SUTRT should be CIGARETTES.",Reported Name of Substance,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUTRT,4,[Type of Substance],What [is/was] the [name/type] of (the) substance used?,Char,
213,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology (e.g., TOBACCO, ALCOHOL, CAFFEINE). Sponsors may require different types of substance-use data (e.g., illicit drug use, cigarettes); the value for category may be preprinted on the CRF. If a more detailed type of substance appears on the CRF (e.g., CIGARETTES, CIGARS, rather than TOBACCO), SUCAT is TOBACCO and SUTRT is CIGARETTES. If the sponsor does not specify a type of tobacco on the CRF, SUTRT is TOBACCO. If SUCAT is not collected (e.g., it is evident from the protocol design), it could be populated during the SDTM-based dataset creation process.",Category for Substance Use,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUCAT,5,[Substance (Used) Category]; NULL,What is/was the category of the substance (used)?,Char,
214,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,A sub-division of the SUCAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. The value for subcategory may be preprinted on the CRF or hidden. SUSCAT can only be used if there is a SUCAT and it must be a subcategorization of SUCAT.,Subcategory for Substance Use,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUSCAT,6,[Substance (Used) Subcategory]; NULL,What was the subcategory of the substance (used)?,Char,
215,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication that a specific intervention or a group of interventions is prespecified on a CRF.,"For prespecified interventions, a hidden field on a CRF defaulted to ""Y"", or added during the SDTM dataset creation. If a study collects both prespecified and free-text interventions, the value of SUPRESP should be ""Y"" for all prespecified interventions and null for interventions reported as free text.",SU Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUPRESP,7,,,Char,['NY']
216,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An indication of whether any data was collected for the intervention topic.,General prompt question to aid in monitoring and data cleaning. This provides verification that all other fields on the CRF were deliberately left blank. This is a field that can be used on any Interventions CRF to indicate whether there is data to record.,Any Substance Used,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,SUYN,8,Any [Substance Name (Used)],Were any [sponsor-phrase/substance name/recreational drugs] used?,Char,['NY']
217,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",R/C,Indication the prespecified substance was used.,"The 3 options (NEVER, CURRENT, FORMER) are sponsor-defined in relation to the protocol. If the sponsor has specific definitions, these definitions are detailed in the instructions to the site. As this type of response does not correspond exactly to an SDTM variable, CDASH recommends using the CDASHIG variable SUNCF. Sponsors must decide how to populate the appropriate relative timing variables when creating the SDTM-based datasets. For example, If SUNCF =""Never"", the value of SUOCCUR will be ""N"" and all relative timing variables will be null. If the sponsor chooses to populate the relative start references (SUSTRTPT, SUSTRF) the value will be ""BEFORE"" when SUNCF= ""CURRENT"" and ""FORMER"". If the sponsor also chooses to use relative end references (SUENRF, SUENRTPT) , the SUENRTPT value will be ""ONGOING"" when SUNCF=""CURRENT"" while the value of SUENRF will be ""DURING/AFTER"". \n Note: When using SUSTRTPT and/or SUENRTPT, these must refer to a time-point anchor (e.g., SCREENING, in SUSTTPT/SUENTPT).",Never Current Former Usage,This does not map directly to an SDTMIG variable. May be used to populate SUOCCUR and relative timing variables.,SUNCF,9,([Substance]) Usage,Has the subject ever [used/consumed] [SUTRT/SUCAT]?,Char,"['NCF', 'SUNCF']"
218,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Substance Use Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,SUSPID,10,[Sponsor defined],[Sponsor-defined question],Char,
219,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,An explanation for why data are not available.,"The reason data are not available may be chosen from a sponsor-defined list (e.g., subject refused) or entered as free text. When SUREASND is used, the SDTMIG variable SUSTAT should also be populated in the SDTM-based dataset.",Reason Substance Use Not Collected,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUREASND,11,Reason Not Collected,What was the reason the data was not collected?,Char,
220,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The amount of substance used (e.g., 1-2 packs, 8 oz).","Where possible, the options for dose/amount are preprinted on the CRF. In the example given in the definition, ""packs"" and ""ounces"" are included as a point of reference. They would, of course, be submitted as SUDOSU. Care should be taken to map each record to the appropriate SDTM variable SUDOSTXT (text results that cannot be represented in a numeric field) and SUDOSE (numeric results).",Substance Dose Description,"This does not map directly to an SDTMIG variable. Numeric values map to SUDOSE in SDTM. Non-numeric values (e.g., 200-400) map to SUDOSTXT in SDTM.",SUDSTXT,12,Amount,What is/was the amount of [SUTRT] used/consumed?,Char,
221,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,The number/amount of the of substance consumed per a specific interval.,"When possible, the options for dose/amount frequency are preprinted on the CRF. (e.g., PER DAY, PER WEEK, OCCASIONAL).",Substance Use Frequency per Interval,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUDOSFRQ,13,Frequency,What [is/was] the frequency of [SUTRT] [use/consumption]?,Char,['FREQ']
222,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The date substance use started, represented in an unambiguous date format (e.g., DD-MON-YYYY.","The sponsor may choose to capture a complete date or any variation thereof (e.g., month and year, year).",Substance Use Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable SUSTDTC in ISO 8601 format.",SUSTDAT,14,Start Date,What was the start date of [SUTRT/SUCAT] use/consumption?,Char,
223,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The date substance use ended, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The sponsor may choose to capture a complete date or any variation thereof (e.g., month and year, year).",Substance Use End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable SUENDTC in ISO 8601 format.",SUENDAT,15,End Date,What was the end date of [SUTRT/SUCAT] use/consumption?,Char,
224,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Collected duration of the substance use.,This is only collected on the CRF if this level of detail is needed and if SUSTDAT and SUENDAT are not collected on the CRF.,Substance Use Collected Duration,"This does not map directly to an SDTMIG variable. For the SDTM-based dataset, concatenating the CDASH collected duration and collected duration unit and populate the SDTMIG variable SUDUR in ISO 8601 format. Example: P1DT2H (for 1 day, 2 hours).",SUCDUR,16,Duration,What was the duration of [SUTRT/SUCAT] use/consumption?,Char,
225,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,Unit of the collected duration of the substance use. Used only if duration was collected on the CRF.,Sponsor-defined options should be preprinted on the CRF to avoid making this a free-text field. This will allow the response to be translated into ISO 8601 format.,Substance Use Collected Duration Unit,"This does not map directly to an SDTMIG variable. For the SDTM-based dataset, concatenating the CDASH collected duration and collected duration unit and populate the SDTMIG variable SUDUR in ISO 8601 format. Example: P1DT2H (for 1 day, 2 hours).",SUCDURU,17,(Duration) Unit,What was the unit of duration of [SUTRT/SUCAT] use/consumption?,Char,['UNIT']
226,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"If the value for SUTERM is modified for coding purposes, then the modified text is placed here.","This is not a data collection field that would appear on the CRF. If the sponsor chooses to code the substance use, the sponsor will populate this through the coding process.",Modified Substance Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUMODIFY,18,,,Char,
227,Interventions,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",SU,Substance Use,"This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)",O,"The dictionary or sponsor-defined standardized text description of SUTRT, or the modified topic variable (SUMODIFY), if applicable.","This is typically not a data collection field that will appear on the CRF. If the sponsor chooses to code the substance use, the sponsor will populate this through the coding process. Equivalent to the generic drug name in published (e.g., WHODrug, SNOMED, ICD9) or sponsor-defined dictionaries. If SUPRESP is used, and the information about a specific standardized substance name is being solicited, the data from SUTRT may map directly to the SDTMIG SUDECOD variable.",Standardized Substance Name,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata to indicate that the data was ""ASSIGNED"".",SUDECOD,19,,,Char,
228,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
229,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted for the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
230,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
231,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether any AEs were experienced during the study.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Adverse Event,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,AEYN,4,Any Adverse Events,Were any adverse events experienced?,Char,['NY']
232,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column heading.",Category for Adverse Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AECAT,5,[Adverse Event Category]; NULL,What is the category of the adverse event?,Char,
233,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the AECAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. AESCAT can only be used if there is an AECAT and it must be a subcategorization of AECAT.,Subcategory for Adverse Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESCAT,6,[Adverse Event Subcategory]; NULL,What is the subcategory of the adverse event?,Char,
234,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, This is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile concomitant medications, procedures and/or medical history records with AEs. If CMAENO or PRAENO is used, this is the identifier to which CMAENO or PRAENO refers. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",AE Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,AESPID,7,[Sponsor defined],[Sponsor-defined question],Char,
235,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,The reported or prespecified name of the adverse event.,"Can be represented either as an open-entry field to capture verbatim terms reported by subjects or preprinted, in the situation where solicited AEs of interest are captured. In most cases, the verbatim term (i.e., investigator-reported term) will be coded to a standard medical dictionary (e.g., MedDRA, WHO ART) after the data have been collected on the CRF.",Reported Term for the Adverse Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AETERM,8,Adverse Event,What is the adverse event term?,Char,
236,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether a prespecified adverse event or a group of adverse events occurred when information about the occurrence of a specific event is solicited.,"The CDASH variable AEOCCUR is used to indicate the occurrence of prespecified adverse events (e.g., ""Did the subject have high blood pressure?""). AEOCCUR should not be used for spontaneously reported adverse events. The site should be able to indicate that the response was not asked or answered.",Adverse Event Occurrence,"This does not map directly to an SDTMIG variable. Because the SDTM AE domain is intended to hold only adverse events that actually happen, all values collected in AEOCCUR for prespecified AEs should be submitted in a Findings About Adverse Events data set (FAAE) where FAORRES=the value of AEOCCUR where FATESTCD=""OCCUR"". In addition, where AEOCCUR=""Y"", there should be a corresponding record in the AE domain.",AEOCCUR,9,[Specific Adverse Event ],Did the subject have [prespecified adverse event/group of adverse events]?,Char,['NY']
237,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication that a specific event or group of events are prespecified on a CRF.,"A hidden field on a CRF defaulted to ""Y"", or added during SDTM-based dataset creation, when the AE is prespecified. Null for spontaneously reported events. If a study collects both prespecified and free-text adverse events, the value of AEPRESP should be ""Y"" for all prespecified events and null for events reported as free-text. AEPRESP is a permissible field in SDTM and may be omitted from the SDTM-based dataset if all events were collected as free text.",prespecified Adverse Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEPRESP,10,,,Char,['NY']
238,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,"The start date of the adverse event, represented in an unambiguous date format (e.g., DD-MON-YYYY).",,Adverse Event Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable AESTDTC in ISO 8601 format.",AESTDAT,11,Start Date,What is the adverse event start date?,Char,
239,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The start time of the adverse event, represented in an unambiguous time format (e.g., hh:mm:ss).",Collecting the time an AE started is only appropriate if it can be realistically determined and if there is a scientific reason for needing to know this level of detail. An example is where the subject is under the direct care of the site at the time the event started and the study design is such that it is important to know the AE start time with respect to dosing.,Start Time of Adverse Event,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable AESTDTC in ISO 8601 format.",AESTTIM,12,Start Time,What is the adverse event start time?,Char,
240,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A description of the anatomical location relevant for the adverse event.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, PORTOT are used to further describe the anatomical location.",AE Location of Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AELOC,13,Anatomical Location,What is the anatomical location of the adverse event?,Char,['LOC']
241,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body relevant for the event.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Adverse Event Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AELAT,14,Side,What is the side of the anatomical location of the adverse event?,Char,['LAT']
242,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Adverse Event Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEDIR,15,Directionality,What is the directionality of the anatomical location of the adverse event?,Char,['DIR']
243,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,AE Location Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEPORTOT,16,Portion or Totality,What is the portion or totality of the anatomical location of the adverse event?,Char,['PORTOT']
244,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication that an adverse event is ongoing when no end date is provided.,"Completed to indicate that the AE has not resolved at the time of data collection, when no end date is collected. In some cases the ongoing status may be determined from AE Outcome. The purpose of collecting this field is to help with data cleaning and monitoring; this field provides further confirmation that End Date was deliberately left blank. Often used as a tick/checkbox.",Ongoing Adverse Event,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTMIG relative timing variable such as AEENRF or AEENRTPT. When populating AEENRF, if the value of AEONGO is ""Y"", the value of ""DURING"", ""AFTER"" or ""DURING/AFTER"" may be used. When populating AEENRTPT, if the value of AEONGO is ""Y"", the value of ""ONGOING"" may be used. When AEONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTMIG variable AEENRF should be populated. When AEONGO is compared to another time point, the SDTMIG variables AEENRTPT and AEENTPT should be used. Note: AEENRTPT must refer to a time-point anchor described in AEENTPT.",AEONGO,17,Ongoing (as of [the study-specific time point or period]),Is the adverse event ongoing (as of [the study-specific time point or period])?,Char,['NY']
245,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The date when the adverse event resolved/ended, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The definition of resolved is sponsor-specific. The preferred method is to collect a complete end date (if applicable). Partial dates (e.g., providing year only, month and year only) may be acceptable.",Adverse Event End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable AEENDTC in ISO 8601 format.",AEENDAT,18,End Date,What was the adverse event end date?,Char,
246,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The time when the adverse event ended/resolved, represented in an unambiguous time format (e.g., hh:mm:ss).",Collecting the time an AE resolved is only appropriate if it can be realistically determined and if there is a scientific reason for needing to know this level of detail. An example is where the subject is under the direct care of the site at the time the event resolved and the study design is such that it is important to know the AE end time with respect to dosing.,End Time of Adverse Event,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable AEENDTC in ISO 8601 format.",AEENTIM,19,End Time,What was the adverse event end time?,Char,
247,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The severity or intensity of the event.,Either AESEV or AETOXGR must appear on the CRF. Some studies may mandate the collection of both. Refer to ICH E3 Section 12.2.4.,AE Severity/Intensity,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESEV,20,Severity,What is the severity of the adverse event?,Char,['AESEV']
248,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The grade of the severity of the event using a standard ""toxicity"" scale (e.g., NCI CTCAE).","Either AESEV or AETOXGR must appear on the CRF. Some studies may mandate the collection of both. Refer to ICH E3 Section 12.2.4. CTCAE grade is commonly used in oncology studies, although it can also be used elsewhere. Other published toxicity-like scales can also be used.",AE Standard Toxicity Grade,Maps directly to the SDTMIG variable listed in the SDTMIG Target columnget. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external codelist attributes.,AETOXGR,21,[NCI CTCAE/ Name of the scale] (Toxicity) Grade,What is the [NCI CTCAE/Name of scale (toxicity) grade] of the adverse event?,Char,
249,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"An indication of whether the adverse event is determined to be ""serious,"" based on what is defined in the regulations/protocol.","This field is related to the individual SAE-type fields, which may or may not be collected on the CRF. Either AESER or all the SAE-type fields must be present on the CRF. Sponsors should consult with regulatory agencies regarding the collection of this data.",AE Serious Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESER,22,Serious,Was the adverse event serious?,Char,['NY']
250,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,An indication the serious adverse event resulted in death.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Results in Death,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESDTH,23,Death,Did the adverse event result in death?,Char,['NY']
251,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Date of death for any subject who died.,"In the CDASH model, Death Date is a timing variable; it is not included as a timing variable in the SDTMIG. It may be collected on any CRF deemed appropriate by the sponsor, but should only be collected once. The SDTMIG variable DTHDTC is mapped to the DM domain during the SDTM submission dataset creation process. The SDTMIG variable DM.DTHFLG is not a CDASH variable, but it is typically populated during the SDTM submission dataset creation process. Death Date may be mapped to other SDTM domains, as deemed appropriate by the sponsor (e.g., DS).",Death Date,"This field does not map directly to an SDTMIG variable. For the SDTM dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable DTHDTC in ISO 8601 format.",DTHDAT,24,Death Date,What [is/was] the subject's date of death?,Char,
252,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,An indication the serious adverse event was life threatening.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Is Life Threatening,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESLIFE,25,Life Threatening,Was the adverse event life threatening?,Char,['NY']
253,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,An indication the serious adverse event resulted in an initial or prolonged hospitalization.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Requires or Prolongs Hospitalization,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESHOSP,26,Hospitalization (initial or prolonged),Did the adverse event result in initial or prolonged hospitalization for the subject?,Char,['NY']
254,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,An indication the serious adverse event was associated with a persistent or significant disability or incapacity.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Persist or Signif Disability/Incapacity,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESDISAB,27,Disability or Permanent Damage,Did the adverse event result in disability or permanent damage?,Char,['NY']
255,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,An indication the serious adverse event was associated with a congenital anomaly or birth defect.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Congenital Anomaly or Birth Defect,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESCONG,28,Congenital Anomaly or Birth Defect,Was the adverse event associated with a congenital anomaly or birth defect?,Char,['NY']
256,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication an adverse event required medical or surgical intervention to preclude permanent impairment of a body function, or prevent permanent damage to a body structure, due to the use of a medical product.","If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Needs Intervention to Prevent Impairment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESINTV,29,Needs Intervention to Prevent Impairment,Did the adverse event require intervention to prevent permanent impairment or damage resulting from the use of a medical product?,Char,['NY']
257,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,An indication additional categories for seriousness apply.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data.",Other Medically Important Serious Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESMIE,30,Other Serious (Important Medical Events),Was the adverse event a medically important event not covered by other serious criteria?,Char,['NY']
258,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication the serious event was associated with the development of cancer.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data. ""Involves cancer"" (AESCAN) and ""Occurred with overdose"" (AESOD) are not part of the ICH definition of an SAE, but these categories are available for use in studies conducted under guidelines that existed prior to the FDA's adoption of the ICH definition.",Involves Cancer,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESCAN,31,Cancer,Was the adverse event associated with the development of cancer?,Char,['NY']
259,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication the serious event occurred with an overdose.,"If details regarding SAEs are collected in the clinical database, then it is recommended that a separate Yes/No variable be defined for each SAE type. Sponsors may only collect the AESER field when collecting individual SAE types in a separate pharmacovigilance database. Sponsors should consult with regulatory agencies regarding the collection of this data. ""Involves cancer"" (AESCAN) and ""Occurred with overdose"" (AESOD) are not part of the ICH definition of an SAE, but these categories are available for use in studies conducted under guidelines that existed prior to the FDA's adoption of the ICH definition.",Occurred with Overdose,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AESOD,32,Overdose,Did the adverse event occur with an overdose?,Char,['NY']
260,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,"An indication the study treatment had a causal effect on the adverse event, as determined by the clinician/investigator.","Sponsor-defined controlled terminology is used to indicate the relationship between the AE and the study treatment (e.g., ICH E2B examples include ""Not Related"", ""Unlikely Related"", ""Possibly Related"", ""Related""). Another possibility is the use of ""Y"" and ""N"". CDISC Controlled Terminology may be defined in the future. It is recommended that sponsors check with the appropriate regulatory authority for population of this variable to ensure it meets expectations for submission. There is no industry-wide controlled terminology for relationship to treatment. It is recommended that sponsors establish terminology and apply it consistently.",AE Causality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEREL,33,Relationship to Study Treatment,Was this adverse event related to study treatment?,Char,
261,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,A description of the action taken with study treatment as a result of the event.,"CDISC Controlled Terminology is used to indicate the action taken with the study treatment in response to the AE. How to handle multiple actions taken is up to the sponsor. If this information is collected elsewhere (e.g., on the Exposure CRF), then it is not required to be collected on the AE CRF. This variable is not to be used for actions taken with devices. See the SDTMIG-MD for information on reporting multiple actions, or actions with multiple devices.",Action Taken with Study Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEACN,34,Action Taken with Study Treatment,What action was taken with study treatment?,Char,['ACN']
262,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A description of the action taken, with respect to a device used in a study (which may or may not be the device under study), as a result of the event.","Sponsor-defined controlled terminology for actions that are related to the device (e.g., device removed, primary care physician notified). See the SDTMIG-MD for information on reporting multiple actions, or actions with multiple devices.",Actions Taken with Device,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEACNDEV,35,Action Taken with Device,What action was taken with a device used in the study?,Char,
263,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication whether any other actions were taken in response to the adverse event that were unrelated to study treatment dose changes or other non-study treatments given because of this adverse event.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that the AEACNOTH field on the CRF was deliberately left blank.,Any Other Actions Taken,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,AEACNOYN,36,Any Other Action(s) Taken,Were any other actions taken in response to this adverse event?,Char,['NY']
264,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A description of other action taken as a result of the event that is unrelated to dose adjustments of the study treatment.,"This is usually collected as a free-text field. If possible/desired, the sponsor can create controlled terminology (e.g., treatment unblinded, primary care physician notified).",Other Action Taken,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEACNOTH,37,Other Action Taken,What other action was taken?,Char,
265,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,A description of the outcome of an event.,"CDISC Controlled Terminology is used to indicate the outcome of the event as it relates to the subject's status. The Outcome controlled terminology includes ICH E2B values. The use of this field is the recommended way to describe whether and how the AE resolved. Because the outcome of an AE may be death, if this field is NOT used, be sure to provide another form, such as Disposition, with clear instructions to record deaths there.",Outcome of Adverse Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEOUT,38,Outcome,What is the outcome of this adverse event?,Char,['OUT']
266,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether the event caused the subject to discontinue from the study.,"Because the Action Taken field was defined to only collect changes made to the study treatment due to the AE, an additional field was created to identify the AE(s) that caused the subject to discontinue from the study. Some sponsors opt to capture this information only on the Subject Disposition CRF, whereas others choose to collect this data on both the Subject Disposition and AE CRFs, so the specific AE term(s) and related data can be identified. If the CRF is designed to link the DS and AE records, then RELREC can be used to identify that relationship.",AE Caused Study Discontinuation,"This does not map directly an SDTMIG variable. May be used to create a RELREC to link the AE to the Disposition record (see the SDTMIG). The sponsor may also submit this data in a SUPPAE dataset where SUPPAE.QNAM = ""AEDIS"" and SUPPAE.QLABEL = ""Caused Study Discontinuation"", if appropriate. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains..",AEDIS,39,Caused Study Discontinuation,Did the adverse event cause the subject to be discontinued from the study?,Char,['NY']
267,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication whether, in the investigator's opinion, the event may have been due to a treatment other than study treatment.",The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that the CDASH AERELNST field on the CRF was deliberately left blank.,AE Related to Non-Study Treatment,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,AERLNSYN,40,Related to Non-Study Treatment,Was this adverse event due to treatment other than study treatment?,Char,['NY']
268,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Description of the investigator's opinion as to whether the adverse event may have been due to a treatment other than study treatment.,"May be reported as free text (e.g., ""MORE LIKELY RELATED TO ASPIRIN USE""). If possible/desired, sponsors can create controlled terminology.",AE Relationship to Non-Study Treatment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AERELNST,41,Relationship to Non-Study Treatment,What is the relationship to non-study treatment?,Char,
269,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An adverse event of special interest (serious or non-serious) is one of scientific and medical concern specific to the sponsor's product or program, for which ongoing monitoring and rapid communication by the investigator to the sponsor can be appropriate. Such an event might warrant further investigation in order to characterize and understand it. Depending on the nature of the event, rapid communication by the trial sponsor to other parties (e.g., regulators) might also be warranted.","This CDASH field may be used just to trigger other CRF pages, or populate a value in AECAT or AESCAT. If submitted, this information could be submitted in a SUPPAE dataset where SUPPAE.QNAM = ""AESI"" and SUPPAE.QLABEL = ""Adverse Event of Special Interest. Refer to the current SDTM and SDTMIG for instructions on placement of NSVs in SDTM domains.",Adverse Event of Special Interest,Does not map to an SDTM variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,AESI,42,Adverse Event of Special Interest,Is this event of special interest?,Char,['NY']
270,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Used to indicate the pattern of the event over time.,"Used to report the pattern of the AE (e.g., ""INTERMITTENT"", ""CONTINUOUS"", ""SINGLE EVENT""). For crossover trials, it is NOT recommended to capture this field for intermittent AEs. Instead, the AE should have corresponding start and stop dates to capture when the AE started and stopped.",Pattern of Adverse Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEPATT,43,Pattern,What is the adverse event pattern?,Char,
271,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication whether a concomitant or additional treatment given because of the occurrence of the event.,"If medication data are reported, the CMAENO variable (on the CM CRF) may be used to collect the associated AE Identifier in order to populate RELREC. If procedures are reported, the PRAENO variable (on the PR CRF) may be used to collect the associated AE Identifier in order to populate RELREC.",Concomitant or Additional Trtmnt Given,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AECONTRT,44,Concomitant or Additional Treatment Given Due to This AE,Was a concomitant or additional treatment given due to this adverse event?,Char,['NY']
272,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"If the value for AETERM is modified to facilitate coding, then AEMODIFY will contain the modified text.",This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process.,AE Modified Reported Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,AEMODIFY,45,,,Char,
273,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The dictionary or standardized text description of AETERM or the modified topic variable (AEMODIFY), if applicable.",This is typically not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process. Equivalent to the Preferred Term (PT) in MedDRA.,AE Dictionary-Derived Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes.,AEDECOD,46,,,Char,
274,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived text description of the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE Lowest Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AELLT,47,,,Char,
275,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived code for the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE Lowest Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AELLTCD,48,,,Num,
276,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived code for the preferred term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE Preferred Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AEPTCD,49,,,Num,
277,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived text description of the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE High Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AEHLT,50,,,Char,
278,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived code for the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE High Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AEHLTCD,51,,,Num,
279,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived text description of the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE High Level Group Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AEHLGT,52,,,Char,
280,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived code for the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,AE High Level Group Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AEHLGTCD,53,,,Num,
281,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived text description of the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as the AEBODSYS if the primary SOC was used for analysis.,AE Primary System Organ Class,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AESOC,54,,,Char,
282,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",AE,Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The dictionary-derived code for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as AEBDSYCD if the primary SOC was used for analysis.,AE Primary System Organ Class Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",AESOCCD,55,,,Num,
283,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
284,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
285,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
286,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Clinical Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CECAT,4,[Clinical Event Category]; NULL,What is the category of the clinical event?,Char,
287,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the CECAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. CESCAT can only be used if there is an CECAT and it must be a subcategorization of CECAT.,Subcategory for Clinical Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CESCAT,5,[Clinical Event Subcategory]; NULL,What is the subcategory of the clinical event?,Char,
288,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether any clinical events were experienced during the study.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Clinical Event,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,CEYN,6,Any Clinical Events,Were any clinical events experienced?,Char,['NY']
289,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile concomitant medications, procedures and/or medical history records with CEs. If CMCENO or PRCENO is used, this is the identifier to which CMCENO or PRCENO refers. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",CE Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,CESPID,7,[Sponsor defined],[Sponsor defined question],Char,
290,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,The reported or prespecified name of the clinical event.,"Can be represented either as a free-text field to capture verbatim terms reported by subjects; or preprinted, in situation where solicited CEs of interest are captured. May be used as Specify Other field to collect more details on a prespecified CEDECOD value, or when CEDECOD=Other. In most cases, the verbatim term (i.e., investigator-reported term) will be coded to a standard medical dictionary (e.g., MedDRA, WHO ART) after the data have been collected on the CRF",Reported Term for the Clinical Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CETERM,8,[Clinical Event]; Specify (Other/Details),What is the clinical event term?,Char,
291,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether a prespecified clinical event or a group of clinical events occurred when information about the occurrence of a specific event is solicited.,The CDASH variable CEOCCUR is used to report the occurrence of prespecified clinical event not considered to be an adverse event by the sponsor. CEOCCUR should not be used for spontaneously reported events. The site should be able to indicate that the question was not asked or answered.,Clinical Event Occurrence,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEOCCUR,9,[Specified Clinical Event],Did the subject have [prespecified clinical event/group of clinical events ]?,Char,['NY']
292,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication that a specific event, or group of events, are prespecified on a CRF.","A hidden field on a CRF defaulted to ""Y"", or added during the SDTM-based dataset creation when the clinical event is prespecified. Null for spontaneously reported events. If a study collects both prespecified CEs and free-text events, the value of CEPRESP should be ""Y"" for all prespecified events and null for events reported as free text. CEPRESP is a permissible field in SDTM and may be omitted from the SDTM-based dataset if all events were collected as free text.",Clinical Event Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEPRESP,10,,,Char,['NY']
293,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The start date of the clinical event, represented in an unambiguous date format (e.g., DD-MON-YYYY).",,Clinical Event Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable CESTDTC in ISO 8601 format.",CESTDAT,11,Start Date,What was the [clinical event] start date?,Char,
294,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start time of the clinical event, represented in an unambiguous date format (e.g., hh:mm:ss).",Collecting the time a CE started is only appropriate if it can be realistically determined and if there is a scientific reason for needing to know this level of detail. An example is where the subject is under the direct care of the site at the time the event started and the study design is such that it is important to know the CE start time with respect to dosing.,Clinical Event Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable CESTDTC in ISO 8601 format.",CESTTIM,12,Start Time,What was the [clinical event] start time?,Char,
295,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A description of the anatomical location relevant for the clinical event.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, PORTOT are used to further describe the anatomical location.",Clinical Event Location,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CELOC,13,Anatomical Location,What was the anatomical location of the [clinical event]?,Char,['LOC']
296,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body relevant for the event.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Clinical Event Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CELAT,14,Side,What was the side of the anatomical location of the [clinical event]?,Char,['LAT']
297,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Clinical Event Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEDIR,15,Directionality,What was the directionality of the anatomical location of the [clinical event]?,Char,['DIR']
298,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,CE Location Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEPORTOT,16,Portion or Totality,What was the portion or totality of the anatomical location of the clinical event?,Char,['PORTOT']
299,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication the clinical event is ongoing when no end date is provided.,"Completed to indicate that the CE has not resolved at the time of data collection, when no end date is collected. In some cases the ongoing status may be determined from CE Outcome. The purpose of collecting this field is to help with data cleaning and monitoring; this field provides further confirmation that the end date was deliberately left blank. Often used as a tick/checkbox.",Ongoing Clinical Event,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTMIG relative timing variable (e.g., CEENRF, CEENRTPT). When populating CEENRF, if the value of CEONGO is ""Y"", the values of ""DURING"", ""AFTER"", or ""DURING/AFTER"" may be used. When populating CEENRTPT, if the value of CEONGO is ""Y"", the value of ""ONGOING"" may be used. When CEONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC), the SDTMIG variable CEENRF should be populated. When CEONGO is compared to another time point, the SDTMIG variables CEENRTPT and CEENTPT should be used. Note: CEENRTPT must refer to a time-point anchor described in CEENTPT.",CEONGO,17,Ongoing (as of the [study-specific timepoint or period]),Was the [clinical event] ongoing (as of [the study-specific timepoint or period]?,Char,['NY']
300,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The date when the clinical event resolved/ ended, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The definition of resolved is sponsor-specific. The preferred method is to collect a complete end date. Partial dates (e.g., providing year only, month and year only) may be acceptable.",Clinical Event End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CEENDTC in ISO 8601 format.",CEENDAT,18,End Date,What was the [clinical event] end date?,Char,
301,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The time when the clinical event ended/resolved, represented in an unambiguous time format (e.g., hh:mm:ss).",Collecting the time an CE resolved is only appropriate if it can be realistically determined and if there is a scientific reason for needing to know this level of detail. An example is where the subject is under the direct care of the site at the time the event resolved and the study design is such that it is important to know the CE end time with respect to dosing.,Clinical Event End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CEENDTC in ISO 8601 format.",CEENTIM,19,End Time,What was the [clinical event] end time?,Char,
302,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The severity or intensity of the event.,Some studies may collect severity and/or toxicity grade.,CE Severity/Intensity,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external codelist attributes.,CESEV,20,Severity,What was the severity of the [clinical event]?,Char,
303,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A description of toxicity quantified by CETOXGR (e.g., NCI CTCAE Short Name).","This would typically be the text description quantified by CETOXGR (e.g., HYPERCALCEMIA, HYPOCALCEMIA).",Clinical Event Toxicity Description,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external code list attributes.,CETOX,21,[NCI CTCAE] Toxicity,What was the description of the toxicity?,Char,
304,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The toxicity grade using a standard toxicity scale (e.g., NCI CTCAE).",Some studies may collect severity and/or toxicity grade. CDISC Controlled Terminology (TOXGRV3; TOXGRV4) may be used.,Clinical Event Toxicity Grade,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external codelist attributes.,CETOXGR,22,[NCI CTCAE Toxicity] Grade,What was the toxicity grade?,Char,
305,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"If the value for CETERM is modified to facilitate coding, then CEMODIFY will contain the modified text.",This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process.,Clinical Event Modified Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEMODIFY,23,,,Char,
306,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The dictionary- or sponsor-defined standardized text description of CETERM or the modified topic variable (CEMODIFY), if applicable.",This is typically not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process. Equivalent to the Preferred Term (PT in MedDRA).,CE Dictionary-Derived Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEDECOD,24,,,Char,
307,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event Lowest Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CELLT,25,,,Char,
308,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event Lowest Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CELLTCD,26,,,Num,
309,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the preferred term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event Preferred Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEPTCD,27,,,Num,
310,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event High Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLT,28,,,Char,
311,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event High Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLTCD,29,,,Num,
312,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event High Level Group Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLGT,30,,,Char,
313,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,CE High Level Group Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLGTCD,31,,,Num,
314,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as the CEBODSYS if the primary SOC was used for analysis.,CE Primary System Organ Class,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CESOC,32,,,Char,
315,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",CE,Clinical Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as CEBDSYCD if the primary SOC was used for analysis.,CE Primary System Organ Class Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CESOCCD,33,,,Num,
316,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
317,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
318,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
319,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Clinical Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CECAT,4,[Clinical Event Category]; NULL,What is the category of the clinical event?,Char,
320,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the CECAT values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. CESCAT can only be used if there is an CECAT and it must be a subcategorization of CECAT.,Subcategory for Clinical Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CESCAT,5,[Clinical Event Subcategory]; NULL,What is the subcategory of the clinical event?,Char,
321,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether any clinical events were experienced during the study.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Clinical Event,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,CEYN,6,Any Clinical Events,Were any clinical events experienced?,Char,['NY']
322,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile concomitant medications, procedures and/or medical history records with CEs. If CMCENO or PRCENO is used, this is the identifier to which CMCENO or PRCENO refers. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",CE Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,CESPID,7,[Sponsor defined],[Sponsor defined question],Char,
323,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,The reported or prespecified name of the clinical event.,"Can be represented either as a free-text field to capture verbatim terms reported by subjects; or preprinted, in situation where solicited CEs of interest are captured. May be used as Specify Other field to collect more details on a prespecified CEDECOD value, or when CEDECOD=Other. In most cases, the verbatim term (i.e., investigator-reported term) will be coded to a standard medical dictionary (e.g., MedDRA, WHO ART) after the data have been collected on the CRF",Reported Term for the Clinical Event,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CETERM,8,[Clinical Event]; Specify (Other/Details),What is the clinical event term?,Char,
324,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether a prespecified clinical event or a group of clinical events occurred when information about the occurrence of a specific event is solicited.,The CDASH variable CEOCCUR is used to report the occurrence of prespecified clinical event not considered to be an adverse event by the sponsor. CEOCCUR should not be used for spontaneously reported events. The site should be able to indicate that the question was not asked or answered.,Clinical Event Occurrence,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEOCCUR,9,[Specified Clinical Event],Did the subject have [prespecified clinical event/group of clinical events ]?,Char,['NY']
325,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication that a specific event, or group of events, are prespecified on a CRF.","A hidden field on a CRF defaulted to ""Y"", or added during the SDTM-based dataset creation when the clinical event is prespecified. Null for spontaneously reported events. If a study collects both prespecified CEs and free-text events, the value of CEPRESP should be ""Y"" for all prespecified events and null for events reported as free text. CEPRESP is a permissible field in SDTM and may be omitted from the SDTM-based dataset if all events were collected as free text.",Clinical Event Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEPRESP,10,,,Char,['NY']
326,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The start date of the clinical event, represented in an unambiguous date format (e.g., DD-MON-YYYY).",,Clinical Event Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable CESTDTC in ISO 8601 format.",CESTDAT,11,Start Date,What was the [clinical event] start date?,Char,
327,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start time of the clinical event, represented in an unambiguous date format (e.g., hh:mm:ss).",Collecting the time a CE started is only appropriate if it can be realistically determined and if there is a scientific reason for needing to know this level of detail. An example is where the subject is under the direct care of the site at the time the event started and the study design is such that it is important to know the CE start time with respect to dosing.,Clinical Event Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable CESTDTC in ISO 8601 format.",CESTTIM,12,Start Time,What was the [clinical event] start time?,Char,
328,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A description of the anatomical location relevant for the clinical event.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, PORTOT are used to further describe the anatomical location.",Clinical Event Location,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CELOC,13,Anatomical Location,What was the anatomical location of the [clinical event]?,Char,['LOC']
329,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body relevant for the event.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Clinical Event Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CELAT,14,Side,What was the side of the anatomical location of the [clinical event]?,Char,['LAT']
330,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Clinical Event Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEDIR,15,Directionality,What was the directionality of the anatomical location of the [clinical event]?,Char,['DIR']
331,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,CE Location Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEPORTOT,16,Portion or Totality,What was the portion or totality of the anatomical location of the clinical event?,Char,['PORTOT']
332,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication the clinical event is ongoing when no end date is provided.,"Completed to indicate that the CE has not resolved at the time of data collection, when no end date is collected. In some cases the ongoing status may be determined from CE Outcome. The purpose of collecting this field is to help with data cleaning and monitoring; this field provides further confirmation that the end date was deliberately left blank. Often used as a tick/checkbox.",Ongoing Clinical Event,"This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTMIG relative timing variable (e.g., CEENRF, CEENRTPT). When populating CEENRF, if the value of CEONGO is ""Y"", the values of ""DURING"", ""AFTER"", or ""DURING/AFTER"" may be used. When populating CEENRTPT, if the value of CEONGO is ""Y"", the value of ""ONGOING"" may be used. When CEONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC), the SDTMIG variable CEENRF should be populated. When CEONGO is compared to another time point, the SDTMIG variables CEENRTPT and CEENTPT should be used. Note: CEENRTPT must refer to a time-point anchor described in CEENTPT.",CEONGO,17,Ongoing (as of the [study-specific timepoint or period]),Was the [clinical event] ongoing (as of [the study-specific timepoint or period]?,Char,['NY']
333,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The date when the clinical event resolved/ ended, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The definition of resolved is sponsor-specific. The preferred method is to collect a complete end date. Partial dates (e.g., providing year only, month and year only) may be acceptable.",Clinical Event End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CEENDTC in ISO 8601 format.",CEENDAT,18,End Date,What was the [clinical event] end date?,Char,
334,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The time when the clinical event ended/resolved, represented in an unambiguous time format (e.g., hh:mm:ss).",Collecting the time an CE resolved is only appropriate if it can be realistically determined and if there is a scientific reason for needing to know this level of detail. An example is where the subject is under the direct care of the site at the time the event resolved and the study design is such that it is important to know the CE end time with respect to dosing.,Clinical Event End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable CEENDTC in ISO 8601 format.",CEENTIM,19,End Time,What was the [clinical event] end time?,Char,
335,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The severity or intensity of the event.,Some studies may collect severity and/or toxicity grade.,CE Severity/Intensity,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external codelist attributes.,CESEV,20,Severity,What was the severity of the [clinical event]?,Char,
336,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A description of toxicity quantified by CETOXGR (e.g., NCI CTCAE Short Name).","This would typically be the text description quantified by CETOXGR (e.g., HYPERCALCEMIA, HYPOCALCEMIA).",Clinical Event Toxicity Description,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external code list attributes.,CETOX,21,[NCI CTCAE] Toxicity,What was the description of the toxicity?,Char,
337,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The toxicity grade using a standard toxicity scale (e.g., NCI CTCAE).",Some studies may collect severity and/or toxicity grade. CDISC Controlled Terminology (TOXGRV3; TOXGRV4) may be used.,Clinical Event Toxicity Grade,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the toxicity scale name and version used to map the terms utilizing the Define-XML external codelist attributes.,CETOXGR,22,[NCI CTCAE Toxicity] Grade,What was the toxicity grade?,Char,
338,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"If the value for CETERM is modified to facilitate coding, then CEMODIFY will contain the modified text.",This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process.,Clinical Event Modified Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CEMODIFY,23,,,Char,
339,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The dictionary- or sponsor-defined standardized text description of CETERM or the modified topic variable (CEMODIFY), if applicable.",This is typically not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process. Equivalent to the Preferred Term (PT in MedDRA).,CE Dictionary-Derived Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEDECOD,24,,,Char,
340,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event Lowest Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CELLT,25,,,Char,
341,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event Lowest Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CELLTCD,26,,,Num,
342,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the preferred term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event Preferred Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEPTCD,27,,,Num,
343,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event High Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLT,28,,,Char,
344,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event High Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLTCD,29,,,Num,
345,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Clinical Event High Level Group Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLGT,30,,,Char,
346,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,CE High Level Group Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CEHLGTCD,31,,,Num,
347,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as the CEBODSYS if the primary SOC was used for analysis.,CE Primary System Organ Class,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CESOC,32,,,Char,
348,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DS,Disposition,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as CEBDSYCD if the primary SOC was used for analysis.,CE Primary System Organ Class Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",CESOCCD,33,,,Num,
349,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
350,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
351,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
352,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Protocol Deviation,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DVCAT,4,[Protocol Deviation Category]; NULL,What is the category of the protocol deviation?,Char,
353,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the DVCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. DVSCAT can only be used if there is an DVCAT, and it must be a subcategorization of DVCAT.",Subcategory for Protocol Deviation,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DVSCAT,5,[Protocol Deviation Subcategory]; NULL,What is the subcategory of the protocol deviation?,Char,
354,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether there were any protocol deviations.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Protocol Deviation,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,DVYN,6,Any Deviations,Were there any protocol deviations?,Char,['NY']
355,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The sponsor-defined standardized text for the name of the protocol deviation.,"DVTERM and DVDECOD may have the same value. If the CRF is collecting protocol deviations using a codelist of responses, then DVDECOD should be used to store the codelist response. Sponsors must use either DVDECOD or DVTERM on the CRF and, in some cases, both may be used. For example, if the CRF collects ""Specify, Other"" or similar additional free-text descriptions of codelist items, then DVTERM should be used to store the detailed descriptive text.",Protocol Deviation Coded Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DVDECOD,7,(Standardized) Protocol Deviation (Term),What was the (standardized) protocol deviation (term/(code)?,Char,
356,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,The reported or prespecified name of the protocol deviation.,"DVTERM and DVDECOD may have the same value. If the CRF is collecting protocol deviations using a free-text field, then DVTERM should be used to store the free-text response. Sponsors may use either DVDECOD or DVTERM on the CRF, but a value in DVTERM is required in the SDTM-based datasets.",Protocol Deviation Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DVTERM,8,(Specify) Protocol Deviation,What was the protocol deviation term?,Char,
357,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start date of deviation, represented in an unambiguous date format (e.g., DD-MON-YYYY).",This may be derived if not collected on a CRF.,Deviation Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable DVSTDTC in ISO 8601 format.",DVSTDAT,9,Start Date,What was the protocol deviation start date?,Char,
358,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start time of the deviation, represented in an unambiguous time format (e.g., hh:mm:ss).",,Deviation Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable DVSTDTC in ISO 8601 format.",DVSTTIM,10,Start Time,What was the protocol deviation start time?,Char,
359,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The end date of the deviation, represented in an unambiguous date format (e.g., DD-MON-YYYY).",,Deviation End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable DVENDTC in ISO 8601 format.",DVENDAT,11,End Date,What was the protocol deviation end date?,Char,
360,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The end time of the deviation, represented in an unambiguous time format (e.g., hh:mm:ss).",,Deviation End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable DVENDTC in ISO 8601 format.",DVENTIM,12,End Time,What was the protocol deviation end time?,Char,
361,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",DV,Protocol Deviations,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",DV Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,DVSPID,13,[Sponsor defined],[Sponsor-defined question],Char,
362,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
363,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
364,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
365,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether there were any healthcare encounters.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Healthcare Encounters,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,HOYN,4,Any Healthcare Encounters,Were there any healthcare encounters?,Char,['NY']
366,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header. Examples include HOSPITALIZATION and OUTPATIENT.",Category for Healthcare Encounter,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HOCAT,5,[Healthcare Encounter Category]; NULL,What was the category of the healthcare encounter?,Char,
367,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the HOCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. HOSCAT can only be used if there is an HOCAT, and it must be a subcategorization of HOCAT.",Subcategory for Healthcare Encounter,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HOSCAT,6,[Healthcare Encounter Subcategory]; NULL,What was the subcategory of the healthcare encounter?,Char,
368,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether a health encounter occurred when information about the occurrence of a specific event is solicited.,The CDASH variable HOOCCUR is used to report the occurrence of a prespecified healthcare encounter. HOOCCUR is not used if the healthcare encounters are collected on the CRF in a manner that requires a free-text response. The site should be able to indicate in a separate item (or system variable) that the question was not asked or answered.,Healthcare Encounter Occurrence,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HOOCCUR,7,[prespecified Healthcare Encounter Term],Did the subject have [prespecified healthcare encounter term]?,Char,['NY']
369,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication that a specific event, or group of events, are specified on a CRF.","A hidden field on a CRF defaulted to ""Y"", or added during the SDTM-based dataset creation, when the healthcare encounter is prespecified. Null for spontaneously reported events. If a study collects both prespecified healthcare encounters as well as free-text events, the value of HOPRESP should be ""Y"" for all prespecified events and null for events reported as free-text. HOPRESP is a permissible field in SDTM and may be omitted from the SDTM-based dataset if all events were collected as free text.",prespecified Healthcare Encounter,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HOPRESP,8,,,Char,['NY']
370,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An explanation for why the data are not available.,"The reason the data are not available may be chosen from a sponsor defined list (e.g., subject not asked) or entered as free text. When HOREASND is used, the SDTMIG variable HOSTAT should also be populated in the SDTM-based dataset.",Reason Healthcare Encounter Not Done,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HOREASND,9,Reason Not Collected,What was the reason the data were not collected?,Char,
371,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, This is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",HO Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,HOSPID,10,[Sponsor-defined],[Sponsor-defined question],Char,
372,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,The reported or prespecified name of the healthcare encounter.,"If collected on the CRF, sponsors must use either HODECOD or HOTERM and in some cases, both may be used. If the CRF is collecting healthcare encounters using a standardized sponsor-defined code list (e.g., INPATIENT ER, ICU, SURGERY, GENERAL WARD, PROVIDER OFFICE - PRIVATE, PROVIDER OFFICE - HOSPITAL, GASTROENTEROLOGIST), then HODECOD may be used to store the code list response. If the CRF collects ""Specify, Other"" or similar additional free-text descriptions of code list items, then HOTERM may be used to store the detailed descriptive text. If HOTERM is entered only as free text, HODECOD would be populated through the sponsor's coding process.",Reported Term for Healthcare Encounter,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HOTERM,11,[Healthcare Encounter]; [Specify],"What was the healthcare encounter?; If [HODECOD], specify",Char,
373,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,"The sponsor-defined standardized text description of HOTERM or the modified topic variable (HOMODIFY), if applicable.","If collected on the CRF, sponsors must use either HODECOD or HOTERM and in some cases, both may be used. If the CRF is collecting healthcare encounters using a standardized sponsor defined code list (e.g., INPATIENT ER, ICU, SURGERY, GENERAL WARD, PROVIDER OFFICE-PRIVATE, PROVIDER OFFICE-HOSPITAL, GASTROENTEROLOGIST), then HODECOD may be used to store the code list response. If the CRF collects ""Specify, Other"" or similar additional free-text descriptions of code list items, then HOTERM may be used to store the detailed descriptive text. If HOTERM is entered only as free text, HODECOD would be populated through the sponsor's coding process.",HO Standardized Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,HODECOD,12,(Standardized) Healthcare Encounter (Term),What was the (standardized) healthcare encounter (term/code)?,Char,
374,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start date the healthcare encounter, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The preferred method is to collect a complete start date. Partial dates (e.g., providing year only, month and year only) may be acceptable.",Healthcare Encounter Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable HOSTDTC in ISO 8601 format.",HOSTDAT,13,([HOTERM])[Start/Admission] Date,What was the [healthcare encounter/HOTERM] [start/admission] date?,Char,
375,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start time of the healthcare encounter, (e.g., time of admission), represented in an unambiguous time format (e.g., hh:mm:ss).",,Healthcare Encounter Start Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable HOSTDTC in ISO 8601 format.",HOSTTIM,14,([HOTERM])[Start/Admission] Time,What was the [healthcare encounter/HOTERM] [start/admission] time?,Char,
376,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The end date of the healthcare encounter (e.g., date of discharge), represented in an unambiguous date format (e.g., DD-MON-YYYY).","The preferred method is to collect a complete end date. Partial dates (e.g., providing year only, month and year only) may be acceptable.",Healthcare Encounter End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable HOENDTC in ISO 8601 format.",HOENDAT,15,([HOTERM])[End/Discharge] Date,What was the [healthcare encounter/HOTERM] [end/discharge] date?,Char,
377,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The end time of the healthcare encounter (e.g., time of discharge), represented in an unambiguous time format (e.g., hh:mm:ss).",,Healthcare Encounter End Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable HOENDTC in ISO 8601 format.",HOENTIM,16,([HOTERM])[End/Discharge]Time,What was the [healthcare encounter/HOTERM] [end/discharge] time?,Char,
378,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Collected duration of the healthcare encounter.,Collected duration of the healthcare encounter. Used only if collected on the CRF and not derived from the start and end date/times.,Healthcare Encounter Collected Duration,"This does not map directly to an SDTMIG variable. For the SDTM-based dataset, concatenate the CDASH collected duration and collected duration unit and populate the SDTMIG variable HODUR in ISO 8601 Period format. Example: P1DT2H (for 1 day, 2 hours).",HOCDUR,17,Duration,What was the duration of the [healthcare encounter/HOTERM]?,Char,
379,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Unit of the collected duration of the healthcare encounter. Used only if duration was collected on the CRF.,"To ensure data quality, it is recommended that the appropriate duration unit(s) be preprinted on the (e)CRF. If only 1 unit is appropriate, no data entry would be required.",HO Collected Duration Unit,"This does not map directly to an SDTMIG variable. For the SDTM-based dataset, concatenate the CDASH collected duration and collected duration unit and populate the SDTMIG variable HODUR in ISO 8601 Period format. Example: P1DT2H (for 1 day, 2 hours).",HOCDURU,18,(Duration) Unit,What was the duration unit of the [healthcare encounter/HOTERM]?,Char,['UNIT']
380,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication that the encounter is ongoing when no end date is provided.,"Completed to indicate that the healthcare encounter has not ended at the time of data collection. It is expected that every reported encounter has either an end date or the Ongoing field is populated, but not both. The purpose of collecting this field is to help with data cleaning and monitoring; this field provides further confirmation that End Date was deliberately left blank. Often used as a tick/checkbox. See Section 3.7, Mapping Relative Times from Collection to Submissions, and SDTMIG for more information.",Ongoing Healthcare Encounter,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable (e.g., HOENRF, HOENRTPT). When populating HOENRF, if the value of HOONGO is ""Y"", the values of ""DURING"", ""AFTER"", or ""DURING/AFTER"" may be used. When populating HOENRTPT, if the value of HOONGO is ""Y"", the value of ""ONGOING"" may be used. When HOONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTMIG variable HOENRF should be populated. When HOONGO is compared to any other time point, the SDTMIG variables HOENRTPT and HOENTPT should be used. \n Note: HOENRTPT must refer to a time-point anchor described in HOENTPT.",HOONGO,19,Ongoing as of the[study-specific timepoint or period],Was the [healthcare encounter/HOTERM] ongoing(as of the[study-specific timepoint or period?,Char,['NY']
381,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Denotes the reason for the healthcare encounter.,"To ensure data quality, it is recommended that the sponsor develop controlled terminology (e.g., LACK OF EFFICACY, ADVERSE EVENT, CHEMOTHERAPY, PHYSICAL THERAPY, INDICATION UNDER STUDY, NOT INDICATION UNDER STUDY). The sponsor may, however choose to collect this as free text or as a combination of preprinted options and free text in the form of ""Specify, Other"".",Reason for the Healthcare Encounter,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPHO dataset as the value of SUPPHO_QVAL where SUPPHO.QNAM =""HOREAS"" and SUPPHO.QLABEL=""Healthcare Encounter Reason"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables in SDTM domains.",HOREAS,20,Reason for the Healthcare Encounter,What was the reason for the [healthcare encounter/HOTERM]?,Char,
382,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HO,Healthcare Encounters,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Identifier for the adverse event that precipitated this encounter.,"The intent is to establish a link between the healthcare encounter record and the AE that was the primary cause of the encounter. HOAENO can be used in RELREC to identify a relationship between records in HO dataset and records in the AE dataset. Other identifiers needed to create RELREC (e.g., HOMHNO) can be created as needed. See SDTMIG for information on RELREC.",Related Adverse Event ID,"This does not map directly to an SDTMIG variable. For the SDTM submission datasets, may be used to create RELREC to link this record with a record in the Adverse Events domain.",HOAENO,21,Adverse Event Identifier,"What was the identifier for the adverse event(s), which precipitated the [healthcare encounter/HOTERM]?",Char,
383,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM- based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
384,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
385,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
386,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether there was any medical history to report.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Medical History Event,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,MHYN,4,Any Medical History,Were any medical conditions or events reported?; Has the subject had any medical conditions or events?,Char,['NY']
387,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology (e.g., CARDIAC, GENERAL). This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header. This would be used when specific medical history (e.g., disease under study details) is captured, in addition to the general medical history.",Category for Medical History,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHCAT,5,[Medical History Category]; NULL,What was the category of the medical history?,Char,
388,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the MHCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. Typically would be used when specific medical history (e.g., disease diagnosis) is captured, in addition to the general medical history. MHSCAT can only be used if there is an MHCAT, and it must be a subcategorization of MHCAT.",Subcategory for Medical History,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHSCAT,6,[Medical History Subcategory]; NULL,What was the subcategory of the medical history?,Char,
389,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The date on which the medical history was collected, represented in an unambiguous date format (e.g., DD-MON-YYYY).",This should be a complete date. The date of collection may be determined from a collected visit date.,Medical History Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable MHDTC in ISO 8601 format.",MHDAT,7,Collection Date,What was the date the medical history was collected?,Char,
390,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile concomitant medications and/or procedure records with MH. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system. If CMMHNO or PRMHNO is used, this is the identifier to which CMMHNO or PRMHNO refers.",MH Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,MHSPID,8,[Sponsor defined],[Sponsor-defined question],Char,
391,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Specifies the aspect of the medical condition or event by which MHSTDTC and/or MHENDTC is defined.,"The type of start/ and or end date (e.g., DIAGNOSIS, SYMPTOMS, RELAPSE, INFECTION). It is not related to the trial's condition. This date type cannot be a PRIMARY DIAGNOSIS, SECONDARY DIAGNOSIS because these terms do not define the date type.",Medical History Event Date Type,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHEVDTYP,9,Medical History Event Date Type,What was the medical history event date type?,Char,['MHEDTTYP']
392,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,The reported or prespecified name of the medical condition or event.,"Sponsors should collect all relevant medical conditions or events, as defined in the protocol. It is a best practice for sponsors to collect all relevant history of surgeries or procedures using the associated diagnosis in the MH domain, while reporting relevant surgeries and procedures in the SDTM PR domain. Sponsors should provide instructions on how surgeries and procedures will be handled based on the protocol requirements. Information on specified surgeries or procedures should be collected in the PR domain.",Reported Term for the Medical History,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHTERM,10,Medical History Term,What is the medical condition or event term?,Char,
393,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether a prespecified medical condition/event or a group of medical conditions/events occurred when information about the occurrence of a specific event is solicited.,MHOCCUR is used to report the occurrence of specified medical conditions or events. MHOCCUR is not used if the medical conditions or events are collected on the CRF in a manner that requires spontaneously free-text response. The site should be able to indicate that the question was not asked or answered.,Medical History Occurrence,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHOCCUR,11,[Medical condition/Event],Did the subject have [prespecified medical condition/event/group of medical conditions]; Is the [prespecified medical occurring]?,Char,['NY']
394,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication that a specific event, or group of events, are prespecified on a CRF.","A hidden field on a CRF defaulted to ""Y"", or added during the SDTM-based dataset creation when the medical condition or event is prespecified. Null for spontaneously reported events. If a study collects both prespecified medical history and free-text events, the value of MHPRESP should be ""Y"" for all prespecified events and null for medical conditions or events reported as free text. MHPRESP is a permissible field in SDTM and may be omitted from the SDTM-based dataset if all events were collected as free text.",Medical History Event Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHPRESP,12,,,Char,['NY']
395,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether the event occurred prior to study start.,"Sponsors may collect this information rather than start dates. See Section 3.7, Mapping Relative Times from Collection to Submissions, and SDTMIG v3.2 Section 4.1.4.7 for more information.",Prior Medical History Event,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable such as MHSTRF or MHSTRTPT. When populating MHSTRF, or MHSTRTPT, if the value of the CDASH field MHPRIOR is ""Y"" a value from the CDISC CT (STENRF) may be used. When MHPRIOR refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTMIG variable MHSTRF should be populated. When MHPRIOR is compared to another time point, the SDTMIG variables MHSTRTPT and MHSTTPT should be used. Note: MHSTRTPT must refer to the time-point anchor described in MHSTTPT.",MHPRIOR,13,Prior to [MHSTTPT]; Prior to Study,Did the medical condition or event start prior to [MHSTTPT]?; Did the medical condition or event start prior to study start?,Char,['NY']
396,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication the medical condition or event is ongoing when no end date is provided.,"Completed to indicate that the condition has not resolved at the time of data collection. It is expected that every reported condition has either an end date or the Ongoing field is populated, but not both. See Section 3.7, Mapping Relative Times from Collection to Submissions, and SDTMIG v3.2 Section 4.1.4.7 for more information.",Ongoing Medical History Event,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable such as MHENRF or MHENRTPT. When populating MHENRF, if the value of MHONGO is ""Y"", the value of ""DURING"", ""AFTER"" or ""DURING/AFTER"" may be used. When populating MHENRTPT, if the value of MHONGO is ""Y"", the value of ""ONGOING"" may be used. When MHONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTMIG variable MHENRF should be populated. When MHONGO is compared to another time point, the SDTMIG variables MHENRTPT and MHENTPT should be used. \n Note: MHENRTPT must refer to a time-point anchor described in MHENTPT.",MHONGO,14,Ongoing (as of the [study-specific timepoint or period]),Is the medical condition or event ongoing (as of the [study-specific timepoint or period])?,Char,['NY']
397,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication of whether the medical condition or event is under control at the time of data collection.,"MHCTRL is not defined in the SDTMIG MH domain. If collected, it should be submitted in the SUPPMH dataset. If MHCTRL is collected, the sponsor must provide information on the relative timeframe. Generally, MHDAT is collected or determined using the visit date of the collection to indicate this is the subject's status at the time of data collection.",MH Disease or Symptom Under Control,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPMH dataset as the value of SUPPMH.QVAL where SUPPMH.QNAM =""MHCTRL"" and SUPPMH.LABEL=""Medical Condition Under Control"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables in SDTM domains.",MHCTRL,15,Medical Condition Under Control,Is the medical condition or event under control?,Char,['NY']
398,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start date of medical history event or condition, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The sponsor may choose to capture a complete date or any variation thereof (e.g., month and year, year).",Medical History Event Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable MHSTDTC in ISO 8601 format.",MHSTDAT,16,Start Date,What [is/was] the [medical event or condition/category of the event] start date?,Char,
399,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The end date of medical history event or condition, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The sponsor may choose to capture a complete date or any variation thereof (e.g., month and year, year).",Medical History Event End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable MHENDTC in ISO 8601 format.",MHENDAT,17,End Date,What[is/was] the[medical event or condition/category of the event] end date?,Char,
400,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A description of the anatomical location relevant for the medical condition or event.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location (e.g., ARM for skin rash). Could be a defaulted or hidden field on the CRF for prespecified [MHTERM/Event Topic]. Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, PORTOT are used to further describe the anatomical location.",Medical History Event Location,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHLOC,18,Anatomical Location,What was the anatomical location of the medical condition or event?,Char,['LOC']
401,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body relevant for the event.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Medical History Event Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHLAT,19,Side,What was the side of the anatomical location of the medical condition or event?,Char,['LAT']
402,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Medical History Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHDIR,20,Directionality,What was the directionality of the anatomical location of the medical condition or event?,Char,['DIR']
403,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,MH Event Location Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHPORTOT,21,Portion or Totality,What was the portion or totality of the anatomical location of the of the medical condition or event?,Char,['PORTOT']
404,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"If the value for MHTERM is modified to facilitate coding, then MHMODIFY will contain the modified text.",This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process.,MH Modified Reported Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHMODIFY,22,,,Char,
405,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The dictionary text description of MHTERM or the modified topic variable (MH MODIFY), if applicable.",This is typically not a data collection field that will appear on the CRF. Sponsors will populate this through the coding process. Equivalent to the Preferred Term (PT in MedDRA).,MH Dictionary-Derived Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHDECOD,23,,,Char,
406,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Medical History Event Lowest Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHLLT,24,,,Char,
407,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event Lowest Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHLLTCD,25,,,Num,
408,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the preferred term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event Preferred Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHPTCD,26,,,Num,
409,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Medical History Event High Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLT,27,,,Char,
410,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event High Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLTCD,28,,,Num,
411,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event High Level Group Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLGT,29,,,Char,
412,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event High Level Group Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLGTCD,30,,,Num,
413,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as MHBODSYS if the primary SOC was used for analysis.,MH Event Primary System Organ Class,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHSOC,31,,,Char,
414,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",MH,Medical History,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as MHBDSYCD if the primary SOC was used for analysis.,MH Event Primary System Organ Class Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHSOCCD,32,,,Num,
415,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM- based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
416,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
417,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
418,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether there was any medical history to report.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Medical History Event,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,MHYN,4,Any Medical History,Were any medical conditions or events reported?; Has the subject had any medical conditions or events?,Char,['NY']
419,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology (e.g., CARDIAC, GENERAL). This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header. This would be used when specific medical history (e.g., disease under study details) is captured, in addition to the general medical history.",Category for Medical History,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHCAT,5,[Medical History Category]; NULL,What was the category of the medical history?,Char,
420,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A sub-division of the MHCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. Typically would be used when specific medical history (e.g., disease diagnosis) is captured, in addition to the general medical history. MHSCAT can only be used if there is an MHCAT, and it must be a subcategorization of MHCAT.",Subcategory for Medical History,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHSCAT,6,[Medical History Subcategory]; NULL,What was the subcategory of the medical history?,Char,
421,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The date on which the medical history was collected, represented in an unambiguous date format (e.g., DD-MON-YYYY).",This should be a complete date. The date of collection may be determined from a collected visit date.,Medical History Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable MHDTC in ISO 8601 format.",MHDAT,7,Collection Date,What was the date the medical history was collected?,Char,
422,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile concomitant medications and/or procedure records with MH. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system. If CMMHNO or PRMHNO is used, this is the identifier to which CMMHNO or PRMHNO refers.",MH Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,MHSPID,8,[Sponsor defined],[Sponsor-defined question],Char,
423,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Specifies the aspect of the medical condition or event by which MHSTDTC and/or MHENDTC is defined.,"The type of start/ and or end date (e.g., DIAGNOSIS, SYMPTOMS, RELAPSE, INFECTION). It is not related to the trial's condition. This date type cannot be a PRIMARY DIAGNOSIS, SECONDARY DIAGNOSIS because these terms do not define the date type.",Medical History Event Date Type,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHEVDTYP,9,Medical History Event Date Type,What was the medical history event date type?,Char,['MHEDTTYP']
424,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",HR,The reported or prespecified name of the medical condition or event.,"Sponsors should collect all relevant medical conditions or events, as defined in the protocol. It is a best practice for sponsors to collect all relevant history of surgeries or procedures using the associated diagnosis in the MH domain, while reporting relevant surgeries and procedures in the SDTM PR domain. Sponsors should provide instructions on how surgeries and procedures will be handled based on the protocol requirements. Information on specified surgeries or procedures should be collected in the PR domain.",Reported Term for the Medical History,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHTERM,10,Medical History Term,What is the medical condition or event term?,Char,
425,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether a prespecified medical condition/event or a group of medical conditions/events occurred when information about the occurrence of a specific event is solicited.,MHOCCUR is used to report the occurrence of specified medical conditions or events. MHOCCUR is not used if the medical conditions or events are collected on the CRF in a manner that requires spontaneously free-text response. The site should be able to indicate that the question was not asked or answered.,Medical History Occurrence,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHOCCUR,11,[Medical condition/Event],Did the subject have [prespecified medical condition/event/group of medical conditions]; Is the [prespecified medical occurring]?,Char,['NY']
426,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"An indication that a specific event, or group of events, are prespecified on a CRF.","A hidden field on a CRF defaulted to ""Y"", or added during the SDTM-based dataset creation when the medical condition or event is prespecified. Null for spontaneously reported events. If a study collects both prespecified medical history and free-text events, the value of MHPRESP should be ""Y"" for all prespecified events and null for medical conditions or events reported as free text. MHPRESP is a permissible field in SDTM and may be omitted from the SDTM-based dataset if all events were collected as free text.",Medical History Event Prespecified,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHPRESP,12,,,Char,['NY']
427,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,An indication of whether the event occurred prior to study start.,"Sponsors may collect this information rather than start dates. See Section 3.7, Mapping Relative Times from Collection to Submissions, and SDTMIG v3.2 Section 4.1.4.7 for more information.",Prior Medical History Event,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable such as MHSTRF or MHSTRTPT. When populating MHSTRF, or MHSTRTPT, if the value of the CDASH field MHPRIOR is ""Y"" a value from the CDISC CT (STENRF) may be used. When MHPRIOR refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTMIG variable MHSTRF should be populated. When MHPRIOR is compared to another time point, the SDTMIG variables MHSTRTPT and MHSTTPT should be used. Note: MHSTRTPT must refer to the time-point anchor described in MHSTTPT.",MHPRIOR,13,Prior to [MHSTTPT]; Prior to Study,Did the medical condition or event start prior to [MHSTTPT]?; Did the medical condition or event start prior to study start?,Char,['NY']
428,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication the medical condition or event is ongoing when no end date is provided.,"Completed to indicate that the condition has not resolved at the time of data collection. It is expected that every reported condition has either an end date or the Ongoing field is populated, but not both. See Section 3.7, Mapping Relative Times from Collection to Submissions, and SDTMIG v3.2 Section 4.1.4.7 for more information.",Ongoing Medical History Event,"This does not map directly to an SDTM variable. May be used to populate a value into an SDTMIG relative timing variable such as MHENRF or MHENRTPT. When populating MHENRF, if the value of MHONGO is ""Y"", the value of ""DURING"", ""AFTER"" or ""DURING/AFTER"" may be used. When populating MHENRTPT, if the value of MHONGO is ""Y"", the value of ""ONGOING"" may be used. When MHONGO refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTMIG variable MHENRF should be populated. When MHONGO is compared to another time point, the SDTMIG variables MHENRTPT and MHENTPT should be used. \n Note: MHENRTPT must refer to a time-point anchor described in MHENTPT.",MHONGO,14,Ongoing (as of the [study-specific timepoint or period]),Is the medical condition or event ongoing (as of the [study-specific timepoint or period])?,Char,['NY']
429,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,Indication of whether the medical condition or event is under control at the time of data collection.,"MHCTRL is not defined in the SDTMIG MH domain. If collected, it should be submitted in the SUPPMH dataset. If MHCTRL is collected, the sponsor must provide information on the relative timeframe. Generally, MHDAT is collected or determined using the visit date of the collection to indicate this is the subject's status at the time of data collection.",MH Disease or Symptom Under Control,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPMH dataset as the value of SUPPMH.QVAL where SUPPMH.QNAM =""MHCTRL"" and SUPPMH.LABEL=""Medical Condition Under Control"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables in SDTM domains.",MHCTRL,15,Medical Condition Under Control,Is the medical condition or event under control?,Char,['NY']
430,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The start date of medical history event or condition, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The sponsor may choose to capture a complete date or any variation thereof (e.g., month and year, year).",Medical History Event Start Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable MHSTDTC in ISO 8601 format.",MHSTDAT,16,Start Date,What [is/was] the [medical event or condition/category of the event] start date?,Char,
431,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The end date of medical history event or condition, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The sponsor may choose to capture a complete date or any variation thereof (e.g., month and year, year).",Medical History Event End Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH END DATE and TIME components and populate the SDTMIG variable MHENDTC in ISO 8601 format.",MHENDAT,17,End Date,What[is/was] the[medical event or condition/category of the event] end date?,Char,
432,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,A description of the anatomical location relevant for the medical condition or event.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location (e.g., ARM for skin rash). Could be a defaulted or hidden field on the CRF for prespecified [MHTERM/Event Topic]. Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, PORTOT are used to further describe the anatomical location.",Medical History Event Location,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHLOC,18,Anatomical Location,What was the anatomical location of the medical condition or event?,Char,['LOC']
433,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body relevant for the event.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Medical History Event Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHLAT,19,Side,What was the side of the anatomical location of the medical condition or event?,Char,['LAT']
434,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Medical History Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHDIR,20,Directionality,What was the directionality of the anatomical location of the medical condition or event?,Char,['DIR']
435,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,MH Event Location Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHPORTOT,21,Portion or Totality,What was the portion or totality of the anatomical location of the of the medical condition or event?,Char,['PORTOT']
436,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"If the value for MHTERM is modified to facilitate coding, then MHMODIFY will contain the modified text.",This is not a data collection field that would appear on the CRF. Sponsors will populate this through the coding process.,MH Modified Reported Term,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,MHMODIFY,22,,,Char,
437,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,"The dictionary text description of MHTERM or the modified topic variable (MH MODIFY), if applicable.",This is typically not a data collection field that will appear on the CRF. Sponsors will populate this through the coding process. Equivalent to the Preferred Term (PT in MedDRA).,MH Dictionary-Derived Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHDECOD,23,,,Char,
438,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Medical History Event Lowest Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHLLT,24,,,Char,
439,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the lowest level term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event Lowest Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHLLTCD,25,,,Num,
440,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the preferred term.,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event Preferred Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHPTCD,26,,,Num,
441,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,Medical History Event High Level Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLT,27,,,Char,
442,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event High Level Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLTCD,28,,,Num,
443,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event High Level Group Term,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLGT,29,,,Char,
444,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the high level group term for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding.,MH Event High Level Group Term Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHHLGTCD,30,,,Num,
445,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived text description of the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as MHBODSYS if the primary SOC was used for analysis.,MH Event Primary System Organ Class,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHSOC,31,,,Char,
446,Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",SA,Serious Adverse Events,"This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). (Source: CDISC Controlled Terminology, GNRLOBSC, C103372, 2023-06-30)",O,The dictionary-derived code for the primary system organ class (SOC).,This field does not typically appear on the CRF. Sponsors will populate this through the coding process. This is applicable to items using MedDRA coding. Will be the same as MHBDSYCD if the primary SOC was used for analysis.,MH Event Primary System Organ Class Code,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The sponsor is expected to provide the dictionary name and version used to code utilizing the Define-XML external codelist attributes. Sponsors should include an Origin in the define metadata document to indicate that the data was ""ASSIGNED"".",MHSOCCD,32,,,Num,
447,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
448,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
449,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
450,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
451,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the cell phenotype specimen was collected can be determined from the visit date variable (VISDAT) and applying that date to all of the cell phenotype at that visit, or the specimen collection date can be collected on the Cell Phenotype CRF using the date (CPDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation, or specimen collection can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable CPDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
452,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column heading.",Category for Cell Phenotype,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CPCAT,6,[Cell Phenotype Category]; NULL,What is the category of the cell phenotype?,Char,
453,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A sub-division of the CPCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. CPSCAT can only be used if there is a CPCAT, and it must be a subcategorization of CPCAT.",Subcategory for Cell Phenotype,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,CPSCAT,7,[Cell Phenotype Subcategory]; NULL,What is the subcategory of the cell phenotype ?,Char,
454,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned cell phenotype measurement, series of cell phenotype measurements, test, or observation was performed or specimens collected.","This may be implemented for an entire cell phenotype category, or a specific cell phenotype test. This general prompt question is used as a data management tool to verify that missing results are confirmed missing.",Cell Phenotype Test Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTMIG variable CPSTAT. If the CDASH variable CPPERF=""N"", the value of CPSTAT will be ""NOT DONE"". If CPPERF=""Y"", CPSTAT should be null. A combination of SDTMIG variables (e.g., CPCAT and CPSCAT, CPTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable CPTESTCD would be populated as CPALL and an appropriate test name (CPTEST) provided. See SDTMIG for additional information.",CPPERF,8,Cell Phenotype Test Performed; Specimen Collected,Was the (cell phenotype) specimen collected?; Was the (cell phenotype) test performed?,Char,['NY']
455,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"An internal or external identifier (e.g., specimen identifier).","This can be used to confirm that the appropriate data record is present in the electronic transfer. May be included for linking back to cell phenotype specimens (e.g., Specimen ID).",Cell Phenotype Specimen Reference ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,CPREFID,9,(Cell Phenotype specimen) [Reference identifier/Accession Number],What was the (cell phenotype specimen) [reference identifier/accession number]?,Char,
456,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time point when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Planned Time Point"" can be included in the column heading.",Cell Phtype Test Planned Time Point Name,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. See the SDTMIG for additional information on representing time points. SDTMIG time-point anchors CPTPTREF (text description) and CPRFTDTC (date/time) may be needed, as well as SDTMIG variables CPTPTNUM, CPELTM.",CPTPT,10,[Planned Time Point Name],What was the planned time point of the collection?,Char,
457,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of cell phenotype specimen collection, represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of cell phenotype specimen collection may be determined from the date of visit (VISDAT) and, if so, a separate collection date field is not required. The SDTMIG CPDTC variable contains either a date/time when a cell phenotype specimen is collected at a point in time or the start date/time, when a cell phenotype specimen is collected over time.",Cell Phenotype Specimen Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable CPDTC in ISO 8601 format.",CPDAT,11,Cell Phenotype Specimen Collection (Start) Date,What was the (start) date of the cell phenotype specimen collection?,Char,
458,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CP,Cell Phenotype Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of cell phenotype specimen collection, represented in an unambiguous time format (e.g., hh:mm:ss).",May be required when multiple cell phenotype specimens are collected on 1 day or when the timing in relationship to study treatment is required for analysis or a cell phenotype specimen is collected over an extended time period.,Cell Phenotype Specimen Collection Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable CPDTC in ISO 8601 format.",CPTIM,12,Cell Phenotype Specimen Collection (Start) Time,What was the (start) time of the cell phenotype specimen collection?,Char,
459,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation.",Study Identifier,Maps directly to the SDTM variable listed in the SDTM Target column .,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
460,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
461,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTM variable listed in the SDTM Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
462,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTM variable listed in the SDTM Target column.,VISIT,4,[Visit],What is the visit name?,Char,
463,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the CV measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the CV CRF using the Cardiovascular Assessments (CVDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable VSDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
464,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response to whether or not a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the -STAT variable in SDTM as "" NOT DONE"".",Cardiovascular Assessment Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable CVSTAT. If the CDASH variable CVPERF=""N"", the value of the SDTM variable CVSTAT is ""NOT DONE"". If CVPERF= ""Y"", CVSTAT is null. A combination of SDTM variables (e.g. CVCAT and CVSCAT, CVTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable CVTESTCD would be populated with CVALL and an appropriate test name (CVTEST) provided. See SDTMIG for additional information.",CVPERF,6,Cardiovascular Assessment Performed,Was cardiovascular assessment performed?,Char,['NY']
465,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the cardiovascular assessment was performed, represented in an unambiguous date format (e.g. DD-MON-YYYY).","The date the CV assessment was performed can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the CV CRF using the Date of Collection (CVDAT) field.",Cardiovascular Assessment Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable CVDTC in ISO 8601 format.",CVDAT,7,Date,What was the date cardiovascular assessment was performed?,Char,
466,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of assessment, represented in an unambiguous time format (e.g. hh:mm:ss).",May be required when multiple assessments are done on 1 day or when the timing in relationship to study treatment is required for analysis,Cardiovascular Assessment Time,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable CVDTC in ISO 8601 format.",CVTIM,8,Time,What was the time of the Cardiovascular assessment performed?,Char,
467,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when assessments should be performed, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then terms such as ""Planned Time Point"" can be included in the column heading.",CV Assessment Planned Time Point Name,"Maps directly to the SDTM variable listed in the SDTM Target column. See the SDTMIG for additional information on representing time points. The SDTM time-point anchors CVTPTREF (text description) and CVRFTDTC (date/time) may be needed, as well as SDTMIG variables CVTPTNUM, CVELTM.",CVTPT,9,[Planned Time Point Name],What is the planned time point for this Cardiovascular assessment performed?,Char,
468,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of assessment used to obtain the measurement or finding.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading. CVTEST is most useful as the PROMPT on the field in which the RESULT for that test is collected.",Cardiovascular Assessment Test Name,Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable CVESTCD may be determined from the value collected in CVTEST using the Controlled Terminology List CVTESTCD. The SDTMIG variables CVTESTCD and CVTEST are required in SDTM.,CVTEST,10,[Cardiovascular Test Name],What is the cardiovascular test name?,Char,['CVTEST']
469,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping of topic variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Cardiovascular Test,Maps directly to the SDTM variable listed in the SDTM Target column.,CVCAT,11,[Cardiovascular Test Category]; NULL,What is the category of the Cardiovascular test?,Char,
470,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the CVCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined code list. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. CVSCAT can only be used if there is a CVCAT, and it must be a subcategorization of CVCAT.",Subcategory Cardiovascular Test,Maps directly to the SDTM variable listed in the SDTM Target column.,CVSCAT,12,[Cardiovascular Test Subcategory]; NULL,What was the subcategory of the cardiovascular test?,Char,
471,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,CV Assessment Result in Original Units,Maps directly to the SDTM variable listed in the SDTM Target column.,CVORRES,13,[CVTEST] Result,What was the result of the measurement?,Char,
472,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",CV Assessment Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,CVORRESU,14,Unit,What was the unit of the result?,Char,['UNIT']
473,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field CVRES is used when the collected results are not mapped directly to the SDTM variable CVORRES and must be transformed. For example,CVRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected.CVORES is collected using Normal, Abnormal and a description of the abnormality is collected.",CV Assessment Test Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation; for example: \n 1. Where CVRES is to used collect Normal, Abnormal or similar type classifications (e.g., Absent/Present) with a description of the abnormal result using the CDASH field CVDESC. For SDTM submission datasets, If the CDASH field CVRES = ""NORMAL"", populate the SDTM variables CVORRES and CVSTRESC with the value of the CDASH field CVRES. If the CDASH field CVRES is ""ABNORMAL"", populate the SDTM variable REORRES with the CDASH field CVDESC. If the reported findings in CVDESC are coded using a dictionary, then the SDTM variable CVSTRESC is populated with the dictionary preferred term and CVMODIFY is populated with the modified text used for coding. If the reported findings in CVDESC are not coded, then the SDTM variable CVSTRESC is populated with the CDASH CVDESC field. The SDTM variable CVNRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. \n 2. Where CVRES is used to collect standardized values (e.g. a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field CVRESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field CVRES field is mapped to the SDTM variable CVSTRESC and the value in the CDASH field CVRESOTH is mapped to the SDTM variable REORR.",CVRES,15,(Result),Was the result (normal/abnormal/absent/present/ [sponsored defined response])?,Char,
474,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Text description of CV test findings.,CVRES and CVDESC are used when a question is asked to collect the finding result with a follow-up question for a description of the finding. See Section 8.3.1 General CDASH Assumptions for Findings Domains.,Description of CV Test Finding,"This does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable CVORRES. If CVRES=""Normal"", populate CVORRES with the value of CVRES. If CVRES=""Abnormal"", populate CVORRES with the value of CVDESC.",CVDESC,16,(abnormal) Findings,What was the description of the (abnormality/observed finding/[Sponsor-defined])?,Char,
475,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as &quot;Not Done&quot;.",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH CVPERF field. Typically a checkbox which indicates the test was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,CV Completion Status,"Maps directly to the SDTM variable listed in the SDTM Target column. If collected, the Origin (a column in the Define-XML) =""CRF""; if populated from other sources such as free text or sponsor-defined listing for CVREASND, the Origin =""DERIVED"".",CVSTAT,21,Not Done,Indicate if the [CVTEST] was not [answered/assessed/done/evaluated/performed].,Char,['ND']
476,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When CVREASND is used, CVSTAT should also be populated in the SDTM-based dataset.",CV Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,CVREASND,22,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],Was the was the reason that the cardiovascular (assessment/[CVTEST]) was not [collected / answered / done / assessed / evaluated]?,Char,
477,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The position of the subject during a measurement or examination.,"Results may be affected by whether conditions for Cardiovascular test, as specified in the protocol, were properly met. One common condition is the subject's position. If the protocol requires this type of information, then a CDASH variable [CVTESTCD]_CVPOS may be created for each CVTESTCD and added to the CRF, if needed.",CV Position of Subject,Maps directly to the SDTM variable listed in the SDTM Target column.,CVPOS,23,Position,What was the position of the subject during the assessment?,Char,['POSITION']
478,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Location used for the measurement.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.LAT, DIR, and PORTOT are used to further describe the anatomical location.",Location of CV Assessment Measurement,Maps directly to the SDTM variable listed in the SDTM Target column.,CVLOC,24,Anatomical Location,What was the anatomical location where the assessment was performed/measurement was taken?,Char,['LOC']
479,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Cardiovascular Assessment Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,CVLAT,25,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
480,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Cardiovascular Assessment Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,CVDIR,26,Directionality,What was the directionality of the anatomical location of the cardiovascular test?,Char,['DIR']
481,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The method of the test or examination.,"This information may be collected when more than 1 method is possible, and collecting the method used is necessary.",Method of Cardiovascular Assessment,Maps directly to the SDTM variable listed in the SDTM Target column.,CVMETHOD,27,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
482,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Cardiovascular Assessment Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,CVEVAL,28,Evaluator,Who was the evaluator?,Char,['EVAL']
483,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",CV,Cardiovascular System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in CVEVAL.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,CV Assessment Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,CVEVALID,29,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
484,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included into the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
485,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
486,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
487,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
488,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the drug accountability assessments were collected can be determined from the Visit Date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the DA CRF using the date (DADAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable DADTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
489,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether a planned accountability assessment was performed.,This may be implemented on a CRF page level on a visit-by-visit basis. This general prompt question is used as a data management tool to verify that missing results are confirmed missing.,Accountability Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTMIG variable DASTAT. If DAPERF=""N"", the value of DASTAT will be ""NOT DONE"". If DAPERF=""Y"", DASTAT should be null. A combination of SDTMIG variables ( e.g., DACAT and DASCAT, DATPT) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable DATESTCD would be populated as DAALL and an appropriate test name (DATEST) provided. See SDTMIG for additional information.",DAPERF,6,Accountability Performed,Was drug accountability performed?,Char,['NY']
490,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. If the protocol allows dispensing different types of treatment (e.g., study medication, rescue medication, run-in medication) the CRF can capture the type of treatment using DACAT. This may be preprinted on the CRF. If DACAT is not collected (e.g., it is self-evident from the protocol design), it can be populated during the SDTM-based dataset creation process. See SDTMIG DA domain examples for populating DACAT and DASCAT.",DA Category of Assessment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DACAT,7,[Study Product Type]; NULL,What was the type of study product for which accountability was assessed?,Char,
491,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the DACAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. If known at the time of data collection, the treatment name may be collected in DASCAT (with appropriate grouping values, but different from those for DACAT). See SDTMIG DA domain examples for populating DACAT and DASCAT. DASCAT can only be used if there is an DACAT, and it must be a subcategorization of DACAT.",DA Subcategory of Assessment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DASCAT,8,[Study Product Name]; NULL,What was the name of the study product for which accountability was assessed?,Char,
492,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the study product was dispensed or returned, represented in an unambiguous date format (e.g., DD-MON-YYYY).",The date study treatment dispensed/returned should be recorded for each dispensation for a study with multiple periods or multiple products dispensed.,Drug Accountability Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable DADTC in ISO 8601 format.",DADAT,9,Date,What was the date the accountability assessment was performed?,Char,
493,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An internal or external identifier such as study product label identifier (e.g., kit number, bottle label, vial identifier).","For the SDTM submission dataset, DAREFID should be used to tie together a block of related records and to link dispensed product to returned product. The packaging identifier (e.g., kit number, bottle label, vial identifier) may be collected in different ways (e.g., affixing label onto CRF, scanning a bar code). For some study dosing regimens, greater granularity for treatment identifiers may be needed. In this situation, sponsors may need to use additional identifier variables.",Accountability Reference ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DAREFID,10,Study Product Label Identifier,What was the study product label identifier?,Char,
494,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Descriptive name of the measurement or finding (e.g., dispensed, returned).","Required to identify which test the result is for. It is recommended that the test names preprinted on the CRF rather than collected in a field that requires the site to enter text. If the form is laid out as a grid, then words such as ""Test"" can be included as the column heading. For a study with multiple periods or multiple products dispensed, drug accountability amounts should be assessed for each dispensation.",Name of Accountability Assessment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable DATESTCD may be determined from the value collected in the CDASH field DATEST. The SDTMIG variables DATESTCD and DATEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,DATEST,11,[Study Product Accountability Test Name],What was the study product accountability being assessed?,Char,['DATEST']
495,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the drug accountability assessment as originally dispensed or returned (e.g., actual amount).","For a study with multiple periods or multiple products dispensed, drug accountability amounts should be assessed for each dispensation.",DA Assessment Result in Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DAORRES,12,Amount,What is the result of the accountability assessment?,Char,
496,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DA,Product Accountability,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field.",DA Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DAORRESU,13,Unit,What was the unit?,Char,"['UNIT', 'DAORRESU']"
497,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
498,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
499,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
500,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
501,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the death details assessments were reported can be determined from the Visit Date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Death Detail CRF using the date (DDDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable DDDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
502,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,General prompt to establish whether any death details are available.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Death Detail Results,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,DDYN,6,Any Death Details,Were any death detail assessments collected?,Char,['NY']
503,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of collection, represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Death Details Date of Collection,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable DDDTC in ISO 8601 format.",DDDAT,7,Collection Date,What was the date death detail assessments were collected?,Char,
504,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Death Details Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,DDSPID,8,[Sponsor defined],[Sponsor-defined question],Char,
505,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Date of death for any subject who died.,"The CDASH Model defines Death Date as a timing variable; this is not included as a timing variable in the SDTMIG. It may be collected on any CRF deemed appropriate by the sponsor, but should only be collected once. The SDTMIG variable DTHDTC is mapped to the DM domain during the SDTM submission dataset creation process. The SDTMIG variable DM.DTHFLG is not a CDASH variable, but it is typically populated during the SDTM submission dataset creation process. Death Date may be mapped to other SDTM domains (e.g., DS), as deemed appropriate by the sponsor.",Death Date,"This field does not map directly to an SDTMIG variable. For the SDTM dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable DTHDTC in ISO 8601 format.",DTHDAT,9,Death Date,What was the subject's date of death?,Char,
506,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for death details.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included as the column header.",Death Detail Assessment Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable DDTESTCD may be determined from the value collected in DDTEST. Both DDTESTCD and DDTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,DDTEST,10,[Death Detail Assessment (Test Name],What was the death detail assessment test name?,Char,['DTHDX']
507,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the death detail assessment, as originally received or collected.",,Death Details Result or Finding,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDORRES,11,(Result),What was the result of the death detail assessment?,Char,
508,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system.,Results Category for Death Details,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDRESCAT,12,[Death Detail Results Category]; NULL,What is the category of the death detail results?,Char,
509,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",DD,Death Details,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the information.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be preprinted, or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Death Details Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDEVAL,13,[Evaluator/Reporter],Who provided the death detail assessment information?,Char,['EVAL']
510,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
511,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
512,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
513,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
514,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the death details assessments were reported can be determined from the Visit Date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Death Detail CRF using the date (DDDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable DDDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
515,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,General prompt to establish whether any death details are available.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Death Detail Results,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,DDYN,6,Any Death Details,Were any death detail assessments collected?,Char,['NY']
516,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of collection, represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Death Details Date of Collection,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable DDDTC in ISO 8601 format.",DDDAT,7,Collection Date,What was the date death detail assessments were collected?,Char,
517,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Death Details Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,DDSPID,8,[Sponsor defined],[Sponsor-defined question],Char,
518,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Date of death for any subject who died.,"The CDASH Model defines Death Date as a timing variable; this is not included as a timing variable in the SDTMIG. It may be collected on any CRF deemed appropriate by the sponsor, but should only be collected once. The SDTMIG variable DTHDTC is mapped to the DM domain during the SDTM submission dataset creation process. The SDTMIG variable DM.DTHFLG is not a CDASH variable, but it is typically populated during the SDTM submission dataset creation process. Death Date may be mapped to other SDTM domains (e.g., DS), as deemed appropriate by the sponsor.",Death Date,"This field does not map directly to an SDTMIG variable. For the SDTM dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable DTHDTC in ISO 8601 format.",DTHDAT,9,Death Date,What was the subject's date of death?,Char,
519,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for death details.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included as the column header.",Death Detail Assessment Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable DDTESTCD may be determined from the value collected in DDTEST. Both DDTESTCD and DDTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,DDTEST,10,[Death Detail Assessment (Test Name],What was the death detail assessment test name?,Char,['DTHDX']
520,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the death detail assessment, as originally received or collected.",,Death Details Result or Finding,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDORRES,11,(Result),What was the result of the death detail assessment?,Char,
521,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system.,Results Category for Death Details,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDRESCAT,12,[Death Detail Results Category]; NULL,What is the category of the death detail results?,Char,
522,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",EG,ECG Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the information.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be preprinted, or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Death Details Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDEVAL,13,[Evaluator/Reporter],Who provided the death detail assessment information?,Char,['EVAL']
523,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
524,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
525,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
526,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
527,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the death details assessments were reported can be determined from the Visit Date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Death Detail CRF using the date (DDDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable DDDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
528,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,General prompt to establish whether any death details are available.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Death Detail Results,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,DDYN,6,Any Death Details,Were any death detail assessments collected?,Char,['NY']
529,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of collection, represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Death Details Date of Collection,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable DDDTC in ISO 8601 format.",DDDAT,7,Collection Date,What was the date death detail assessments were collected?,Char,
530,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Death Details Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,DDSPID,8,[Sponsor defined],[Sponsor-defined question],Char,
531,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Date of death for any subject who died.,"The CDASH Model defines Death Date as a timing variable; this is not included as a timing variable in the SDTMIG. It may be collected on any CRF deemed appropriate by the sponsor, but should only be collected once. The SDTMIG variable DTHDTC is mapped to the DM domain during the SDTM submission dataset creation process. The SDTMIG variable DM.DTHFLG is not a CDASH variable, but it is typically populated during the SDTM submission dataset creation process. Death Date may be mapped to other SDTM domains (e.g., DS), as deemed appropriate by the sponsor.",Death Date,"This field does not map directly to an SDTMIG variable. For the SDTM dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable DTHDTC in ISO 8601 format.",DTHDAT,9,Death Date,What was the subject's date of death?,Char,
532,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for death details.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included as the column header.",Death Detail Assessment Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable DDTESTCD may be determined from the value collected in DDTEST. Both DDTESTCD and DDTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,DDTEST,10,[Death Detail Assessment (Test Name],What was the death detail assessment test name?,Char,['DTHDX']
533,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the death detail assessment, as originally received or collected.",,Death Details Result or Finding,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDORRES,11,(Result),What was the result of the death detail assessment?,Char,
534,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system.,Results Category for Death Details,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDRESCAT,12,[Death Detail Results Category]; NULL,What is the category of the death detail results?,Char,
535,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",GF,Genomics Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the information.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be preprinted, or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Death Details Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,DDEVAL,13,[Evaluator/Reporter],Who provided the death detail assessment information?,Char,['EVAL']
536,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
537,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
538,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
539,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
540,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the inclusion and exclusion assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Inclusion/Exclusion CRF using the date (IEDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable IEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
541,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Indication whether the subject met all the eligibility requirements for this study at the time the subject was enrolled.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification if all other fields on the CRF were deliberately left blank.,Any Incl/Excl Criteria Findings,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,IEYN,6,Met Criteria,Were all eligibility criteria met?,Char,['NY']
542,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The date of collection of the inclusion/exclusion criteria represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Inclusion/Exclusion Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable IEDTC in ISO 8601 format.",IEDAT,7,Date,What was the date the eligibility criteria assessment was performed?,Char,
543,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping category to denote whether the protocol entry criterion being assessed is inclusion criteria or exclusion criteria.,These categories have been defined in SDTM and have controlled terminology that must be used. Only records for criteria that are not met appear in the IE SDTMIG domain. IECAT must be populated. This criterion category may be collected on the CRF in a tick/checkbox format or it may be included as part of the criterion identification and mapped when the SDTM submission datasets are created.,Inclusion/Exclusion Category,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IECAT,8,Criterion Type,What was the category of the criterion?,Char,['IECAT']
544,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the IECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included as the column heading. This can be used to distinguish criteria for a sub-study or to categorize the criterion as a major or minor exception.",Inclusion/Exclusion Subcategory,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IESCAT,9,[Criterion Subtype]; NULL,What was the subcategory of the criterion?,Char,
545,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,The unique identifier associated with the criterion that was the exception.,"This field is required to appear on the CRF, but may be null if there are no exceptions to the inclusion/exclusion criteria. The CRF should allow multiple exceptions to be recorded. See SDTMIG for assumptions regarding protocol versioning. Sponsors may provide a list of inclusion/exclusion criteria and the unique identifying codes to the site. The list provided should be versioned/updated when the protocol changes and the criteria are changed. Sponsors should use sponsor-developed controlled terminology for IETESTCD.",Inclusion/Exclusion Criterion Short Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IETESTCD,10,Exception Criterion Identifier,What was the identifier of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
546,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Descriptive name of the inclusion or exclusion criterion that was the exception.,Sponsors could automatically populated the text in EDC systems when the criterion identifier is populated by the investigator. This can be verified by the PI to ensure the right exception identifier was selected.,Inclusion/Exclusion Criterion,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable IETESTCD may be determined from the value collected in IETEST. The SDTMIG variables IETESTCD and IETEST are required in the SDTM submission datasets.,IETEST,11,Exception Criterion Description,What was the description of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
547,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",IE,Inclusion/Exclusion Criteria Not Met,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,An indication of which inclusion criterion was not met or exclusion criterion was met.,"This is only a data collection field when a complete list of inclusion and exclusion criteria are included on the CRF with Yes/No response options. If the sponsor collects only the criteria that are not fulfilled, then, when an inclusion criterion is not met, IEORRES is mapped to ""N"" and when an exclusion criterion is met, IEORRES is mapped to ""Y"".",I/E Criterion Original Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IEORRES,12,(Result),What is the result?,Char,['NY']
548,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
549,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
550,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
551,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
552,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the inclusion and exclusion assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Inclusion/Exclusion CRF using the date (IEDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable IEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
553,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Indication whether the subject met all the eligibility requirements for this study at the time the subject was enrolled.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification if all other fields on the CRF were deliberately left blank.,Any Incl/Excl Criteria Findings,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,IEYN,6,Met Criteria,Were all eligibility criteria met?,Char,['NY']
554,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The date of collection of the inclusion/exclusion criteria represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Inclusion/Exclusion Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable IEDTC in ISO 8601 format.",IEDAT,7,Date,What was the date the eligibility criteria assessment was performed?,Char,
555,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping category to denote whether the protocol entry criterion being assessed is inclusion criteria or exclusion criteria.,These categories have been defined in SDTM and have controlled terminology that must be used. Only records for criteria that are not met appear in the IE SDTMIG domain. IECAT must be populated. This criterion category may be collected on the CRF in a tick/checkbox format or it may be included as part of the criterion identification and mapped when the SDTM submission datasets are created.,Inclusion/Exclusion Category,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IECAT,8,Criterion Type,What was the category of the criterion?,Char,['IECAT']
556,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the IECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included as the column heading. This can be used to distinguish criteria for a sub-study or to categorize the criterion as a major or minor exception.",Inclusion/Exclusion Subcategory,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IESCAT,9,[Criterion Subtype]; NULL,What was the subcategory of the criterion?,Char,
557,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,The unique identifier associated with the criterion that was the exception.,"This field is required to appear on the CRF, but may be null if there are no exceptions to the inclusion/exclusion criteria. The CRF should allow multiple exceptions to be recorded. See SDTMIG for assumptions regarding protocol versioning. Sponsors may provide a list of inclusion/exclusion criteria and the unique identifying codes to the site. The list provided should be versioned/updated when the protocol changes and the criteria are changed. Sponsors should use sponsor-developed controlled terminology for IETESTCD.",Inclusion/Exclusion Criterion Short Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IETESTCD,10,Exception Criterion Identifier,What was the identifier of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
558,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Descriptive name of the inclusion or exclusion criterion that was the exception.,Sponsors could automatically populated the text in EDC systems when the criterion identifier is populated by the investigator. This can be verified by the PI to ensure the right exception identifier was selected.,Inclusion/Exclusion Criterion,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable IETESTCD may be determined from the value collected in IETEST. The SDTMIG variables IETESTCD and IETEST are required in the SDTM submission datasets.,IETEST,11,Exception Criterion Description,What was the description of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
559,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",LB,Laboratory Test Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,An indication of which inclusion criterion was not met or exclusion criterion was met.,"This is only a data collection field when a complete list of inclusion and exclusion criteria are included on the CRF with Yes/No response options. If the sponsor collects only the criteria that are not fulfilled, then, when an inclusion criterion is not met, IEORRES is mapped to ""N"" and when an exclusion criterion is met, IEORRES is mapped to ""Y"".",I/E Criterion Original Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IEORRES,12,(Result),What is the result?,Char,['NY']
560,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
561,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
562,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
563,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
564,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the inclusion and exclusion assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Inclusion/Exclusion CRF using the date (IEDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable IEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
565,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Indication whether the subject met all the eligibility requirements for this study at the time the subject was enrolled.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification if all other fields on the CRF were deliberately left blank.,Any Incl/Excl Criteria Findings,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,IEYN,6,Met Criteria,Were all eligibility criteria met?,Char,['NY']
566,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The date of collection of the inclusion/exclusion criteria represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Inclusion/Exclusion Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable IEDTC in ISO 8601 format.",IEDAT,7,Date,What was the date the eligibility criteria assessment was performed?,Char,
567,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping category to denote whether the protocol entry criterion being assessed is inclusion criteria or exclusion criteria.,These categories have been defined in SDTM and have controlled terminology that must be used. Only records for criteria that are not met appear in the IE SDTMIG domain. IECAT must be populated. This criterion category may be collected on the CRF in a tick/checkbox format or it may be included as part of the criterion identification and mapped when the SDTM submission datasets are created.,Inclusion/Exclusion Category,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IECAT,8,Criterion Type,What was the category of the criterion?,Char,['IECAT']
568,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the IECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included as the column heading. This can be used to distinguish criteria for a sub-study or to categorize the criterion as a major or minor exception.",Inclusion/Exclusion Subcategory,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IESCAT,9,[Criterion Subtype]; NULL,What was the subcategory of the criterion?,Char,
569,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,The unique identifier associated with the criterion that was the exception.,"This field is required to appear on the CRF, but may be null if there are no exceptions to the inclusion/exclusion criteria. The CRF should allow multiple exceptions to be recorded. See SDTMIG for assumptions regarding protocol versioning. Sponsors may provide a list of inclusion/exclusion criteria and the unique identifying codes to the site. The list provided should be versioned/updated when the protocol changes and the criteria are changed. Sponsors should use sponsor-developed controlled terminology for IETESTCD.",Inclusion/Exclusion Criterion Short Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IETESTCD,10,Exception Criterion Identifier,What was the identifier of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
570,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Descriptive name of the inclusion or exclusion criterion that was the exception.,Sponsors could automatically populated the text in EDC systems when the criterion identifier is populated by the investigator. This can be verified by the PI to ensure the right exception identifier was selected.,Inclusion/Exclusion Criterion,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable IETESTCD may be determined from the value collected in IETEST. The SDTMIG variables IETESTCD and IETEST are required in the SDTM submission datasets.,IETEST,11,Exception Criterion Description,What was the description of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
571,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MB,Microbiology Specimen,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,An indication of which inclusion criterion was not met or exclusion criterion was met.,"This is only a data collection field when a complete list of inclusion and exclusion criteria are included on the CRF with Yes/No response options. If the sponsor collects only the criteria that are not fulfilled, then, when an inclusion criterion is not met, IEORRES is mapped to ""N"" and when an exclusion criterion is met, IEORRES is mapped to ""Y"".",I/E Criterion Original Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IEORRES,12,(Result),What is the result?,Char,['NY']
572,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
573,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
574,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
575,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
576,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,The date the inclusion and exclusion assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit or the collection date can be included on the Inclusion/Exclusion CRF using the date (IEDAT) field.,Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable IEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
577,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Indication whether the subject met all the eligibility requirements for this study at the time the subject was enrolled.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification if all other fields on the CRF were deliberately left blank.,Any Incl/Excl Criteria Findings,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,IEYN,6,Met Criteria,Were all eligibility criteria met?,Char,['NY']
578,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The date of collection of the inclusion/exclusion criteria represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. The date of collection may be determined from the date of visit (VISDAT) and, if so, a separate assessment date field is not required.",Inclusion/Exclusion Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable IEDTC in ISO 8601 format.",IEDAT,7,Date,What was the date the eligibility criteria assessment was performed?,Char,
579,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping category to denote whether the protocol entry criterion being assessed is inclusion criteria or exclusion criteria.,These categories have been defined in SDTM and have controlled terminology that must be used. Only records for criteria that are not met appear in the IE SDTMIG domain. IECAT must be populated. This criterion category may be collected on the CRF in a tick/checkbox format or it may be included as part of the criterion identification and mapped when the SDTM submission datasets are created.,Inclusion/Exclusion Category,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IECAT,8,Criterion Type,What was the category of the criterion?,Char,['IECAT']
580,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the IECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included as the column heading. This can be used to distinguish criteria for a sub-study or to categorize the criterion as a major or minor exception.",Inclusion/Exclusion Subcategory,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IESCAT,9,[Criterion Subtype]; NULL,What was the subcategory of the criterion?,Char,
581,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,The unique identifier associated with the criterion that was the exception.,"This field is required to appear on the CRF, but may be null if there are no exceptions to the inclusion/exclusion criteria. The CRF should allow multiple exceptions to be recorded. See SDTMIG for assumptions regarding protocol versioning. Sponsors may provide a list of inclusion/exclusion criteria and the unique identifying codes to the site. The list provided should be versioned/updated when the protocol changes and the criteria are changed. Sponsors should use sponsor-developed controlled terminology for IETESTCD.",Inclusion/Exclusion Criterion Short Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IETESTCD,10,Exception Criterion Identifier,What was the identifier of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
582,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Descriptive name of the inclusion or exclusion criterion that was the exception.,Sponsors could automatically populated the text in EDC systems when the criterion identifier is populated by the investigator. This can be verified by the PI to ensure the right exception identifier was selected.,Inclusion/Exclusion Criterion,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable IETESTCD may be determined from the value collected in IETEST. The SDTMIG variables IETESTCD and IETEST are required in the SDTM submission datasets.,IETEST,11,Exception Criterion Description,What was the description of the inclusion criterion the subject did not meet or the exclusion criterion the subject met?,Char,
583,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MI,Microscopic Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,An indication of which inclusion criterion was not met or exclusion criterion was met.,"This is only a data collection field when a complete list of inclusion and exclusion criteria are included on the CRF with Yes/No response options. If the sponsor collects only the criteria that are not fulfilled, then, when an inclusion criterion is not met, IEORRES is mapped to ""N"" and when an exclusion criterion is met, IEORRES is mapped to ""Y"".",I/E Criterion Original Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,IEORRES,12,(Result),What is the result?,Char,['NY']
584,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation.",Study Identifier,Maps directly to the SDTM variable listed in the SDTM Target column .,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
585,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site.",Study Site Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
586,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTM variable listed in the SDTM Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
587,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTM variable listed in the SDTM Target column.,VISIT,4,[Visit],What is the visit name?,Char,
588,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the musculoskeletal system findings assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the MK CRF using the Collection Date (MKDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable VSDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
589,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response to whether or not a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the -STAT variable in SDTM as "" NOT DONE"".",MK Test Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable MKSTAT. If the CDASH variable MKPERF=""N"", the value of the SDTM variable MKSTAT is ""NOT DONE"". If MKPERF= ""Y"", MKSTAT is null. A combination of SDTM variables (e.g., MKCAT and MKSCAT, MKTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable MKTESTCD would be populated with MKALL and an appropriate test name (MKTEST) provided. See SDTMIG for additional information.",MKPERF,6,Musculoskeletal System Findings Collected,Was a musculoskeletal system findings [measurement/examination] collected?,Char,['NY']
590,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the musculoskeletal system findings assessment was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the musculoskeletal system findings assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the MK CRF using the Collection Date (MKDAT) field.",MK Collection Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable MKDTC in ISO 8601 format.",MKDAT,7,Collection Date,What was the date the musculoskeletal system findings assessment was collected?,Char,
591,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time the musculoskeletal system findings assessment was performed, represented in an unambiguous time format (e.g., hh:mm:ss).","A single collection time (e.g., MKTIM) may be collected for all the measurements when they are performed at the same time. The time of each measurement can also be collected using a CDASH variable [MKTESTCD]_MKTIM.",MK Collection Time,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable MKDTC in ISO 8601 format.",MKTIM,8,Collection Time,What was the time the musculoskeletal system findings [measurement/examination] was collected?,Char,
592,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then terms such as ""Planned Time Point"" can be included in the column heading.",MK Planned Time Point Name,"Maps directly to the SDTM variable listed in the SDTM Target column. See the SDTMIG for additional information on representing time points. The SDTM time-point anchors MKTPTREF (text description) and MKRFTDTC (date/time) may be needed, as well as SDTMIG variables MKTPTNUM, MKELTM.",MKTPT,9,[Planned Time Point Name],What is the planned time point for this musculoskeletal system findings [measurement/examination] collection?,Char,
593,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading. MKTEST is most useful as the PROMPT on the field in which the RESULT for that test is collected.",Name of Musculoskeletal Test,Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable MKTESTCD may be determined from the value collected in MKTEST using the Controlled Terminology List MUSCTSCD. The SDTMIG variables MKTESTCD and MKTEST are required in SDTM.,MKTEST,10,[Musculoskeletal System Findings Test Name],What is the musculoskeletal system findings test name?,Char,['MUSCTS']
594,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be a heading on the CRF or screen, not a question to which the site would provide an answer. MKSCAT can only be used if there is a MKCAT. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Musculoskeletal Test,Maps directly to the SDTM variable listed in the SDTM Target column.,MKCAT,11,[Musculoskeletal System Findings Category]; NULL,What is the category of the musculoskeletal system findings [measurement/examination]?,Char,
595,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the MKCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. MKSCAT can only be used if there is a MKCAT, and it must be a subcategorization of MKCAT.",Subcategory for Musculoskeletal Test,Maps directly to the SDTM variable listed in the SDTM Target column.,MKSCAT,12,[Musculoskeletal System Findings Subcategory]; NULL,What was the subcategory of the musculoskeletal system findings [measurement/examination]?,Char,
596,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,MK Test Result in Original Units,Maps directly to the SDTM variable listed in the SDTM Target column.,MKORRES,13,[MKTEST] Result,What was the result of the test?,Char,
597,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",MK Test Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,MKORRESU,14,Unit,What was the unit of the result?,Char,['UNIT']
598,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field MKRES is used when the collected results are not mapped directly to the SDTM variable MKORRES and must be transformed. For example, \n MKRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected.MKORRES is collected using ""Normal"", ""Abnormal"", and a description of the abnormality is collected.",MK Test Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation; for example: \n \n 1. Where MKRES is to used collect normal/abnormal or similar type classifications (e.g., absent/present) with a description of the abnormal result using the CDASH field MKDESC. For SDTM submission datasets, If the CDASH field MKRES = ""NORMAL"", populate the SDTM variables MKORRES and MKSTRESC with the value of the CDASH field MKRES. If the CDASH field MKRES is ""ABNORMAL"", populate the SDTM variable MKORRES with the CDASH field MKDESC. If the reported findings in MKDESC are coded using a dictionary, then the SDTM variable MKSTRESC is populated with the dictionary preferred term and MKMODIFY is populated with the modified text used for coding. If the reported findings in MKDESC are not coded, then the SDTM variable MKSTRESC is populated with the CDASH MKDESC field. The SDTM variable MKNRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. \n 2. Where MKRES is used to collect standardized (e.g., codelist) values on the CRF and the value of ""OTHER"" is included, the CDASH field MKRESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field MKRES field is mapped to the SDTM variable MKSTRESC and the value in the CDASH field MKRESOTH is mapped to the SDTM variable MKORRES. See SDTMIG for additional information.",MKRES,15,(Result),Was the result (normal/abnormal/absent/present/ [sponsored defined response])?,Char,
599,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Text description of musculoskeletal system findings.,"MKRES and MKDESC are used when a question is asked to collect the finding result, with a follow-up question for a description of the finding. See Section 8.3.1, General CDASH Assumptions for Findings Domains.",Musculoskeletal Findings Descriptions,"This does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable MKORRES. If MKRES=""Normal"", populate MKORRES with the value of MKRES. If MKRES=""Abnormal"", populate MKORRES with the value of MKDESC.",MKDESC,16,(Abnormal) Findings,What was the description of the (abnormality/observed finding/[Sponsor-defined])?,Char,
600,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In cases where MKRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field MKRESOTH can be used to collect free-text values for ""Specify Other"".",Musculoskeletal Findings Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field MKRES is mapped to the SDTM variable MKSTRESC and the value in the CDASH field MKRESOTH is mapped to the SDTM variable MKORRES.",MKRESOTH,17,[Specify Other/Explain/Specify Details],"If other is selected, [explain/specify/provide more detail].",Char,
601,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by MKSTNRC or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",MK Findings Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,MKNRIND,18,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
602,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as &quot;Not Done&quot;.",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH MKPERF field. Typically a checkbox which indicates the measurement or examination was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,MK System Findings Completion Status,"Maps directly to the SDTM variable listed in the SDTM Target column. If collected, the Origin (a column in the Define-XML) =""CRF""; if populated from other sources such as free text or sponsor-defined listing for MKREASND, the Origin =""DERIVED"".",MKSTAT,19,Not Done,Indicate if the [MKTEST] was not [answered/done/performed].,Char,['ND']
603,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When MKREASND is used, MKSTAT should also be populated in the SDTM-based dataset.",MK System Findings Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,MKREASND,20,Reason Not [Answered/Collected/Done/Available],Was the was the reason that the musculoskeletal system (measurement/examination/[MKTEST]) was not [collected / answered / done]?,Char,
604,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The position of the subject during a measurement or examination.,"Results may be affected by whether conditions for musculoskeletal measurement or examination, as specified in the protocol, were properly met. One common condition is the subject's position. If the protocol requires this type of information, then a CDASH variable [MKTESTCD]_MKPOS may be created for each MKTESTCD and added to the CRF, if needed.",MK System Findings Position of Subject,Maps directly to the SDTM variable listed in the SDTM Target column.,MKPOS,21,Position,What was the position of the subject during the [measurement/ examination]?,Char,['POSITION']
605,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Location used for the measurement.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.LAT, DIR, and PORTOT are used to further describe the anatomical location.",Musculoskeletal Findings Location,Maps directly to the SDTM variable listed in the SDTM Target column.,MKLOC,22,Anatomical Location,What was the anatomical location where the [measurement/ examination] was [collected/done]?,Char,['LOC']
606,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Musculoskeletal Findings Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,MKLAT,23,Side,What was the side of the anatomical location of the [measurement/ examination]?,Char,['LAT']
607,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Musculoskeletal Findings Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,MKDIR,24,Directionality,What was the directionality of the anatomical location of the [measurement/ examination]?,Char,['DIR']
608,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The method of the test or examination.,"This information may be collected when more than 1 method is possible, and collecting the method used is necessary.",MK Method of Test or Examination,Maps directly to the SDTM variable listed in the SDTM Target column.,MKMETHOD,25,Method,What was the method (used for the [measurement/ examination])?,Char,['METHOD']
609,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Musculoskeletal Test Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,MKEVAL,26,Evaluator,Who was the evaluator?,Char,['EVAL']
610,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in MKEVAL.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Musculoskeletal Test Evaluator ID,Maps directly to the SDTM variable listed in the SDTM Target column.,MKEVALID,27,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
611,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Use where more than one assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",MK Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,MKACPTFL,28,Accepted Evaluation,Was this record considered to be the accepted evaluation?,Char,['NY']
612,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MK,Musculoskeletal System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).",The repetition number of the examination/measurement within the time point may be preprinted on the CRF.,Musculoskeletal Test Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,MKREPNUM,29,Repetition Number,What was the repetition number within the time point for this [measurement/ examination]?,Char,
613,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation.",Study Identifier,Maps directly to the SDTM variable listed in the SDTM Target column .,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
614,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site.",Study Site Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
615,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTM variable listed in the SDTM Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
616,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTM variable listed in the SDTM Target column.,VISIT,4,[Visit],What is the visit name?,Char,
617,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the musculoskeletal system findings assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the MK CRF using the Collection Date (MKDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable VSDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
618,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response to whether or not a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the -STAT variable in SDTM as "" NOT DONE"".",MK Test Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable MKSTAT. If the CDASH variable MKPERF=""N"", the value of the SDTM variable MKSTAT is ""NOT DONE"". If MKPERF= ""Y"", MKSTAT is null. A combination of SDTM variables (e.g., MKCAT and MKSCAT, MKTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable MKTESTCD would be populated with MKALL and an appropriate test name (MKTEST) provided. See SDTMIG for additional information.",MKPERF,6,Musculoskeletal System Findings Collected,Was a musculoskeletal system findings [measurement/examination] collected?,Char,['NY']
619,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the musculoskeletal system findings assessment was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the musculoskeletal system findings assessments were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the MK CRF using the Collection Date (MKDAT) field.",MK Collection Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable MKDTC in ISO 8601 format.",MKDAT,7,Collection Date,What was the date the musculoskeletal system findings assessment was collected?,Char,
620,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time the musculoskeletal system findings assessment was performed, represented in an unambiguous time format (e.g., hh:mm:ss).","A single collection time (e.g., MKTIM) may be collected for all the measurements when they are performed at the same time. The time of each measurement can also be collected using a CDASH variable [MKTESTCD]_MKTIM.",MK Collection Time,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable MKDTC in ISO 8601 format.",MKTIM,8,Collection Time,What was the time the musculoskeletal system findings [measurement/examination] was collected?,Char,
621,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then terms such as ""Planned Time Point"" can be included in the column heading.",MK Planned Time Point Name,"Maps directly to the SDTM variable listed in the SDTM Target column. See the SDTMIG for additional information on representing time points. The SDTM time-point anchors MKTPTREF (text description) and MKRFTDTC (date/time) may be needed, as well as SDTMIG variables MKTPTNUM, MKELTM.",MKTPT,9,[Planned Time Point Name],What is the planned time point for this musculoskeletal system findings [measurement/examination] collection?,Char,
622,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading. MKTEST is most useful as the PROMPT on the field in which the RESULT for that test is collected.",Name of Musculoskeletal Test,Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable MKTESTCD may be determined from the value collected in MKTEST using the Controlled Terminology List MUSCTSCD. The SDTMIG variables MKTESTCD and MKTEST are required in SDTM.,MKTEST,10,[Musculoskeletal System Findings Test Name],What is the musculoskeletal system findings test name?,Char,['MUSCTS']
623,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be a heading on the CRF or screen, not a question to which the site would provide an answer. MKSCAT can only be used if there is a MKCAT. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Musculoskeletal Test,Maps directly to the SDTM variable listed in the SDTM Target column.,MKCAT,11,[Musculoskeletal System Findings Category]; NULL,What is the category of the musculoskeletal system findings [measurement/examination]?,Char,
624,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the MKCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. MKSCAT can only be used if there is a MKCAT, and it must be a subcategorization of MKCAT.",Subcategory for Musculoskeletal Test,Maps directly to the SDTM variable listed in the SDTM Target column.,MKSCAT,12,[Musculoskeletal System Findings Subcategory]; NULL,What was the subcategory of the musculoskeletal system findings [measurement/examination]?,Char,
625,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,MK Test Result in Original Units,Maps directly to the SDTM variable listed in the SDTM Target column.,MKORRES,13,[MKTEST] Result,What was the result of the test?,Char,
626,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",MK Test Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,MKORRESU,14,Unit,What was the unit of the result?,Char,['UNIT']
627,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field MKRES is used when the collected results are not mapped directly to the SDTM variable MKORRES and must be transformed. For example, \n MKRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected.MKORRES is collected using ""Normal"", ""Abnormal"", and a description of the abnormality is collected.",MK Test Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation; for example: \n \n 1. Where MKRES is to used collect normal/abnormal or similar type classifications (e.g., absent/present) with a description of the abnormal result using the CDASH field MKDESC. For SDTM submission datasets, If the CDASH field MKRES = ""NORMAL"", populate the SDTM variables MKORRES and MKSTRESC with the value of the CDASH field MKRES. If the CDASH field MKRES is ""ABNORMAL"", populate the SDTM variable MKORRES with the CDASH field MKDESC. If the reported findings in MKDESC are coded using a dictionary, then the SDTM variable MKSTRESC is populated with the dictionary preferred term and MKMODIFY is populated with the modified text used for coding. If the reported findings in MKDESC are not coded, then the SDTM variable MKSTRESC is populated with the CDASH MKDESC field. The SDTM variable MKNRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. \n 2. Where MKRES is used to collect standardized (e.g., codelist) values on the CRF and the value of ""OTHER"" is included, the CDASH field MKRESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field MKRES field is mapped to the SDTM variable MKSTRESC and the value in the CDASH field MKRESOTH is mapped to the SDTM variable MKORRES. See SDTMIG for additional information.",MKRES,15,(Result),Was the result (normal/abnormal/absent/present/ [sponsored defined response])?,Char,
628,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Text description of musculoskeletal system findings.,"MKRES and MKDESC are used when a question is asked to collect the finding result, with a follow-up question for a description of the finding. See Section 8.3.1, General CDASH Assumptions for Findings Domains.",Musculoskeletal Findings Descriptions,"This does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable MKORRES. If MKRES=""Normal"", populate MKORRES with the value of MKRES. If MKRES=""Abnormal"", populate MKORRES with the value of MKDESC.",MKDESC,16,(Abnormal) Findings,What was the description of the (abnormality/observed finding/[Sponsor-defined])?,Char,
629,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In cases where MKRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field MKRESOTH can be used to collect free-text values for ""Specify Other"".",Musculoskeletal Findings Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field MKRES is mapped to the SDTM variable MKSTRESC and the value in the CDASH field MKRESOTH is mapped to the SDTM variable MKORRES.",MKRESOTH,17,[Specify Other/Explain/Specify Details],"If other is selected, [explain/specify/provide more detail].",Char,
630,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by MKSTNRC or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",MK Findings Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,MKNRIND,18,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
631,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as &quot;Not Done&quot;.",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH MKPERF field. Typically a checkbox which indicates the measurement or examination was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,MK System Findings Completion Status,"Maps directly to the SDTM variable listed in the SDTM Target column. If collected, the Origin (a column in the Define-XML) =""CRF""; if populated from other sources such as free text or sponsor-defined listing for MKREASND, the Origin =""DERIVED"".",MKSTAT,19,Not Done,Indicate if the [MKTEST] was not [answered/done/performed].,Char,['ND']
632,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When MKREASND is used, MKSTAT should also be populated in the SDTM-based dataset.",MK System Findings Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,MKREASND,20,Reason Not [Answered/Collected/Done/Available],Was the was the reason that the musculoskeletal system (measurement/examination/[MKTEST]) was not [collected / answered / done]?,Char,
633,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The position of the subject during a measurement or examination.,"Results may be affected by whether conditions for musculoskeletal measurement or examination, as specified in the protocol, were properly met. One common condition is the subject's position. If the protocol requires this type of information, then a CDASH variable [MKTESTCD]_MKPOS may be created for each MKTESTCD and added to the CRF, if needed.",MK System Findings Position of Subject,Maps directly to the SDTM variable listed in the SDTM Target column.,MKPOS,21,Position,What was the position of the subject during the [measurement/ examination]?,Char,['POSITION']
634,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Location used for the measurement.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.LAT, DIR, and PORTOT are used to further describe the anatomical location.",Musculoskeletal Findings Location,Maps directly to the SDTM variable listed in the SDTM Target column.,MKLOC,22,Anatomical Location,What was the anatomical location where the [measurement/ examination] was [collected/done]?,Char,['LOC']
635,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Musculoskeletal Findings Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,MKLAT,23,Side,What was the side of the anatomical location of the [measurement/ examination]?,Char,['LAT']
636,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Musculoskeletal Findings Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,MKDIR,24,Directionality,What was the directionality of the anatomical location of the [measurement/ examination]?,Char,['DIR']
637,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The method of the test or examination.,"This information may be collected when more than 1 method is possible, and collecting the method used is necessary.",MK Method of Test or Examination,Maps directly to the SDTM variable listed in the SDTM Target column.,MKMETHOD,25,Method,What was the method (used for the [measurement/ examination])?,Char,['METHOD']
638,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Musculoskeletal Test Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,MKEVAL,26,Evaluator,Who was the evaluator?,Char,['EVAL']
639,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in MKEVAL.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Musculoskeletal Test Evaluator ID,Maps directly to the SDTM variable listed in the SDTM Target column.,MKEVALID,27,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
640,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Use where more than one assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",MK Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,MKACPTFL,28,Accepted Evaluation,Was this record considered to be the accepted evaluation?,Char,['NY']
641,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",MS,Microbiology Susceptibility,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).",The repetition number of the examination/measurement within the time point may be preprinted on the CRF.,Musculoskeletal Test Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,MKREPNUM,29,Repetition Number,What was the repetition number within the time point for this [measurement/ examination]?,Char,
642,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation.",Study Identifier,Maps directly to the SDTM variable listed in the SDTM Target column .,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
643,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
644,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTM variable listed in the SDTM Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
645,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTM variable listed in the SDTM Target column.,VISIT,4,[Visit],What is the visit name?,Char,
646,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the NV measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the NV CRF using the Nervous System Assessments (NVDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable NVDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
647,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response to whether or not a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the -STAT variable in SDTM as "" NOT DONE"".",Neurology Assessment Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable NVSTAT. If the CDASH variable NVPERF=""N"", the value of the SDTM variable NVSTAT is ""NOT DONE"". If NVPERF= ""Y"", NVSTAT is null. A combination of SDTM variables (e.g., NVCAT and NVSCAT, NVTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable NVTESTCD would be populated with NVALL and an appropriate test name (NVTEST) provided. See the SDTMIG for additional information.",NVPERF,6,Neurology Assessment Performed,Was a neurology assessment performed?,Char,['NY']
648,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the neurology measurement was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the NV measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the NV CRF using the Date of Collection (NVDAT) field.",Neurology Assessment Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable NVDTC in ISO 8601 format.",NVDAT,7,Date,What was the date the neurology measurement was taken?,Char,
649,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",May be required when multiple assessments are done on 1 day or when the timing in relationship to study treatment is required for analysis,Neurology Assessment Time,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable NVDTC in ISO 8601 format.",NVTIM,8,Time,What was the time of the neurology measurement?,Char,
650,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then terms such as ""Planned Time Point"" can be included in the column heading.",NV Planned Time Point Name,"Maps directly to the SDTM variable listed in the SDTM Target column. See the SDTMIG for additional information on representing time points. The SDTM time-point anchors NVTPTREF (text description) and NVRFTDTC (date/time) may be needed, as well as SDTMIG variables NVTPTNUM, NVELTM.",NVTPT,9,[Planned Time Point Name],What is the planned time point for this neurology assessment measurement?,Char,
651,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading. NVTEST is most useful as the PROMPT on the field in which the RESULT for that test is collected.",Neurology Test Name,Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable NVTESTCD may be determined from the value collected in NVTEST using the Controlled Terminology List NVTESTCD. The SDTMIG variables NVTESTCD and NVTEST are required in SDTM.,NVTEST,10,[Neurology Test Name],What is the neurology test name?,Char,['NVTEST']
652,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Neurology Test,Maps directly to the SDTM variable listed in the SDTM Target column.,NVCAT,12,[Neurology Assessment Category]; NULL,What was the category of the neurology assessment?,Char,
653,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the NVCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. NVSCAT can only be used if there is a NVCAT, and it must be a subcategorization of NVCAT.",Subcategory for Neurology Test,Maps directly to the SDTM variable listed in the SDTM Target column.,NVSCAT,13,[Neurology Assessment Subcategory]; NULL,What was the subcategory of the neurology assessment?,Char,
654,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,Neurology Test Result in Original Units,Maps directly to the SDTM variable listed in the SDTM Target column.,NVORRES,14,[NVTEST] Result,What was the result of the measurement?,Char,
655,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Neurology Test Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,NVORRESU,15,Unit,What was the unit of the result?,Char,['UNIT']
656,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field NVRES is used when the collected results are not mapped directly to the SDTM variable NVORRES and must be transformed. For example,NVRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected.NVORRES is collected using ""Normal"", ""Abnormal"", and a description of the abnormality is collected.",Neurology Test Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation; for example: \n 1. Where NVRES is to used collect Normal, Abnormal or similar type classifications (e.g., Absent/Present) with a description of the abnormal result using the CDASH field NVDESC. For SDTM submission datasets, If the CDASH field NVRES = ""NORMAL"", populate the SDTM variables NVORRES and NVSTRESC with the value of the CDASH field NVRES. If the CDASH field NVRES is ""ABNORMAL"", populate the SDTM variable NVORRES with the CDASH field NVDESC. If the reported findings in NVDESC are coded using a dictionary, then the SDTM variable NVSTRESC is populated with the dictionary preferred term and NVMODIFY is populated with the modified text used for coding. If the reported findings in NVDESC are not coded, then the SDTM variable NVSTRESC is populated with the CDASH NVDESC field. The SDTM variable NVNRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. \n 2. Where NVRES is used to collect standardized values (e.g. a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field NVRESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field NVRES field is mapped to the SDTM variable NVSTRESC and the value in the CDASH field NVRESOTH is mapped to the SDTM variable NVORRES. See the SDTMIG for additional information.",NVRES,16,(Result),Was the result (normal/abnormal/absent/present/ [sponsored defined response])?,Char,
657,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Text description of neurology test findings.,"NVRES and NVDESC are used when a question is asked to collect the finding result, with a follow-up question for a description of the finding. See CDASH General finding Assumptions",Description of Neurology Test Finding,"This does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable NVORRES. If NVRES=""Normal"", populate NVORRES with the value of NVRES. If NVRES=""Abnormal"", populate NVORRES with the value of NVDESC.",NVDESC,17,(Abnormal) Findings,What was the description of the (abnormality/observed finding/[Sponsor-defined])?,Char,
658,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In cases where NVRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field NVRESOTH can be used to collect free-text values for ""Specify Other"".",Neurology Test Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field NVRESOTH is mapped to the SDTM variable NVSTRESC and the value in the CDASH field NVRESOTH is mapped to the SDTM variable NVORRES.",NVRESOTH,18,[Specify Other/Explain/Specify Details],"If other is selected, [explain/specify/provide more detail].",Char,
659,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The lower end of normal range or reference range for continuous results stored in NVORRES.,NVORNRLO should be populated only for continuous findings. The SDTM variable NVSTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site or lab specific set of normal ranges stored in a look-up table.,NV Ref Range Lower Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,NVORNRLO,19,Normal Range Lower Limit,What was the lower limit of the reference range?,Char,
660,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The upper end of normal range or reference range for continuous results stored in NVORRES.,NVORNRHI should be populated only for continuous findings. The SDTM variable NVSTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site or lab specific set of normal ranges stored in a look-up table.,NV Ref Range Upper Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,NVORNRHI,20,Normal Range Upper Limit,What was the upper limit of the reference range?,Char,
661,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by NVORNRLO, NVORNRHI, NVSTNRC or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",NV Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,NVNRIND,21,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
662,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as &quot;Not Done&quot;.",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH NVPERF field. Typically a checkbox which indicates the test was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,Neurology Test Completion Status,"Maps directly to the SDTM variable listed in the SDTM Target column. If collected, the Origin (a column in the Define-XML) =""CRF""; if populated from other sources such as free text or sponsor-defined listing for NVREASND, the Origin =""DERIVED"".",NVSTAT,22,Not Done,Indicate if the [NVTEST] was not [answered/assessed/done/evaluated/performed].,Char,['ND']
663,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When NVREASND is used, NVSTAT should also be populated in the SDTM-based dataset.",Neurology Test Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,NVREASND,23,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],Was the was the reason that the neurology (assessment/[NVTEST]) was not [collected / answered / done / assessed / evaluated]?,Char,
664,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The position of the subject during a measurement or examination.,"Results may be affected by whether conditions for neurology test, as specified in the protocol, were properly met. One common condition is the subject's position. If the protocol requires this type of information, then a CDASH variable [NVTESTCD]_NVPOS may be created for each NVTESTCD and added to the CRF, if needed.",Position of Subject During Observation,Maps directly to the SDTM variable listed in the SDTM Target column.,NVPOS,24,Position,What was the position of the subject during the assessment?,Char,['POSITION']
665,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Location used for the measurement.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.LAT, DIR, and PORTOT are used to further describe the anatomical location.",Location,Maps directly to the SDTM variable listed in the SDTM Target column.,NVLOC,25,Anatomical Location,What was the anatomical location where the measurement was taken?,Char,['LOC']
666,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,NVLAT,26,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
667,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,NVDIR,27,Directionality,What was the directionality of the anatomical location of the neurology test?,Char,['DIR']
668,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The method of the test or examination.,"This information may be collected when more than 1 method is possible, and collecting the method used is necessary.",Method of Neurology Test,Maps directly to the SDTM variable listed in the SDTM Target column.,NVMETHOD,28,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
669,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Neurology Test Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,NVEVAL,29,Evaluator,Who was the evaluator?,Char,['EVAL']
670,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in NVEVAL.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Neurology Test Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,NVEVALID,30,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
671,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).",The repetition number of the test/measurement within the time point may be preprinted on the CRF.,Neurology Test Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,NVREPNUM,31,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
672,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",NV,Nervous System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether the test results were clinically significant.,"Could apply to specific measurements or to overall interpretation, as required by the protocol.",Neurology Test Clinical Significance,Maps directly to the SDTM variable listed in the SDTM Target column.,NVCLSIG,32,Clinically Significant,Was this result clinically significant?,Char,['NY']
673,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
674,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
675,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTM.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
676,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
677,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the OE measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the OE CRF using the Ophthalmic Examinations (OEDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable OEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
678,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"An identifier used for the identification of a focus of study-specific interest on or within a subject or specimen (as described in the protocol), for which a measurement, test, or examination was performed, such as a drug application site (e.g., ""Injection site 1"", ""Biopsy site 1"", ""Treated site 1""), or a more specific focus (e.g., ""OD"" (right eye), ""Upper left quadrant of the back""). The value in this variable should have inherent semantic meaning.",This variable is expected to be populated for ophthalmic studies. It is used as the key identifying variable to denote the focus (which eye or eyes) of the test finding or observation.,Focus of Study-specific Interest,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FOCID,6,Eye/Eyes,Which eye/eyes?,Char,['OEFOCUS']
679,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response regarding whether a planned measurement, test, or observation was performed. A negative response can be collected as ""N"" and mapped to the --STAT variable in SDTM as ""NOT DONE"".",Ophthalmic Examination Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable OESTAT. If the CDASH variable OEPERF=""N"", the value of the SDTM variable OESTAT is ""NOT DONE"". If OEPERF= ""Y"", OESTAT is null. A combination of SDTM variables (e.g., OECAT and OESCAT, OETPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable OETESTCD would be populated with OEALL and an appropriate test name (OETEST) provided. See SDTMIG v3.3 Section 4.5.1.2.",OEPERF,7,Ophthalmic Examination Performed,Was an ophthalmic examination performed?,Char,['NY']
680,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the ophthalmic examination measurement, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date of measurement can be determined from a collected date of visit (VISDAT); in such cases, a separate measurement date field is not required.",Ophthalmic Examination Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable OEDTC in ISO 8601 format.",OEDAT,8,Date,What was the date of the ophthalmic examination measurement?,Char,
681,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of the measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",May be required when multiple assessments are done on 1 day or when the timing in relationship to study treatment is required for analysis,Ophthalmic Examination Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable VSDTC in ISO 8601 format.",OETIM,9,Time,What was the time the ophthalmic examination measurement?,Char,
682,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for the test being performed.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included as the column heading. OETEST is most useful as the PROMPT on the field in which the RESULT for that test is collected. See CDASHIG metadata tables for domain-specific TEST codelist names (e.g. EGTEST, FATEST).","Name of Measurement, Test or Examination",Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable OETESTCD may be determined from the value collected in OETEST. The SDTMIG variables OETESTCD and OETEST are required in SDTM.,OETEST,10,[Ophthalmic Examination] Test Name,What was the name of the ophthalmic [measurement/test/examination]?,Char,['OETEST']
683,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A further description of OETESTCD and OETEST.,"It is recommended that the test detail name be preprinted on the CRF. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading.","Measurement, Test or Examination Detail",Maps directly to the SDTM variable listed in the SDTM Target column.,OETSTDTL,11,[Measurement/Test/Examination] Detail (Name),What was the [measurement/test/examination] detail name?,Char,
684,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category,Maps directly to the SDTM variable listed in the SDTM Target column.,OECAT,12,[Ophthalmic Examination Category]; NULL,What was the [type/category] of the ophthalmic examination?,Char,
685,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the OECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be a heading on the CRF or screen, not a question to which the site would provide an answer. OESCAT can only be used if there is a OECAT. Examples are provided in the CDASHIG metadata table and in the SDTMIG. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. OESCAT can only be used if there is a OECAT.",Subcategory,Maps directly to the SDTM variable listed in the SDTM Target column.,OESCAT,13,[Ophthalmic Examination Subcategory]; NULL,What was the [subtype/subcategory] of the ophthalmic examination?,Char,
686,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,Result of Finding in Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORRES,14,([Result/Amount] of) [value from OETEST]; NULL,What was the result of the ophthalmic examination test?,Char,
687,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORRESU,15,Unit,What was the unit (of the [measurement/test/examination])?,Char,['UNIT']
688,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field OERES is used when the collected results are not mapped directly to the SDTM variable OEORRES and must be mapped, for example: OERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected. OERES is collected using Normal, Abnormal and a description of the abnormality is collected.",Collected Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation, for example: Where OERES Normal, Abnormal or other similar type classifications (e.g., absent/present) with a description of the abnormal result using the CDASH field OEDESC. For SDTM submission datasets, If the CDASH field OERES = ""NORMAL"", populate the SDTM variables OEORRES and OESTRESC with the value of the CDASH field OERES. If the CDASH field OERES is ""ABNORMAL"", populate the SDTM variable OEORRES with the CDASH field OEDESC. If the reported findings in OEDESC are coded using a dictionary, then the SDTM variable OESTRESC is populated with the dictionary preferred term and OEMODIFY is populated with the modified text used for coding. If the reported findings in OEDESC are not coded, then the SDTM variable OESTRESC is populated with the CDASH OEDESC field. The SDTM variable OENRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. Where OERES is used to collect standardized values (e.g., a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field OERESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field OERES field is mapped to the SDTM variable OESTRESC and the value in the CDASH field OERESOTH is mapped to the SDTM variable OEORRES. See the SDTMIG for additional information.",OERES,16,([Result/Amount] of) [value from OETEST],What [is/was] the [result/amount] (of the [measurement/test/examination])?; [Is/Was] the result [normal/abnormal/absent/present/ sponsored defined response]?,Char,
689,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In a case where OERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field OERESOTH can be used to collect free-text values for ""Specify Other"".",Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field OERES is mapped to the SDTM variable OESTRESC and the value in the CDASH field OERESOTH is mapped to the SDTM variable OEORRES. See the SDTMIG for additional information.",OERESOTH,17,Specify ([Other/Details]),"If other is selected, [explain/specify/provide more detail].",Char,
690,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The lower end of normal range or reference range for continuous results stored in OEORRES.,OEORNRLO should be populated only for continuous findings. The SDTM variable OESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Normal Range Lower Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORNRLO,18,Normal Range Lower Limit,What was the lower limit of the reference range (for the [measurement/test/examination]?,Char,
691,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The upper end of normal range or reference range for continuous results stored in OEORRES.,OEORNRHI should be populated only for continuous findings. The SDTM variable OESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Normal Range Upper Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORNRHI,19,Normal Range Upper Limit,What was the upper limit of the reference range (for the [measurement/test/examination])?,Char,
692,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Normal references ranges that are expressed as characters (""Negative to Trace"") or ordinal (-1 to 1).",Should be populated for normal ranges that are reported as character in ordinal scale or if categorical ranges were supplied. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Collected Character/Ordinal Normal Range,Maps directly to the SDTM variable listed in the SDTM Target column.,OECSTNRC,20,Normal Reference Range,What was the normal reference range (for this [measurement/test/examination])?,Char,
693,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by OEORNRLO, OEORNRHI, OESTNRC, or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",Normal/Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,OENRIND,21,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
694,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indicator of the result of a finding or medical status per interpretation of test results.,"Used to categorize the result of a finding or medical status per interpretation of test results (e.g., ""POSITIVE"", ""NEGATIVE""). The variable OERESCAT is not meant to replace the use of OENRIND for cases where normal ranges are provided.",Result Category,Maps directly to the SDTM variable listed in the SDTM Target column.,OERESCAT,22,Result Category,What is the the category for the reported values?,Char,
695,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation of why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When OEREASND is used, OESTAT should also be populated in the SDTM-based dataset.",Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,OEREASND,23,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],What was the reason that the [ophthalmic examination finding] was not [collected/answered/done/assessed/evaluated]?,Char,
696,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The anatomical location of the subject, relevant to the collection of the measurement.","For the OE domain, this value is prepopulated as ""EYE"". It does not need to be preprinted on the CRF or collected.",Location,Maps directly to the SDTM variable listed in the SDTM Target column.,OELOC,24,Anatomical Location,What was the anatomical location of the ophthalmic examination?,Char,['LOC']
697,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.","Further detailing the laterality of the location of the OETEST within a given eye. It should never be used to designate ""Right Eye"" versus ""Left Eye"". OEFOCID is used to denote which eye is the focus of the observation. This may be preprinted or collected.",Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,OELAT,25,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
698,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.","Further detailing the directionality of the location of the OETEST (e.g., ANTERIOR, LOWER, PROXIMAL). This may be preprinted or collected. Sponsors may collect the data using a subset list of CT on the CRF.",Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,OEDIR,26,Directionality,What was the directionality (of the anatomical location of the [measurement/test/examination])?,Char,['DIR']
699,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Further detailing the portion or totality of the location of the OETEST. This may be preprinted or collected.,Portion or Totality,Maps directly to the SDTM variable listed in the SDTM Target column.,OEPORTOT,27,Portion or Totality,What was the portion or totality (of the anatomical location of the [measurement/test/examination])?,Char,['PORTOT']
700,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The method of the test or examination.,,Method of Test or Examination,Maps directly to the SDTM variable listed in the SDTM Target column.,OEMETHOD,28,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
701,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted, or collected. Sponsors may collect the data using a subset list of CT on the CRF.",Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,OEEVAL,29,Evaluator,Who was the evaluator?,Char,['EVAL']
702,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in OEEVAL.,,Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,OEEVALID,30,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
703,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Used where more than 1 assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,OEACPTFL,31,[Accepted/Final] Evaluation,Is this record considered to be the [accepted/final] evaluation?,Char,['NY']
704,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",OE,Ophthalmic Examinations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).","The repetition number of the test/measurement within the time point may be preprinted on the CRF (e.g., multiple measurements of blood pressure, multiple analyses of a sample.",Ophthalmic Examination Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,OEREPNUM,32,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
705,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
706,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
707,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTM.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
708,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
709,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the OE measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the OE CRF using the Ophthalmic Examinations (OEDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable OEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
710,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"An identifier used for the identification of a focus of study-specific interest on or within a subject or specimen (as described in the protocol), for which a measurement, test, or examination was performed, such as a drug application site (e.g., ""Injection site 1"", ""Biopsy site 1"", ""Treated site 1""), or a more specific focus (e.g., ""OD"" (right eye), ""Upper left quadrant of the back""). The value in this variable should have inherent semantic meaning.",This variable is expected to be populated for ophthalmic studies. It is used as the key identifying variable to denote the focus (which eye or eyes) of the test finding or observation.,Focus of Study-specific Interest,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FOCID,6,Eye/Eyes,Which eye/eyes?,Char,['OEFOCUS']
711,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response regarding whether a planned measurement, test, or observation was performed. A negative response can be collected as ""N"" and mapped to the --STAT variable in SDTM as ""NOT DONE"".",Ophthalmic Examination Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable OESTAT. If the CDASH variable OEPERF=""N"", the value of the SDTM variable OESTAT is ""NOT DONE"". If OEPERF= ""Y"", OESTAT is null. A combination of SDTM variables (e.g., OECAT and OESCAT, OETPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable OETESTCD would be populated with OEALL and an appropriate test name (OETEST) provided. See SDTMIG v3.3 Section 4.5.1.2.",OEPERF,7,Ophthalmic Examination Performed,Was an ophthalmic examination performed?,Char,['NY']
712,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the ophthalmic examination measurement, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date of measurement can be determined from a collected date of visit (VISDAT); in such cases, a separate measurement date field is not required.",Ophthalmic Examination Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable OEDTC in ISO 8601 format.",OEDAT,8,Date,What was the date of the ophthalmic examination measurement?,Char,
713,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of the measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",May be required when multiple assessments are done on 1 day or when the timing in relationship to study treatment is required for analysis,Ophthalmic Examination Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable VSDTC in ISO 8601 format.",OETIM,9,Time,What was the time the ophthalmic examination measurement?,Char,
714,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for the test being performed.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included as the column heading. OETEST is most useful as the PROMPT on the field in which the RESULT for that test is collected. See CDASHIG metadata tables for domain-specific TEST codelist names (e.g. EGTEST, FATEST).","Name of Measurement, Test or Examination",Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable OETESTCD may be determined from the value collected in OETEST. The SDTMIG variables OETESTCD and OETEST are required in SDTM.,OETEST,10,[Ophthalmic Examination] Test Name,What was the name of the ophthalmic [measurement/test/examination]?,Char,['OETEST']
715,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A further description of OETESTCD and OETEST.,"It is recommended that the test detail name be preprinted on the CRF. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading.","Measurement, Test or Examination Detail",Maps directly to the SDTM variable listed in the SDTM Target column.,OETSTDTL,11,[Measurement/Test/Examination] Detail (Name),What was the [measurement/test/examination] detail name?,Char,
716,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category,Maps directly to the SDTM variable listed in the SDTM Target column.,OECAT,12,[Ophthalmic Examination Category]; NULL,What was the [type/category] of the ophthalmic examination?,Char,
717,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the OECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be a heading on the CRF or screen, not a question to which the site would provide an answer. OESCAT can only be used if there is a OECAT. Examples are provided in the CDASHIG metadata table and in the SDTMIG. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. OESCAT can only be used if there is a OECAT.",Subcategory,Maps directly to the SDTM variable listed in the SDTM Target column.,OESCAT,13,[Ophthalmic Examination Subcategory]; NULL,What was the [subtype/subcategory] of the ophthalmic examination?,Char,
718,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,Result of Finding in Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORRES,14,([Result/Amount] of) [value from OETEST]; NULL,What was the result of the ophthalmic examination test?,Char,
719,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORRESU,15,Unit,What was the unit (of the [measurement/test/examination])?,Char,['UNIT']
720,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field OERES is used when the collected results are not mapped directly to the SDTM variable OEORRES and must be mapped, for example: OERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected. OERES is collected using Normal, Abnormal and a description of the abnormality is collected.",Collected Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation, for example: Where OERES Normal, Abnormal or other similar type classifications (e.g., absent/present) with a description of the abnormal result using the CDASH field OEDESC. For SDTM submission datasets, If the CDASH field OERES = ""NORMAL"", populate the SDTM variables OEORRES and OESTRESC with the value of the CDASH field OERES. If the CDASH field OERES is ""ABNORMAL"", populate the SDTM variable OEORRES with the CDASH field OEDESC. If the reported findings in OEDESC are coded using a dictionary, then the SDTM variable OESTRESC is populated with the dictionary preferred term and OEMODIFY is populated with the modified text used for coding. If the reported findings in OEDESC are not coded, then the SDTM variable OESTRESC is populated with the CDASH OEDESC field. The SDTM variable OENRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. Where OERES is used to collect standardized values (e.g., a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field OERESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field OERES field is mapped to the SDTM variable OESTRESC and the value in the CDASH field OERESOTH is mapped to the SDTM variable OEORRES. See the SDTMIG for additional information.",OERES,16,([Result/Amount] of) [value from OETEST],What [is/was] the [result/amount] (of the [measurement/test/examination])?; [Is/Was] the result [normal/abnormal/absent/present/ sponsored defined response]?,Char,
721,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In a case where OERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field OERESOTH can be used to collect free-text values for ""Specify Other"".",Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field OERES is mapped to the SDTM variable OESTRESC and the value in the CDASH field OERESOTH is mapped to the SDTM variable OEORRES. See the SDTMIG for additional information.",OERESOTH,17,Specify ([Other/Details]),"If other is selected, [explain/specify/provide more detail].",Char,
722,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The lower end of normal range or reference range for continuous results stored in OEORRES.,OEORNRLO should be populated only for continuous findings. The SDTM variable OESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Normal Range Lower Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORNRLO,18,Normal Range Lower Limit,What was the lower limit of the reference range (for the [measurement/test/examination]?,Char,
723,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The upper end of normal range or reference range for continuous results stored in OEORRES.,OEORNRHI should be populated only for continuous findings. The SDTM variable OESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Normal Range Upper Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORNRHI,19,Normal Range Upper Limit,What was the upper limit of the reference range (for the [measurement/test/examination])?,Char,
724,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Normal references ranges that are expressed as characters (""Negative to Trace"") or ordinal (-1 to 1).",Should be populated for normal ranges that are reported as character in ordinal scale or if categorical ranges were supplied. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Collected Character/Ordinal Normal Range,Maps directly to the SDTM variable listed in the SDTM Target column.,OECSTNRC,20,Normal Reference Range,What was the normal reference range (for this [measurement/test/examination])?,Char,
725,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by OEORNRLO, OEORNRHI, OESTNRC, or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",Normal/Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,OENRIND,21,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
726,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indicator of the result of a finding or medical status per interpretation of test results.,"Used to categorize the result of a finding or medical status per interpretation of test results (e.g., ""POSITIVE"", ""NEGATIVE""). The variable OERESCAT is not meant to replace the use of OENRIND for cases where normal ranges are provided.",Result Category,Maps directly to the SDTM variable listed in the SDTM Target column.,OERESCAT,22,Result Category,What is the the category for the reported values?,Char,
727,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation of why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When OEREASND is used, OESTAT should also be populated in the SDTM-based dataset.",Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,OEREASND,23,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],What was the reason that the [ophthalmic examination finding] was not [collected/answered/done/assessed/evaluated]?,Char,
728,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The anatomical location of the subject, relevant to the collection of the measurement.","For the OE domain, this value is prepopulated as ""EYE"". It does not need to be preprinted on the CRF or collected.",Location,Maps directly to the SDTM variable listed in the SDTM Target column.,OELOC,24,Anatomical Location,What was the anatomical location of the ophthalmic examination?,Char,['LOC']
729,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.","Further detailing the laterality of the location of the OETEST within a given eye. It should never be used to designate ""Right Eye"" versus ""Left Eye"". OEFOCID is used to denote which eye is the focus of the observation. This may be preprinted or collected.",Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,OELAT,25,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
730,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.","Further detailing the directionality of the location of the OETEST (e.g., ANTERIOR, LOWER, PROXIMAL). This may be preprinted or collected. Sponsors may collect the data using a subset list of CT on the CRF.",Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,OEDIR,26,Directionality,What was the directionality (of the anatomical location of the [measurement/test/examination])?,Char,['DIR']
731,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Further detailing the portion or totality of the location of the OETEST. This may be preprinted or collected.,Portion or Totality,Maps directly to the SDTM variable listed in the SDTM Target column.,OEPORTOT,27,Portion or Totality,What was the portion or totality (of the anatomical location of the [measurement/test/examination])?,Char,['PORTOT']
732,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The method of the test or examination.,,Method of Test or Examination,Maps directly to the SDTM variable listed in the SDTM Target column.,OEMETHOD,28,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
733,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted, or collected. Sponsors may collect the data using a subset list of CT on the CRF.",Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,OEEVAL,29,Evaluator,Who was the evaluator?,Char,['EVAL']
734,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in OEEVAL.,,Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,OEEVALID,30,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
735,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Used where more than 1 assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,OEACPTFL,31,[Accepted/Final] Evaluation,Is this record considered to be the [accepted/final] evaluation?,Char,['NY']
736,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PC,Pharmacokinetics Concentrations,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).","The repetition number of the test/measurement within the time point may be preprinted on the CRF (e.g., multiple measurements of blood pressure, multiple analyses of a sample.",Ophthalmic Examination Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,OEREPNUM,32,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
737,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
738,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
739,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTM.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
740,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
741,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the OE measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the OE CRF using the Ophthalmic Examinations (OEDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable OEDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
742,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"An identifier used for the identification of a focus of study-specific interest on or within a subject or specimen (as described in the protocol), for which a measurement, test, or examination was performed, such as a drug application site (e.g., ""Injection site 1"", ""Biopsy site 1"", ""Treated site 1""), or a more specific focus (e.g., ""OD"" (right eye), ""Upper left quadrant of the back""). The value in this variable should have inherent semantic meaning.",This variable is expected to be populated for ophthalmic studies. It is used as the key identifying variable to denote the focus (which eye or eyes) of the test finding or observation.,Focus of Study-specific Interest,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FOCID,6,Eye/Eyes,Which eye/eyes?,Char,['OEFOCUS']
743,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response regarding whether a planned measurement, test, or observation was performed. A negative response can be collected as ""N"" and mapped to the --STAT variable in SDTM as ""NOT DONE"".",Ophthalmic Examination Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable OESTAT. If the CDASH variable OEPERF=""N"", the value of the SDTM variable OESTAT is ""NOT DONE"". If OEPERF= ""Y"", OESTAT is null. A combination of SDTM variables (e.g., OECAT and OESCAT, OETPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable OETESTCD would be populated with OEALL and an appropriate test name (OETEST) provided. See SDTMIG v3.3 Section 4.5.1.2.",OEPERF,7,Ophthalmic Examination Performed,Was an ophthalmic examination performed?,Char,['NY']
744,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the ophthalmic examination measurement, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date of measurement can be determined from a collected date of visit (VISDAT); in such cases, a separate measurement date field is not required.",Ophthalmic Examination Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable OEDTC in ISO 8601 format.",OEDAT,8,Date,What was the date of the ophthalmic examination measurement?,Char,
745,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of the measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",May be required when multiple assessments are done on 1 day or when the timing in relationship to study treatment is required for analysis,Ophthalmic Examination Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable VSDTC in ISO 8601 format.",OETIM,9,Time,What was the time the ophthalmic examination measurement?,Char,
746,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for the test being performed.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included as the column heading. OETEST is most useful as the PROMPT on the field in which the RESULT for that test is collected. See CDASHIG metadata tables for domain-specific TEST codelist names (e.g. EGTEST, FATEST).","Name of Measurement, Test or Examination",Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable OETESTCD may be determined from the value collected in OETEST. The SDTMIG variables OETESTCD and OETEST are required in SDTM.,OETEST,10,[Ophthalmic Examination] Test Name,What was the name of the ophthalmic [measurement/test/examination]?,Char,['OETEST']
747,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A further description of OETESTCD and OETEST.,"It is recommended that the test detail name be preprinted on the CRF. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading.","Measurement, Test or Examination Detail",Maps directly to the SDTM variable listed in the SDTM Target column.,OETSTDTL,11,[Measurement/Test/Examination] Detail (Name),What was the [measurement/test/examination] detail name?,Char,
748,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category,Maps directly to the SDTM variable listed in the SDTM Target column.,OECAT,12,[Ophthalmic Examination Category]; NULL,What was the [type/category] of the ophthalmic examination?,Char,
749,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the OECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be a heading on the CRF or screen, not a question to which the site would provide an answer. OESCAT can only be used if there is a OECAT. Examples are provided in the CDASHIG metadata table and in the SDTMIG. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. OESCAT can only be used if there is a OECAT.",Subcategory,Maps directly to the SDTM variable listed in the SDTM Target column.,OESCAT,13,[Ophthalmic Examination Subcategory]; NULL,What was the [subtype/subcategory] of the ophthalmic examination?,Char,
750,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,Result of Finding in Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORRES,14,([Result/Amount] of) [value from OETEST]; NULL,What was the result of the ophthalmic examination test?,Char,
751,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORRESU,15,Unit,What was the unit (of the [measurement/test/examination])?,Char,['UNIT']
752,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field OERES is used when the collected results are not mapped directly to the SDTM variable OEORRES and must be mapped, for example: OERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected. OERES is collected using Normal, Abnormal and a description of the abnormality is collected.",Collected Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation, for example: Where OERES Normal, Abnormal or other similar type classifications (e.g., absent/present) with a description of the abnormal result using the CDASH field OEDESC. For SDTM submission datasets, If the CDASH field OERES = ""NORMAL"", populate the SDTM variables OEORRES and OESTRESC with the value of the CDASH field OERES. If the CDASH field OERES is ""ABNORMAL"", populate the SDTM variable OEORRES with the CDASH field OEDESC. If the reported findings in OEDESC are coded using a dictionary, then the SDTM variable OESTRESC is populated with the dictionary preferred term and OEMODIFY is populated with the modified text used for coding. If the reported findings in OEDESC are not coded, then the SDTM variable OESTRESC is populated with the CDASH OEDESC field. The SDTM variable OENRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. Where OERES is used to collect standardized values (e.g., a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field OERESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field OERES field is mapped to the SDTM variable OESTRESC and the value in the CDASH field OERESOTH is mapped to the SDTM variable OEORRES. See the SDTMIG for additional information.",OERES,16,([Result/Amount] of) [value from OETEST],What [is/was] the [result/amount] (of the [measurement/test/examination])?; [Is/Was] the result [normal/abnormal/absent/present/ sponsored defined response]?,Char,
753,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In a case where OERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field OERESOTH can be used to collect free-text values for ""Specify Other"".",Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field OERES is mapped to the SDTM variable OESTRESC and the value in the CDASH field OERESOTH is mapped to the SDTM variable OEORRES. See the SDTMIG for additional information.",OERESOTH,17,Specify ([Other/Details]),"If other is selected, [explain/specify/provide more detail].",Char,
754,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The lower end of normal range or reference range for continuous results stored in OEORRES.,OEORNRLO should be populated only for continuous findings. The SDTM variable OESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Normal Range Lower Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORNRLO,18,Normal Range Lower Limit,What was the lower limit of the reference range (for the [measurement/test/examination]?,Char,
755,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The upper end of normal range or reference range for continuous results stored in OEORRES.,OEORNRHI should be populated only for continuous findings. The SDTM variable OESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Normal Range Upper Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,OEORNRHI,19,Normal Range Upper Limit,What was the upper limit of the reference range (for the [measurement/test/examination])?,Char,
756,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Normal references ranges that are expressed as characters (""Negative to Trace"") or ordinal (-1 to 1).",Should be populated for normal ranges that are reported as character in ordinal scale or if categorical ranges were supplied. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.,Collected Character/Ordinal Normal Range,Maps directly to the SDTM variable listed in the SDTM Target column.,OECSTNRC,20,Normal Reference Range,What was the normal reference range (for this [measurement/test/examination])?,Char,
757,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by OEORNRLO, OEORNRHI, OESTNRC, or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",Normal/Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,OENRIND,21,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
758,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indicator of the result of a finding or medical status per interpretation of test results.,"Used to categorize the result of a finding or medical status per interpretation of test results (e.g., ""POSITIVE"", ""NEGATIVE""). The variable OERESCAT is not meant to replace the use of OENRIND for cases where normal ranges are provided.",Result Category,Maps directly to the SDTM variable listed in the SDTM Target column.,OERESCAT,22,Result Category,What is the the category for the reported values?,Char,
759,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation of why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When OEREASND is used, OESTAT should also be populated in the SDTM-based dataset.",Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,OEREASND,23,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],What was the reason that the [ophthalmic examination finding] was not [collected/answered/done/assessed/evaluated]?,Char,
760,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The anatomical location of the subject, relevant to the collection of the measurement.","For the OE domain, this value is prepopulated as ""EYE"". It does not need to be preprinted on the CRF or collected.",Location,Maps directly to the SDTM variable listed in the SDTM Target column.,OELOC,24,Anatomical Location,What was the anatomical location of the ophthalmic examination?,Char,['LOC']
761,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.","Further detailing the laterality of the location of the OETEST within a given eye. It should never be used to designate ""Right Eye"" versus ""Left Eye"". OEFOCID is used to denote which eye is the focus of the observation. This may be preprinted or collected.",Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,OELAT,25,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
762,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.","Further detailing the directionality of the location of the OETEST (e.g., ANTERIOR, LOWER, PROXIMAL). This may be preprinted or collected. Sponsors may collect the data using a subset list of CT on the CRF.",Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,OEDIR,26,Directionality,What was the directionality (of the anatomical location of the [measurement/test/examination])?,Char,['DIR']
763,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e., arrangement of, apportioning of).",Further detailing the portion or totality of the location of the OETEST. This may be preprinted or collected.,Portion or Totality,Maps directly to the SDTM variable listed in the SDTM Target column.,OEPORTOT,27,Portion or Totality,What was the portion or totality (of the anatomical location of the [measurement/test/examination])?,Char,['PORTOT']
764,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The method of the test or examination.,,Method of Test or Examination,Maps directly to the SDTM variable listed in the SDTM Target column.,OEMETHOD,28,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
765,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted, or collected. Sponsors may collect the data using a subset list of CT on the CRF.",Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,OEEVAL,29,Evaluator,Who was the evaluator?,Char,['EVAL']
766,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in OEEVAL.,,Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,OEEVALID,30,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
767,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Used where more than 1 assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,OEACPTFL,31,[Accepted/Final] Evaluation,Is this record considered to be the [accepted/final] evaluation?,Char,['NY']
768,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",PE,Physical Examination,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).","The repetition number of the test/measurement within the time point may be preprinted on the CRF (e.g., multiple measurements of blood pressure, multiple analyses of a sample.",Ophthalmic Examination Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,OEREPNUM,32,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
769,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation.",Study Identifier,Maps directly to the SDTM variable listed in the SDTM Target column .,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
770,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically pre-printed in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be pre-printed on the CRFs that are shipped to each site. \n EDC: This should be pre-populated.",Study Site Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
771,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a pre-populated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTM variable listed in the SDTM Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
772,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically pre-printed on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTM variable listed in the SDTM Target column.,VISIT,4,[Visit],What is the visit name?,Char,
773,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the RE measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the RE CRF using the Respiratory Assessments (REDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable VSDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
774,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response to whether or not a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the -STAT variable in SDTM as "" NOT DONE"".",Respiratory Assessment Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable RESTAT. If the CDASH variable REPERF=""N"", the value of the SDTM variable RESTAT is ""NOT DONE"". If REPERF= ""Y"", RESTAT is null. A combination of SDTM variables (e.g., RECAT and RESCAT, RETPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable RETESTCD would be populated with REALL and an appropriate test name (RETEST) provided. See SDTMIG for additional information.",REPERF,6,Respiratory Assessment Performed,Was a respiratory assessment performed?,Char,['NY']
775,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the respiratory measurement was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the RE measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the RE CRF using the Date of Collection (REDAT) field.",Respiratory Assessment Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable REDTC in ISO 8601 format.",REDAT,7,Date,What was the date the respiratory measurement was taken?,Char,
776,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of measurement, represented in an unambiguous time format (e.g., hh:mm:ss).","A single collection time (e.g., RETIM) may be collected for all the measurements when they are performed at the same time. The time of each measurement can also be collected using a CDASH variable [RETESTCD]_RETIM.",Respiratory Assessment Time,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable REDTC in ISO 8601 format.",RETIM,8,Time,What was the time of the respiratory system measurement?,Char,
777,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be pre-printed on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then terms such as ""Planned Time Point"" can be included in the column heading.",RE Assessment Planned Time Point Name,"Maps directly to the SDTM variable listed in the SDTM Target column. See the SDTMIG for additional information on representing time points. The SDTM time-point anchors RETPTREF (text description) and RERFTDTC (date/time) may be needed, as well as SDTMIG variables RETPTNUM, REELTM.",RETPT,9,[Planned Time Point Name],What is the planned time point for this respiratory assessment measurement?,Char,
778,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"The test name will usually be pre-printed on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading. RETEST is most useful as the PROMPT on the field in which the RESULT for that test is collected.",Respiratory Test Name,Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable RETESTCD may be determined from the value collected in RETEST using the Controlled Terminology List RETESTCD. The SDTMIG variables RETESTCD and RETEST are required in SDTM.,RETEST,10,[Respiratory Test Name],What is the respiratory test name?,Char,['RETEST']
779,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a pre-printed category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included as the column header.",Category for Respiratory Test,Maps directly to the SDTM variable listed in the SDTM Target column.,RECAT,11,[Respiratory Test Category]; NULL,What is the category of the respiratory test?,Char,
780,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the RECAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a pre-printed category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. RESCAT can only be used if there is a RECAT, and it must be a subcategorization of RECAT.",Subcategory for Respiratory Test,Maps directly to the SDTM variable listed in the SDTM Target column.,RESCAT,12,[Respiratory Assessment Subcategory]; NULL,What was the subcategory of the respiratory assessment?,Char,
781,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,RE Test Result in Original Units,Maps directly to the SDTM variable listed in the SDTM Target column.,REORRES,13,[RETEST] Result,What was the result of the measurement?,Char,
782,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be pre-printed on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Respiratory Test Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,REORRESU,14,Unit,What was the unit of the result?,Char,['UNIT']
783,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field RERES is used when the collected results are not mapped directly to the SDTM variable REORRES and must be transformed. For example,RERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected.REORES is collected using Normal, Abnormal and a description of the abnormality is collected.",Respiratory Test Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation; for example: \n 1. Where RERES is to used collect Normal, Abnormal or similar type classifications (e.g., Absent/Present) with a description of the abnormal result using the CDASH field REDESC. For SDTM submission datasets, If the CDASH field RERES = ""NORMAL"", populate the SDTM variables REORRES and RESTRESC with the value of the CDASH field RERES. If the CDASH field RERES is ""ABNORMAL"", populate the SDTM variable REORRES with the CDASH field REDESC. If the reported findings in REDESC are coded using a dictionary, then the SDTM variable RESTRESC is populated with the dictionary preferred term and REMODIFY is populated with the modified text used for coding. If the reported findings in REDESC are not coded, then the SDTM variable RESTRESC is populated with the CDASH REDESC field. The SDTM variable RENRIND may be populated with ""NORMAL"" or ""ABNORMAL"" if appropriate. \n 2. Where RERES is used to collect standardized values (e.g. a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field RERESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field RERES field is mapped to the SDTM variable RESTRESC and the value in the CDASH field RERESOTH is mapped to the SDTM variable REORRES. See SDTMIG for additional information.",RERES,15,(Result),Was the result (normal/abnormal/absent/present/ [sponsored defined response])?,Char,
784,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Text description of respiratory test findings.,"RERES and REDESC are used when a question is asked to collect the finding result, with a follow-up question for a description of the finding. See CDASH General finding Assumptions",Description of Respiratory Test Finding,"This does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable REORRES. If RERES=""Normal"", populate REORRES with the value of RERES. If RERES=""Abnormal"", populate REORRES with the value of REDESC.",REDESC,16,(Abnormal) Findings,What was the description of the (abnormality/observed finding/[Sponsor-defined])?,Char,
785,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In cases where RERES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field RERESOTH can be used to collect free-text values for ""Specify Other"".",Respiratory Test Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field RERES is mapped to the SDTM variable RESTRESC and the value in the CDASH field RERESOTH is mapped to the SDTM variable REORRES.",RERESOTH,17,[Specify Other/Explain/Specify Details],"If other is selected, [explain/specify/provide more detail].",Char,
786,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The lower end of normal range or reference range for continuous results stored in REORRES.,REORNRLO should be populated only for continuous findings. The SDTM variable RESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site or lab specific set of normal ranges stored in a look-up table.,RE Ref Range Lower Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,REORNRLO,18,Normal Range Lower Limit,What was the lower limit of the reference range?,Char,
787,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The upper end of normal range or reference range for continuous results stored in REORRES.,REORNRHI should be populated only for continuous findings. The SDTM variable RESTNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment. These data could be derived from a site or lab specific set of normal ranges stored in a look-up table.,RE Ref Range Upper Limit- Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,REORNRHI,19,Normal Range Upper Limit,What was the upper limit of the reference range?,Char,
788,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by REORNRLO, REORNRHI, RESTNRC or other objective criteria. Reference Range Indicator (e.g., Y, N; HIGH, LOW; NORMAL, ABNORMAL) may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",RE Reference Range Indicator,Maps directly to the SDTM variable listed in the SDTM Target column.,RENRIND,20,Comparison to [Reference/Expected/Normal] Range,How do the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
789,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as &quot;Not Done&quot;.",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH REPERF field. Typically a checkbox which indicates the test was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,Completion Status,"Maps directly to the SDTM variable listed in the SDTM Target column. If collected, the Origin (a column in the Define-XML) =""CRF""; if populated from other sources such as free text or sponsor-defined listing for REREASND, the Origin =""DERIVED"".",RESTAT,21,Not Done,Indicate if the [RETEST] was not [answered/assessed/done/evaluated/performed].,Char,['ND']
790,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When REREASND is used, RESTAT should also be populated in the SDTM-based dataset.",Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,REREASND,22,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],Was the was the reason that the respiratory (assessment/[RETEST]) was not [collected / answered / done / assessed / evaluated]?,Char,
791,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The position of the subject during a measurement or examination.,"Results may be affected by whether conditions for respiratory test, as specified in the protocol, were properly met. One common condition is the subject's position. If the protocol requires this type of information, then a CDASH variable [RETESTCD]_REPOS may be created for each RETESTCD and added to the CRF, if needed.",Position of Subject During Observation,Maps directly to the SDTM variable listed in the SDTM Target column.,REPOS,23,Position,What was the position of the subject during the assessment?,Char,['POSITION']
792,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Location used for the measurement.,"Collected or pre-printed when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.LAT, DIR, and PORTOT are used to further describe the anatomical location.",Location,Maps directly to the SDTM variable listed in the SDTM Target column.,RELOC,24,Anatomical Location,What was the anatomical location where the measurement was taken?,Char,['LOC']
793,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be pre-printed or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,RELAT,25,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
794,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be pre-printed or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,REDIR,26,Directionality,What was the directionality of the anatomical location of the respiratory test?,Char,['DIR']
795,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The method of the test or examination.,"This information may be collected when more than 1 method is possible, and collecting the method used is necessary.",Method of Respiratory Test,Maps directly to the SDTM variable listed in the SDTM Target column.,REMETHOD,27,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
796,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a pre-printed or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Respiratory Test Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,REEVAL,28,Evaluator,Who was the evaluator?,Char,['EVAL']
797,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in REEVAL.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Respiratory Test Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,REEVALID,29,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
798,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Use where more than one assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,REACPTFL,30,Accepted Evaluation,Was this record considered to be the accepted evaluation?,Char,['NY']
799,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).",The repetition number of the test/measurement within the time point may be pre-printed on the CRF.,Respiratory Test Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,REREPNUM,31,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
800,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RE,Respiratory System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether the test results were clinically significant.,"Could apply to specific measurements or to overall interpretation, as required by the protocol.",Respiratory Test Clinical Significance,Maps directly to the SDTM variable listed in the SDTM Target column.,RECLSIG,32,Clinically Significant,Was this result clinically significant?,Char,['NY']
801,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM- based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
802,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically pre-printed in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be pre-printed on the CRFs that are shipped to each site. \n EDC: This should be pre-populated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
803,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
804,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically pre-printed on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
805,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the reproductive system findings were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the reproductive system findings at that visit, or the collection date can be included on the RP CRF using the date (RPDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable RPDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
806,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a pre-printed category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Repro System Findings,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RPCAT,6,[Reproductive System Category]; NULL,What was the category of the reproductive system?,Char,
807,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the RPCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a pre-printed category value on the CRF, and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. RPSCAT can only be used if there is an RPCAT, and it must be a subcategorization of RPCAT.",Subcategory for Repro System Findings,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RPSCAT,7,Reproductive System Subcategory]; NULL,What was the subcategory of the reproductive system?,Char,
808,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, series of measurements, test, or observation was performed.","This may be implemented for a series of reproductive system evaluations, or a specific reproductive system test. This general prompt question is used as a data management tool to verify that missing results are confirmed missing.",Reproductive System Evaluation Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTMIG variable RPSTAT. If the CDASH field RPPERF=""N"", the value of RPSTAT will be ""NOT DONE"". If RPPERF=""Y"", RPSTAT should be null. A combination of SDTMIG variables (e.g., RPCAT and RPSCAT, RPTPT) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable RPTESTCD would be populated as RPALL and an appropriate test name (RPTEST) provided. See SDTMIG for additional information.",RPPERF,8,Reproductive System Evaluation Performed,Was a reproductive system evaluation performed?,Char,['NY']
809,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"The reason the data are not available may be chosen from a sponsor-defined list (e.g., broken equipment, subject refused) or entered as free text. When PCREASND is used, the SDTMIG variable PCSTAT should also be populated in the SDTM-based dataset.",RP Reason Not Performed,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RPREASND,9,Reason Not Done,What was the reason the reproductive system test was not collected?,Char,
810,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,General prompt question regarding whether any reproductive system findings are available.,The intent/purpose of collecting this field is to help with data cleaning and monitoring. It provides verification that all other fields on the CRF were deliberately left blank.,Any Reproductive System Findings,Does not map to an SDTMIG variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,RPYN,10,Any Reproductive System Findings,Were there any reproductive system findings?,Char,['NY']
811,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for pre-printed or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record pre-printed number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",RP Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,RPSPID,11,[Sponsor defined],[Sponsor-defined question],Char,
812,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name for reproductive system finding.,"Required to identify which test the result is for. It is recommended that test names be pre-printed on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Reproductive System Findings Test Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable RPTESTCD may be determined from the value collected in RPTEST. The SDTMIG variables RPTESTCD and RPTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,RPTEST,12,[Reproductive System Findings Test Name],What is the reproductive finding name?,Char,['RPTEST']
813,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the finding defined in reproductive system finding, as originally received or collected.",Both quantitative results and interpretive findings or summaries may be recorded here.,RP Result or Finding in Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RPORRES,13,(Result),What was the result for the reproductive system question?,Char,
814,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be pre-printed on the CRF with the associated test when possible, rather than collected in a free-text field.",RP Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RPORRESU,14,Unit,What was the unit of the result?,Char,['UNIT']
815,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RP,Reproductive System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date on which the reproductive system result or finding was collected, represented in an unambiguous date format (e.g., DD-MON-YYYY).",This should be a complete date. The date of collection may be determined from the date of visit (VISDAT).,Reproductive System Finding Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable RPDTC in ISO 8601 format.",RPDAT,15,Collection Date,What was the date the reproductive system question was collected?,Char,
816,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
817,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
818,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
819,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
820,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"If the date the tests were collected can be determined from the visit date variable (VISDAT), apply that date to all of the tests at that visit, or the collection date can be collected on the CRF using the date (RSDAT). In this domain, it may not be appropriate to use the visit date as RSDTC.",Visit Date,"This field is not an SDTM variable. If the date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM), concatenate the CDASH VISDAT/VISTIM components and populate the SDTMIG variable RSDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
821,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response is typically a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading. There are separate codelists used for categorizing records about oncology response criteria (ONCRCAT) or other clinical classification (CRSCAT). Collect if multiple clinical classifications, or disease responses are active in a single study/database; otherwise, information should be distinguished somewhere on a form (e.g., table name, title, tab).",Category for Response or Clin Class,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSCAT,6,[Disease Response/Clinical Classification Category]; NULL,What is the [category/ criteria] for the [disease response/clinical classification] or What is the [response/clinical classification] criteria?,Char,"['CCCAT', 'ONCRSCAT']"
822,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A sub-division of the RSCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. RSSCAT can only be used if there is an RSCAT, and it must be a subcategorization of RSCAT.",Subcategory for Response or Clin Class,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSSCAT,7,[Disease Response/Clinical Classification Sub-Category]; NULL,What is the subcategory for the [disease response/clinical classification]?,Char,
823,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether a planned disease response or clinical classification assessment was performed.,"A Not Done checkbox, which indicates the test was ""NOT DONE"". Typically, there would be 1 check box for each measurement. This field can be useful to confirm that a blank result field is meant to be blank.",Response or Clin Class Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTMIG variable RSSTAT. If RSPERF=""N"", the value of RSSTAT will be ""NOT DONE"". If RSPERF=""Y"", RSSTAT should be null. A combination of SDTMIG variables ( e.g., RSCAT and RSSCAT, RSTPT) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable RSTESTCD would be populated as RSALL and an appropriate test name (RSTEST) provided. See SDTMIG for additional information.",RSPERF,8,[Disease Response/Clinical Classification] Assessment,Was the [(disease) response/clinical classification] assessment performed?,Char,['NY']
824,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation of why the data are not available.,"The reason that data are not available may be chosen from a sponsor-defined list (e.g., Not Imaged, Patient Refusal, Site Error) or entered as free text. When RSREASND is used, the SDTMIG variable RSSTAT should also be populated in the SDTM-based dataset.",Response or Clin Class Reason Not Done,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSREASND,9,Reason Response Assessment Not Performed,Why was the [disease response/clinical classification] assessment not performed?,Char,
825,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the Response or Clin Class was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the RS CRF using the Date of Collection (RSDAT) field.",Response or Clin Class Assessment Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable RSDTC in ISO 8601 format.",RSDAT,10,Date,What was the date the response or clinical classification was performed?,Char,
826,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The role of the person who provided the information.,Used only for results that are subjective (assigned by a person or a group). RSEVAL is expected for oncology response criteria. It can be null when the investigator provides all the data in a study. It should contain no null values when data from 1 or more evaluator are used in a study.,Response or Clin Class Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSEVAL,11,Evaluator,What was the role of the person performing the [disease response/clinical classification] assessment?,Char,['EVAL']
827,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Used to distinguish multiple evaluators with the same role.,"When multiple assessors play the role identified in RSEVAL, values of RSEVALID will attribute a row of data to a particular assessor.",Response or Clin Class Evaluator ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSEVALID,12,Evaluator Identifier,What is the evaluator identifier?,Char,['MEDEVAL']
828,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to link the disease response assessment to the related record in another domain which was used to determine the response result.,"This variable is used to provide a unique code in order to link records across related CRFs (e.g., RS and TR) when appropriate. Sponsors develop their own conventions for populating RSLNKID.",Response or Clin Class Link ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSLNKID,13,[Disease Response or Clinical Classification ]Link ID,What was the [Disease Response or Clinical Classification ]Link ID Identifier?,Char,
829,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping identifier used to link the disease response assessment to a group of related record in another domain which was used to determine the response result.,"This variable is used to provide a unique code in order to link a group of records across related CRFs (e.g., RS and TR) when appropriate. Sponsors develop their own conventions for populating RSLNKGRP.",Response or Clin Class Link Group,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSLNKGRP,14,[Disease Response or Clinical Classification ]Link Group,What was the [Disease Response or Clinical Classification] Link Group Identifier?,Char,
830,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the disease response or clinical classification used to obtain the measurement or finding.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Response or Clin Class Assessment Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable RSTESTCD may be determined from the value collected in RSTEST. The SDTMIG variables RSTESTCD and RSTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,RSTEST,15,[Disease Response / Clinical Classification Test Name],What was the [disease response/clinical classification] test name?,Char,['ONCRTS']
831,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the disease response or clinical classification as originally received, collected, or calculated.",Both quantitative results and interpretive findings or summaries may be recorded here.,Response or Clin Class Original Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSORRES,16,(Result),What was the [disease response/clinical classification]?,Char,
832,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",RS,Disease Response and Clin Classification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Response or Clin Class Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,RSORRESU,17,Unit,What was the [disease response/clinical classification] unit?,Char,['UNIT']
833,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
834,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
835,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
836,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
837,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the subject characteristics were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the subject characteristics at that visit, or the collection date can be included on the SC CRF using the date (SCDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable SCDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
838,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Subject Characteristic,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SCCAT,6,[Subject Characteristics Category ]; NULL,What was the category of the subject characteristics?,Char,
839,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the SCCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. SCSCAT can only be used if there is an SCCAT, and it must be a subcategorization of SCCAT.",Subcategory for Subject Characteristic,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SCSCAT,7,[Subject Characteristics Subcategory]; NULL,What was the subcategory of the subject characteristics?,Char,
840,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether any subject characteristics were collected.,General prompt question to be used as a data management tool to verify that missing results are confirmed missing.,SC Assessment Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTM variable SCSTAT. If SCPERF=""N"", the value of SCSTAT will be ""NOT DONE"". If SCPERF=""Y"", SCSTAT should be null. A combination of SDTMIG variables (e.g., SCCAT and SCSCAT, SCTPT) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable SCTESTCD would be populated as SCALL and an appropriate test name (SCTEST) provided. See the SDTMIG for additional information.",SCPERF,8,Subject Characteristics Collected,Were subject characteristics collected?,Char,['NY']
841,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",SC Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SCSPID,9,[Sponsor defined],[Sponsor-defined question],Char,
842,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of collection represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date of collection can be determined from a collected date of the visit (VISDAT); in such cases, a date field is not required.",Subject Characteristic Collection Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable SCDTC in ISO 8601 format.",SCDAT,10,Date,What was the date the subject characteristics were collected?,Char,
843,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the subject characteristic of interest.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column header.",Subject Characteristic,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable SCTESTCD may be determined from the value collected in SCTEST. The SDTMIG variables SCTESTCD and SCTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,SCTEST,11,[Subject Characteristic Test Name],What is the subject characteristics name?,Char,['SCTEST']
844,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",SC,Subject Characteristics,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the subject characteristic as originally received or collected.,,SC Result or Finding in Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SCORRES,12,(Result),What is the subject characteristic?,Char,
845,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
846,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
847,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
848,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
849,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"If the date the test was collected can be determined from the visit date variable (VISDAT), apply that date to all of the tests at that visit, or the collection date can be collected on the CRF using the date (TRDAT). In this domain, it may not be appropriate to use the vist date as TRDTC.",Visit Date,"This field is not an SDTM variable. If the date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable TRDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
850,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to link related records across domains.,"Because TRLNKGRP is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. This is typically used in oncology clincial trials. It is intended to group all the assessments at a evaluation time point represented in the TR domain with the associated response assessments represented in the RS domain.",Tumor/Lesion Result Link Group,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRLNKGRP,6,[Tumor/Lesion] [Link Group] ID,What was the [tumor/lesion] [link group] identifier?,Char,
851,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category of Tumor/Lesion Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRCAT,7,[Tumor/Lesion Result Category]; or NULL,What is the category of the [tumor/lesion] results?,Char,
852,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A subgrouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. TRSCAT can only be used if there is a TRCAT, and it must be a subcategorization of TRCAT.",Subcategory of Tumor/Lesion Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRSCAT,8,[Tumor/Lesion Result Subcategory]; or NULL,What is the subcategory of the [tumor/lesion] results?,Char,
853,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site record the value as ""Not Done"".","A Not Done checkbox, which indicates the test was NOT DONE. Typically, there would be 1 check box for each result. This field can be useful to confirm that a blank result field is meant to be blank.",Tumor/Lesion Result Completion Status,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRSTAT,9,Not Done,Indicate if the [tumor/lesion] evaluation was not done.,Char,['ND']
854,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation of why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When TRREASND is used, TRSTAT should also be populated in the SDTM-based dataset.",Reason Tumor Measurement Not Performed,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRREASND,10,Reason Not Done,What was the reason that the [tumor/lesion] was not [evaluated/assessed]?,Char,
855,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the information.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Tumor/Lesion Result Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TREVAL,11,[Evaluator/Reporter],Who provided the information?; Who was the evaluator?,Char,['EVAL']
856,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Used to distinguish multiple evaluators with the same role.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Tumor/Lesion Result Evaluator Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TREVALID,12,Evaluator Identifier,What was the identifier of the evaluator?,Char,['MEDEVAL']
857,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the procedure used for tumor/lesion assessment, represented in an unambiguous date format (e.g., DD-MON-YYYY).",This is the date of the scan/image/physical exam used to evaluate the tumor/lesion. It is not the date the MRI or scan was read. This is typically not the visit date.,Tumor/Lesion Result Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable TRDTC in ISO 8601 format.",TRDAT,13,[Tumor/Lesion] Assessment Procedure Date,What was the date of the procedure used for [tumor/lesion] assessment?,Char,
858,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,An identifier used to link identified tumor/lesion to the assessment result.,"This variable is used to provide a unique code for each identified tumor in order to link records across related CRFs (TU and TR) when appropriate. Sponsors develop their own conventions for populating --LNKID. Typically, the lesion/tumor is assigned the --LNKID at baseline when the tumor/lesion is identified, and this --LNKID is used at other visits to collect assessments on this tumor or lesion. \n Note: This variable may be collected using 1 CDASH variable name (e.g., TULNKID) and populated into TRLNKID when creating submisson datasets.",Tumor/Lesion Result Link ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRLNKID,14,[Tumor/ Lesion] ID,What was the [tumor/lesion] Identifier?,Char,
859,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the measurement or finding.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Tumor/Lesion Assessment Test Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable TRTESTCD may be determined from the value collected in TRTEST. The SDTMIG variables TRTESTCD and TRTEST are required in SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,TRTEST,15,[Tumor/Lesion] (Assessment) Test Name],What was the [tumor/ lesion] (assessment) test name?,Char,['TRTEST']
860,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the tumor/lesion assessment.,Result of the tumor/lesion assessment. Both quantitative and qualitative results may be recorded here.,TR Result or Finding in Original Units,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. In addition to the SDTMIG variable TRORRES, create TRTESTCD from the CDASH variable name and determine the value of TRTEST from TRTESTCD. The CDASH prompt may also contain the TRTEST. Use appropriate CDISC Controlled Terminology for the test and test code.",TRORRES,16,(Result),What is the result for the [tumor/lesion assessment]?,Char,
861,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Usually, the unit of the test is preprinted on the CRF.",TR Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRORRESU,17,Unit,What was the unit of the [result/measurement]?,Char,['UNIT']
862,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TR,Tumor/Lesion Results,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The name or identifier of the vendor (e.g., laboratory) that provided the test results.",It is recommended to collect on the CRF if vendor name was not collected at the site/study level or if multiple vendors are used by a site.,Tumor/Lesion Result Vendor Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TRNAM,18,Vendor Name,What was the name of the vendor used?,Char,
863,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
864,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
865,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
866,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
867,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"If the date the test was collected can be determined from the visit date variable (VISDAT), apply that date to all of the tests at that visit, or the collection date can be collected on the CRF using the date (TUDAT). In this domain, it may not be appropriate to use the visit date as TUDTC.",Visit Date,"This field is not an SDTM variable. If the date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM), then concatenate the CDASH VISDAT/VISTIM components and populate the SDTMIG variable TUDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
868,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category of Tumor/Lesion Identification,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUCAT,6,[Tumor/Lesion] Identification Category]; or NULL,What is the category of the [tumor/lesion] identification?,Char,
869,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the TUCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly preprinted on the CRF or screen and prepopulated in the data management system. This is not typically a question to which the site would provide an answer. TUSCAT can only be used if there is a TUCAT, and it must be a subcategorization of TUCAT.",Subcategory Tumor/Lesion Identification,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUSCAT,7,[Tumor/Lesion] Identification Subcategory; or NULL,What is the subcategory for the [tumor/lesion] identification?,Char,
870,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether any tumors were identified.,"This is intended to be used as a data management tool to verify that missing tumor/lesions evaluations are confirmed missing. The sponsor may decide to map ""No"" responses using the appropriate SDTMIG variables. Typically, this would use the SDTMIG variable TUOCCUR, with an appropriate TUTEST.",Any Tumors/ Lesions Identification,Not submitted.,TUYN,8,Any ([Target/Non-target/New/Sponsor-defined) [Tumors/Lesions] Identified,Were any [target/non-target/new/sponsor-defined) [tumors/lesions] identified?,Char,['NY']
871,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the [examination/procedure] used for tumor/lesion identification, represented in an unambiguous date format (e.g., DD-MON-YYYY).",This is the date of the scan/image/physical exam used to identified the tumor/lesion. It is not the date the MRI or scan was read. This is typically not the visit date.,Tumor/Lesion Identification Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable TUDTC in ISO 8601 format.",TUDAT,9,[Tumor/Lesion] Identification Procedure Date,What was the date of the [examination/procedure] used for [tumor/lesion identification]?,Char,
872,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the information.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be preprinted, or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Tumor/Lesion Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUEVAL,10,[Evaluator/Reporter],Who provided the information?; Who was the evaluator?,Char,['EVAL']
873,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Used to distinguish multiple evaluators with the same role.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Tumor/Lesion Evaluator Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUEVALID,11,[Evaluator/Reporter] Identifier,What was the identifier of the evaluator?,Char,['MEDEVAL']
874,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,An identifier used to link identified tumor/lesion to the assessment result.,"This variable is used to provide a unique code for each identified tumor in order to link records across related CRFs (TU and TR) when appropriate. Sponsors develop their own conventions for populating --LNKID. Typically, the lesion/tumor is assigned the --LNKID at baseline when the tumor/lesion is identified, and the this --LNKID is used at other visits to collect assessments on this tumor/lesion.",Tumor/Lesion Identification Link ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TULNKID,12,[Tumor/Lesion] ID,What was the [tumor/lesion] (link) identifier?,Char,
875,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The identifier for the procedure used to identify the tumor.,Intent is to establish a link between the TU identified and the procedure undergone to identify this tumor/lesion. TUPRNO can be used to identify a relationship between records in the TU dataset and records in the PR dataset. See SDTMIG for information on RELREC.,Tumor/Lesion Related Procedure ID,"This does not map directly to an SDTMIG variable. For the SDTM submission datasets, may be used to create RELREC to link this record with a record in the PR domain.",TUPRNO,13,Procedure Identifier,What was the identifier for the procedure used to identify this [tumor/lesion] ?,Char,
876,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Method of the test or examination.,"Sponsors may collect the method used to identify the tumor/lesions via a codelist which includes the most commonly known or generally recognized terms. The values will represent the method generically, not the product of the method (e.g., photograph). A sponsor may customize or restrict the list of values per response criteria or protocol needs. At a minimum, the primary method of identification should be entered and is expected to be consistent throughout the study; recording secondary methods is at the discretion of the sponsor.",Tumor/Lesion Method of Identification,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUMETHOD,14,Method of [Evaluation/Identification],What was the method used to [evaluate/identify] the [tumor/lesion]?,Char,['METHOD']
877,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An internal or external identifier, such as image ID number (e.g., CT scan, MRI, ultrasound identifier).",This variable may be used to collect a reference/accession number associated with the method used to identify the tumor/lesion. Sponsors may use the CDASH variable TUPRNO as an identifier for a procedure.,Tumor/Lesion Identification Reference ID,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUREFID,15,[Tumor/Lesion] Reference ID,What was the procedure [reference identifier/accession number]?,Char,
878,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the measurement or finding.,"Required to identify which test the result is for. It is recommended that test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Tumor/Lesion Identification Test Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable TUTESTCD may be determined from the value collected in TUTEST. The SDTMIG variables TUTESTCD and TUTEST are required in SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,TUTEST,16,[Tumor/Lesion Identification Test Name],What was the [tumor/lesion] Identification test name?,Char,['TUTEST']
879,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,"Result of the tumor identification (e.g., classification or type of tumor).","Each test may be collected using the CDASH variable TESTCD (e.g., TUMERGE, TUSPLIT, TUMIDENT) or TESTCD_TUORRES where TESTCD is the appropriate CT for the TU test code. This is an example of the types of CDASH variable names that can be used in a denormalized data structure.",Tumor/Lesion Identification Result,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUORRES,17,(Result),What is the [type/classification] of [tumor/lesion] as defined by the criteria being employed?,Char,
880,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A description of the anatomical location of the identified tumor/lesion.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, and PORTOT are used to further describe the anatomical location. A location detail text field (TULOCDTL) is conditional for entry (i.e., can be left blank) and allows the study site to specify the lesion in its own terms or can be used to distinguish tumors within the same location if other location qualifiers are not specific enough.",Location of the Tumor/Lesion,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TULOC,18,Anatomical Location,What was the anatomical location of the [tumor/lesion] (identified)?,Char,['LOC']
881,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body relevant for the event.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Tumor/Lesion Identification Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TULAT,19,[Tumor/Lesion Identification] Side,What was the laterality of the anatomical location?,Char,['LAT']
882,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Tumor/Lesion Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUDIR,20,[Tumor/Lesion Identification] Directionality,What was the directionality of the anatomical location?,Char,['DIR']
883,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A detailed description of the location of the identified tumor/lesion.,"Use if TULOC and TULAT and/or TUDIR values cannot provide uniqueness from other identified tumors. TULOCDTL is not meant to replace TULOC, TULAT, and/or TUDIR or serve as the free-text description field for TULOC (e.g., Location, Other).",TU Identification Location Detail,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPTU dataset as the value of SUPPTU.QVAL where SUPPTU.QNAM=""TULOCDTL"" and SUPPTU.QLABEL= ""TU Identification Location Detail"".",TULOCDTL,21,[Tumor/Lesion Identification] Location Detail,What [were/are] additional details on the exact location of the [tumor/lesion] so that it can be distinguished from other [tumor/lesion] in the same anatomical location?,Char,
884,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",TU,Tumor/Lesion Identification,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The name or identifier of the vendor (e.g., laboratory) that provided the test results.",Recommended to collect on the CRF if vendor name was not collected at the site/study level or if multiple vendors are used by a site.,Tumor/Lesion Identification Vendor Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,TUNAM,22,[Tumor/Lesion Identification] Vendor Name,What was the name of the vendor used?,Char,
885,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation.",Study Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
886,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
887,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTM variable listed in the SDTM Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
888,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed in the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTM variable listed in the SDTM Target column.,VISIT,4,[Visit],What is the visit name?,Char,
889,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the UR measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the UR CRF using the Urinary Assessments (URDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable VISDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
890,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned measurement, test, observation or specimen was performed/collected.","This field is used to capture a response to whether or not a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the -STAT variable in SDTM as "" NOT DONE"".",Urinary Assessment Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable URSTAT. If the CDASH variable URPERF=""N"", the value of the SDTM variable URSTAT is ""NOT DONE"". If URPERF= ""Y"", URSTAT is null. A combination of SDTM variables (e.g., URCAT and URSCAT, URTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTM variable URTESTCD would be populated with URALL and an appropriate test name (URTEST) provided. See SDTMIG for additional information.",URPERF,6,Urinary Assessment Performed,Was a urinary assessment performed?,Char,['NY']
891,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date the urinary measurement was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the UR measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the UR CRF using the Date of Collection (URDAT) field.",Urinary Assessment Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable URDTC in ISO 8601 format.",URDAT,7,Date,What was the date the urinary measurement was taken?,Char,
892,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",May be required when multiple assessments are done on 1 day or when the timing in relationship to study treatment is required for analysis or a specimen is collected over an extended time period.,Urinary Assessment Time,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable URDTC in ISO 8601 format.",URTIM,8,Time,What was the time of the urinary system measurement?,Char,
893,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then terms such as ""Planned Time Point"" can be included in the column heading.",UR Assessment Planned Time Point Name,"Maps directly to the SDTM variable listed in the SDTM Target column. See the SDTMIG for additional information on representing time points. The SDTM time-point anchors URTPTREF (text description) and URRFTDTC (date/time) may be needed, as well as SDTMIG variables URTPTNUM, URELTM.",URTPT,9,[Planned Time Point Name],What is the planned time point for this urinary assessment measurement?,Char,
894,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"The test name will usually be preprinted on the CRF, and not solicited as a question. If the form is laid out as a grid, then ""Test"" or ""Test Name"" can be included in the column heading. URTEST is most useful as the PROMPT on the field in which the RESULT for that test is collected.",Urinary Test Name,Maps directly to the SDTM variable listed in the SDTM Target column. The SDTM variable URTESTCD may be determined from the value collected in URTEST using the Controlled Terminology List URNSTSCD. The SDTMIG variables URTESTCD and URTEST are required in SDTM.,URTEST,10,[Urinary Test Name],What is the urinary test name?,Char,['URNSTS']
895,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be a heading on the CRF or screen, not a question to which the site would provide an answer. URSCAT can only be used if there is a URCAT. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Urinary Test,Maps directly to the SDTM variable listed in the SDTM Target column.,URCAT,11,[Urinary Test Category]; NULL,What is the category of the urinary test?,Char,
896,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the URCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This would most commonly be either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. URSCAT can only be used if there is a URCAT, and it must be a subcategorization of URCAT.",Subcategory for Urinary Test,Maps directly to the SDTM variable listed in the SDTM Target column.,URSCAT,12,[Urinary Assessment Subcategory]; NULL,What was the subcategory of the urinary assessment?,Char,
897,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,UR Test Result in Original Units,Maps directly to the SDTM variable listed in the SDTM Target column.,URORRES,13,[URTEST] Result,What was the result of the measurement?,Char,
898,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",Urinary Test Original Unit,Maps directly to the SDTM variable listed in the SDTM Target column.,URORRESU,14,Unit,What was the unit of the result?,Char,['UNIT']
899,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The result of the measurement or finding as originally received or collected.,"The CDASH field URRES is used when the collected results are not mapped directly to the SDTM variable URORRES and must be transformed. For example,URRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included and ""Specify Other"" is collected.URORRES is collected using ""Normal"", ""Abnormal"", and a description of the abnormality is collected.",Urinary Test Result or Finding,"This does not map directly to an SDTM variable. The mapping instructions depend on the implementation, for example: \n 1. Where URRES is used to collect normal/abnormal or similar type classifications (e.g., absent/present) with a description of the abnormal result using the CDASH field URDESC. For SDTM submission datasets, If the CDASH field URRES = ""NORMAL"", populate the SDTM variables URORRES and URSTRESC with the value of the CDASH field URRES. If the CDASH field URRES is ""ABNORMAL"", populate the SDTM variable URORRES with the CDASH field URDESC. If the reported findings in URDESC are coded using a dictionary, then the SDTM variable URSTRESC is populated with the dictionary preferred term and URMODIFY is populated with the modified text used for coding. If the reported findings in URDESC are not coded, then the SDTM variable URSTRESC is populated with the CDASH URDESC field. \n 2. Where URRES is used to collect standardized values (e.g. a codelist) on the CRF and the value of ""OTHER"" is included, the CDASH field URRESOTH can be used to collect free-text values for ""Specify Other"". When using this field, the ""OTHER"" value recorded in the CDASH field URRES field is mapped to the SDTM variable URSTRESC and the value in the CDASH field URRESOTH is mapped to the SDTM variable URORRES. See the SDTMIG for additional information.",URRES,15,(Result),Was the result (normal/abnormal/absent/present/ [sponsored defined response])?,Char,
900,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Text description of urinary test findings.,"URRES and URDESC are used when a question is asked to collect the finding result, with a follow-up question for a description of the finding. See Section 8.3.1, General CDASH Assumptions for Findings Domains.",Description of Urinary Test Finding,"This does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable URORRES. If URRES=""Normal"", populate URORRES with the value of URRES. If URRES=""Abnormal"", populate URORRES with the value of URDESC.",URDESC,16,(Abnormal) Findings,What was the description of the (abnormality/observed finding/[Sponsor-defined])?,Char,
901,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A free-text result which provides further information about the original received or collected result.,"In cases where URRES is used to collect standardized values on the CRF and the value of ""OTHER"" is included, the CDASH field URRESOTH can be used to collect free-text values for ""Specify Other"".",Urinary Test Result Other,"When using this CDASH field, the ""OTHER"" value collected in the CDASH field URRES is mapped to the SDTM variable URSTRESC and the value in the CDASH field URRESOTH is mapped to the SDTM variable URORRES.",URRESOTH,17,[Specify Other/Explain/Specify Details],"If other is selected, [explain/specify/provide more detail].",Char,
902,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as &quot;Not Done&quot;.",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH URPERF field. Typically a checkbox which indicates the test was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,Completion Status,"Maps directly to the SDTM variable listed in the SDTM Target column. If collected, the Origin (a column in the Define-XML) =""CRF""; if populated from other sources such as free text or sponsor-defined listing for URREASND, the Origin =""DERIVED"".",URSTAT,21,Not Done,Indicate if the [URTEST] was not [answered/assessed/done/evaluated/performed].,Char,['ND']
903,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An explanation for why the data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused) or entered as free text. When URREASND is used, URSTAT should also be populated in the SDTM-based dataset.",Reason Not Done,Maps directly to the SDTM variable listed in the SDTM Target column.,URREASND,22,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],Was the was the reason that the urinary (assessment/[URTEST]) was not [collected / answered / done / assessed / evaluated]?,Char,
904,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,Location used for the measurement.,"Collected or preprinted when the sponsor needs to identify the specific anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.LAT, DIR, and PORTOT are used to further describe the anatomical location.",Location,Maps directly to the SDTM variable listed in the SDTM Target column.,URLOC,24,Anatomical Location,What was the anatomical location where the measurement was taken?,Char,['LOC']
905,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Laterality,Maps directly to the SDTM variable listed in the SDTM Target column.,URLAT,25,Side,What was the side of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
906,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Directionality,Maps directly to the SDTM variable listed in the SDTM Target column.,URDIR,26,Directionality,What was the directionality of the anatomical location of the urinary test?,Char,['DIR']
907,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The method of the test or examination.,"This information may be collected when more than 1 method is possible, and collecting the method used is necessary.",Method of Urinary Test,Maps directly to the SDTM variable listed in the SDTM Target column.,URMETHOD,27,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
908,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Urinary Test Evaluator,Maps directly to the SDTM variable listed in the SDTM Target column.,UREVAL,28,Evaluator,Who was the evaluator?,Char,['EVAL']
909,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in UREVAL.,Collect if multiple evaluators are used in the study (may be omitted if multiple evaluators are not used); values should follow controlled terminology.,Urinary Test Evaluator Identifier,Maps directly to the SDTM variable listed in the SDTM Target column.,UREVALID,29,Evaluator Identifier,What is the identifier of the evaluator?,Char,['MEDEVAL']
910,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication that the evaluation is considered, by an independent assessor, to be the accepted or final evaluation.","Use where more than one assessor provides an evaluation of a result or response. Typically a checkbox with the value of ""Y"" or ""NULL"", which indicates the evaluation was accepted.",Accepted Record Flag,Maps directly to the SDTM variable listed in the SDTM Target column.,URACPTFL,30,Accepted Evaluation,Was this record considered to be the accepted evaluation?,Char,['NY']
911,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).",The repetition number of the test/measurement within the time point may be preprinted on the CRF.,Urinary Test Repetition Number,Maps directly to the SDTM variable listed in the SDTM Target column.,URREPNUM,31,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
912,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",UR,Urinary System Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication of whether the test results were clinically significant.,"Could apply to specific measurements or to overall interpretation, as required by the protocol.",Urinary Test Clinical Significance,Maps directly to the SDTM variable listed in the SDTM Target column.,URCLSIG,32,Clinically Significant,Was this result clinically significant?,Char,['NY']
913,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
914,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
915,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be provided to the site using a prepopulated list in the system. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTM.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,Subject,What is the subject identifier?,Char,
916,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted on the CRF or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
917,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the VS measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the VS CRF using the Vital Signs Date (VSDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable VSDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
918,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"An indication of whether a planned vital signs measurement, series of vital signs measurements, tests, or observations was performed.",This general prompt question is used as a data management tool to verify that missing results are confirmed missing.,Vital Signs Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTM variable VSSTAT. If VSPERF=""N"", the value of VSSTAT will be ""NOT DONE"". If VSPERF=""Y"", VSSTAT should be null. A combination of SDTMIG variables (e.g., VSCAT and VSSCAT, VSTPT) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable VSTESTCD would be populated as VSALL and an appropriate test name VSTEST provided. See SDTMIG for additional information.",VSPERF,6,Vital Signs Performed,Were vital signs performed?,Char,['NY']
919,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The date of the vital signs measurement, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date of measurement can be determined from a collected date of visit (VISDAT); in such cases, a separate measurement date field is not required.",Vital Signs Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable VSDTC in ISO 8601 format.",VSDAT,7,Date,What was the date of the vital signs measurement?,Char,
920,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"The time of measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",Collect time if it is relevant for the analysis.,Vital Signs Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable VSDTC in ISO 8601 format.",VSTIM,8,Time,What was the time of the vital signs measurement?,Char,
921,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g. line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Vital Signs Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,VSSPID,9,[Sponsor defined],[Sponsor-defined question],Char,
922,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,"A text description of planned time points when measurements should be taken, as defined in the protocol.","Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points should be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Planned Time Point"" can be included in the column heading.",Vital Signs Planned Time Point Name,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. See the SDTMIG for information on representing time points. The SDTMIG time-point anchors VSTPTREF (text description) and VSRFTDTC (date/time) may be needed, as well as SDTMIG variables VSTPTNUM, VSELTM.",VSTPT,10,[Planned Time Point Name],What is the planned time point for this vital signs measurement?,Char,
923,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be from a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Vital Signs,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSCAT,11,[Vital Signs Category]; NULL,What was the category of the vital signs?,Char,
924,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,A sub-division of the VSCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. VSSCAT can only be used if there is a VSCAT, and it must be a subcategorization of VSCAT.",Subcategory for Vital Signs,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSSCAT,12,[Vital Signs Subcategory]; NULL,What was the subcategory of the vital signs?,Char,
925,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"The instance number of a test that is repeated within a given timeframe for the same test. The level of granularity can vary (e.g., within a time point, within a visit).","The repetition number of the test/measurement within the time point may be preprinted on the CRF (e.g., multiple measurements of blood pressure, multiple analyses of a sample).",Vital Signs Repetition Number,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSREPNUM,13,Repetition Number,What was the repetition number within the time point for this measurement?,Char,
926,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"Required to identify which test the result is for. It is recommended that test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Vital Signs Test Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTMIG variable VSTESTCD may be determined from the value collected in VSTEST. Both VSTESTCD and VSTEST are required in the SDTM submission datasets. Use appropriate CDISC CT for the test and test code.,VSTEST,14,[Vital Signs Test Name],What is the vital sign test name?,Char,['VSTEST']
927,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as ""Not Done"".","A Not Done checkbox, which indicates the test was NOT DONE. Typically, there would be 1 checkbox for each measurement. This field can be useful on individual VS tests to confirm that a blank result field is meant to be blank.",Vital Signs Completion Status,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSSTAT,15,Not Done,Indicate if the vital signs measurement was not done,Char,['ND']
928,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",HR,Result of the vital signs measurement as originally received or collected.,,VS Result or Finding in Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSORRES,16,(Result),What was the result of the measurement?,Char,
929,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"This should be preprinted on the CRF (or enterable from a picklist) with the associated test when possible, rather than collected as free-text.",VS Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSORRESU,17,Unit,What was the unit of the measurement?,Char,['UNIT']
930,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,An indication whether the vital sign result was clinically significant.,,Vital Signs Clinical Significance,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSCLSIG,18,Clinically Significant,Was the result clinically significant?,Char,['NY']
931,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"A description of the anatomical location of the subject, relevant to the collection of vital signs measurements.","Collected or preprinted when the sponsor needs to identify the specific anatomical location (e.g., ARM for blood pressure). Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, and PORTOT are used to further describe the anatomical location.",Location of Vital Signs Measurement,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSLOC,19,Anatomical Location,What was the anatomical location where the measurement was taken?,Char,['LOC']
932,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",R/C,The position of the subject during a measurement or examination.,"Results may be affected by whether conditions for vital signs, as specified in the protocol, were properly met. One common condition is the subject's position.",Vital Signs Position of Subject,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSPOS,20,Position,What was the position of the subject during the measurement?,Char,"['POSITION', 'VSPOS']"
933,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Vital Signs Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSDIR,21,Directionality,What was the directionality of the anatomical location of the measurement?,Char,['DIR']
934,Findings,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",VS,Vital Signs,"This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. (Source: CDISC Controlled Terminology, GNRLOBSC, C103373, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Vital Signs Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VSLAT,22,Side,What was the side of the anatomical location of the vital signs measurement?,Char,['LAT']
935,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
936,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
937,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
938,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the clinical encounter is typically preprinted or displayed within the EDC for any visit-based data collection, most often in Findings domains. This Visit text description is then available in any EDC data extract for that Findings domain.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
939,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the finding about measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the FA CRF using the Findings About Date (FADAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, observation, or specimen collection can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable FADTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
940,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A description of the object or focal point of the findings observation that is represented by FATEST.,"The FAOBJ will usually be preprinted or hidden, not solicited as an actual question. These FA domains are usually created by the sponsor.",Findings About Object of the Observation,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAOBJ,6,[Sponsored-defined phrase],[Sponsored-defined phrase],Char,
941,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An indication of whether data was collected for the finding topic.,"This is a field that can be used in any CRF to indicate whether there is data to record. Used primarily as a data cleaning field, it provides verification that all other fields on the CRF were deliberately left blank. FAPERF should be used to capture a response about whether planned measurements, tests, or observations were done.",Findings About Collected,Does not map to an SDTM variable. The SDTM annotated CRF indicates that this field is NOT SUBMITTED.,FAYN,7,Any [Finding Topic],Has the subject had any [Findings topic(s)] (after/before [study specific time frame])?; [Was/Were] (there) any [Findings topic(s)] (reported) (after/before [study specific time frame])?; Were all eligibility criteria met?,Char,['NY']
942,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"An indication of whether a planned measurement, series of measurements, test, observation or specimen was performed or collected.","This field is used to capture a response to whether a planned measurement, test or observation was performed. A negative response can be collected as ""N"" and mapped to the FASTAT variable in SDTM as ""NOT DONE"".",Findings About Performed,"This field does not map directly to an SDTM variable. May be used to populate a value into the SDTM variable FASTAT. If the CDASH variable FAPERF=""N"", the value of the STDM variable FASTAT is ""OT DONE"". If FAPERF=""Y"", FASTAT is null. A combination of SDTM variables (e.g., FACAT and FASCAT, FATPT) is used to indicate that multiple tests were not done. In this situation, the SDTM variable FATESTCD would be populated with FAALL and an appropriate test name (FATEST) provided. See the SDTMIG for additional information.",FAPERF,8,([FATEST/ topic] ([Measurement (s)/Test(s)/Examination(s)/Specimen(s)/Sample(s)]) [Performed/Collected]?,[Were any/Was the] [FATEST/topic] ([measurement(s)/test(s)/examination(s)/specimen(s)/sample(s))] [performed/collected]?,Char,['NY']
943,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The date when the findings about assessment was performed, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date the FA measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the observations at that visit, or the collection date can be included on the FA CRF using the Date of Collection (FADAT) field.",Findings About Assessment Date,"This field does not map directly to an SDTM variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTM variable FADTC in ISO 8601 format.",FADAT,9,Date,What was the date the findings about assessment was performed?,Char,
944,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The time of measurement, represented in an unambiguous time format (e.g., hh:mm:ss).",Collect time if it is relevant for the analysis.,Findings About Assessment Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable VSDTC in ISO 8601 format.",FATIM,10,Time,What was the time of the findings about assessment?,Char,
945,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,Descriptive name for the test being performed.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Findings About Test Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. The SDTM variable FATESTCD may be determined from the value collected in FATEST. The SDTMIG variables FATESTCD and FATEST are required in SDTM.,FATEST,11,[Measurement/Test/Examination/] (Name),What [is/was] the name (of the [measurement/test/examination])?,Char,
946,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,A further description of FATESTCD and FATEST.,"It is recommended that the test detail name be preprinted on the CRF. If the form is laid out as a grid, then words such as ""Test,"" ""Test Name"" can be included in the column heading.",Findings About Test Detail,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FATSTDTL,12,[Measurement/Test/Examination] Detail (Name),What [is/was] the [measurement/test/examination] detail name?,Char,
947,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Category for Findings About,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FACAT,13,[Category/Category Value]; NULL,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,Char,
948,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,A sub-division of the FACAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. FASCAT can only be used if there is an FACAT, and it must be a subcategorization of FACAT.",Subcategory for Findings About,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FASCAT,14,[FA Subcategory/FA Subcategory Value]; NULL,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,Char,
949,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The position of the subject during a measurement or examination.,,Findings About Position of Subject,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAPOS,15,Position,In what position was the subject during the [measurement/ test/examination/specimen collection/sample collection]?; What was the position of the subject (during the [measurement/test/examination/specimen collection/sample collection])?,Char,['POSITION']
950,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,Result of the measurement or finding as originally received or collected.,Both quantitative results and interpretive findings or summaries may be recorded here.,FA Result or Finding in Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAORRES,16,([Result/Amount] of) [value from FATEST],What [is/was] the [result/amount/(subject's) characteristic] (of the [measurement/test/examination/question/assessment])?,Char,
951,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field. Should be included if applicable and not available elsewhere.",FA Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAORRESU,17,Unit,What [is/was] the unit (of the [measurement/test/examination])?,Char,['UNIT']
952,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The lower end of normal range or reference range for continuous results stored in FAORRES.,"--ORNRLO should be populated only for continuous findings. The SDTM variable --STNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment, or could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.",FA Normal Range Lower Limit- Orig Unit,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAORNRLO,18,Normal Range Lower Limit,What [is/was] the lower limit of the reference range (for the [measurement/test/examination])?,Char,
953,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The upper end of normal range or reference range for continuous results stored in FAORRES.,"--ORNRHI should be populated only for continuous findings. The SDTM variable --STNRC should be populated only for noncontinuous results. These data may be obtained from the lab or the electronic equipment, or could be derived from a site- or lab-specific set of normal ranges stored in a look-up table.",FA Normal Range Upper Limit- Orig Unit,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAORNRHI,19,Normal Range Upper Limit,What [is/was] the upper limit of the reference range (for the [measurement/test/examination])?,Char,
954,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,"Reference ranges may be defined by FAORNRLO, FAORNRHI, FASTNRC or other objective criteria. Reference Range Indicator may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.",Findings About Reference Range Indicator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FANRIND,20,Comparison to [Reference/Expected/Normal] Range,How [did/do] the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
955,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"This variable is used to indicate that data are not available, by having the site recording the value as ""Not Done"".",Used only when the response value is collected as NOT DONE or NULL in lieu of or in addition to the CDASH FAPERF field. Typically a checkbox which indicates the test was NOT DONE. This field can be useful when multiple questions are asked to confirm that a blank result field is meant to be blank.,Findings About Completion Status,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. If collected, the Origin (a column in the Define-XML) =""CRF"", if populated from other sources such as a free text or sponsor-defined listing for FAREASND, the Origin =""DERIVED"".",FASTAT,21,Not Done,Was the [--TEST ] not [completed/answered/done/assessed/evaluated ]?; Indicate if the([--TEST] was) not [answered/assessed/done/evaluated/performed].,Char,['ND']
956,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An explanation of why data are not available.,"Sponsor-defined controlled terminology may be used. The reason the data are not available may be chosen from a sponsor-defined codelist (e.g., broken equipment, subject refused, etc.) or entered as free text. When --REASND is used, --STAT should also be populated in the SDTM-based dataset.",Findings About Reason Not Performed,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAREASND,22,Reason Not [Answered/Collected/Done/Evaluated/Assessed/Available],Was the [is/was] the reason that the [Findings topic/data/information/sponsor-defined phrase] was not [collected/answered/done/assessed/evaluated]?,Char,
957,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The type of specimen used for a measurement.,"The type of specimen used for a measure. Should be collected if not available elsewhere, or if required to differentiate multiple specimens.",Findings About Specimen Type,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FASPEC,23,Specimen Type,What [is/was] the specimen type?,Char,['SPECTYPE']
958,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,Description of the condition of the specimen.,"May be collected using free or standardized text. Results may be affected by whether conditions for specimen were properly met. When local processing is used, sponsors may not routinely collect specimen condition.",Findings About Specimen Condition,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FASPCCND,24,Specimen Condition,What [is/was] the condition of the specimen?,Char,['SPECCOND']
959,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"The anatomical location of the subject, relevant to the collection of the measurement.","Collected or preprinted when the sponsor needs to identify the specific anatomical location (e.g., ARM for blood pressure). Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, and PORTOT are used to further describe the anatomical location.",Location of the Finding About,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FALOC,25,Anatomical Location,What [is/was] the anatomical location (of the [measurement/test/examination]) or What [is/was] the anatomical location where the [measurement/specimen] was taken/collected)?,Char,['LOC']
960,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Laterality of Location of Finding About,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FALAT,26,Side,What [is/was] the side (of the anatomical location of the [measurement/test/examination])?,Char,['LAT']
961,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Findings About Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FADIR,27,Directionality,What [is/was] the directionality (of the anatomical location of the [measurement/test/examination])?,Char,['DIR']
962,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the distribution (i.e.,arrangement of, apportioning of).",Collected when the sponsor needs to identify the specific portionality for the anatomical locations of the location of the FATEST. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,FA Location Portion or Totality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAPORTOT,28,Portion or Totality,What [is/was] the portion or totality (of the anatomical location of the [measurement/test/examination])?,Char,['PORTOT']
963,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,Method of the test or examination.,,Findings About Method,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAMETHOD,29,Method,What was the method (used for the [measurement/test/examination])?,Char,['METHOD']
964,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The lead or leads identified to capture the measurement for a test from an instrument.,,Findings About Lead,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FALEAD,30,Lead,What [is/was] the lead (used to measure [measurement/test/examination])?,Char,
965,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An indication that the subject has abstained from food/water for the specified amount of time.,Results may be affected by whether the subject was fasting. This may not be relevant for all tests.,Findings About Fasting Status,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAFAST,31,Fasting,[Is/Was] the subject fasting (prior to the [test being performed/sample being collected])?,Char,['NY']
966,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The role of the person providing the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted, or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Findings About Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAEVAL,32,[Evaluator/Reporter],Who provided the (sponsor-defined phrase) information?; Who was the evaluator?,Char,['EVAL']
967,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An identifier used to distinguish multiple evaluators with the same role recorded in FAEVAL.,This variable is used in conjunction with FAEVAL to provide an additional level of detail.,Findings About Evaluator Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,FAEVALID,33,[Evaluator/Reporter] Identifier,What [is/was] the identifier of the [evaluator name/reporter name] (providing the-sponsor-defined phrase-information)?,Char,['MEDEVAL']
968,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",FA,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An indication whether the test results were clinically significant.,,Findings About Clinical Significance,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPFA dataset as the value of SUPPFA.QVAL when SUPPFA.QNAM = ""CLSIG"" and SUPPFA.QLABEL = ""Clinical Significance"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables in SDTM domains.",FACLSIG,34,([Measurement/Test/Examination/])/Clinically Significant,[Is/Was] the ([measurement/test/examination]) result clinically significant?,Char,['NY']
969,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or in the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
970,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on the CRFs that are shipped to each site. \n EDC: This should be prepopulated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
971,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
972,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The name of a clinical encounter that encompasses planned and unplanned trial interventions, procedures, and assessments that may be performed on a subject.","The name of the visit is typically preprinted on the CRF, and should match the name of the visit in the protocol. May be used to derive the SDTM variable VISITNUM. \n Note: Sponsors may have CDASH visit-numbering or visit-naming conventions to handle special circumstances (e.g., unscheduled visits). In such cases, the appropriate visit numbers and visit names may need to be populated when creating SDTM submission datasets.",Visit Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,VISIT,4,[Visit],What is the visit name?,Char,
973,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,Date the clinical encounter occurred (or started).,"The date the skin response measurements were collected can be determined from the visit date variable (VISDAT) and applying that date to all of the skin response measurements at that visit, or the collection date can be included on the Skin Response CRF using the date (SRDAT) field.",Visit Date,"This field is not an SDTM variable. The date of a measurement, test, or observation can be determined from the date/time of visit (VISDAT/VISTIM) and then concatenating the CDASH VISDAT/VISTIM components and populating the SDTMIG variable SRDTC in ISO 8601 format.",VISDAT,5,(Visit) Date,What [is/was] the date of the visit?,Char,
974,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"An indication of whether a planned skin response measurement, series of skin response measurements, tests, or observations was performed.",General prompt question to be used as a data management tool to verify that missing results are confirmed missing.,Skin Response Test Performed,"This does not map directly to an SDTMIG variable. May be used to derive a value into the SDTM variable SRSTAT. If SRPERF=""N"", the value of SRSTAT will be ""NOT DONE"". If SRPERF=""Y"", SRSTAT should be null. A combination of SDTMIG variables (e.g., SRCAT and SRSCAT, SRTPT ) is used to indicate that multiple tests were not done. In this situation, the SDTMIG variable SRTESTCD would be populated as SRALL and an appropriate test name (SRTEST) provided. See the SDTMIG for additional information.",SRPERF,6,Skin Response Test Performed,Was a skin response test performed?,Char,['NY']
975,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An explanation for why data are not available.,"The reason the data are not available may be chosen from a sponsor-defined list (e.g., broken equipment, subject refused) or entered as free text. When SRREASND is used, the SDTMIG variable SRSTAT should also be populated in the SDTM-based dataset.",Skin Response Reason Not Done,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRREASND,7,Reason Not Done,What was the reason the test was not done?,Char,
976,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,A grouping of topic-variable values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Category"" can be included in the column heading.",Skin Response Category for Test,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRCAT,8,[Skin Response Category]; NULL,What was the category of the skin response?,Char,
977,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,A sub-division of the SRCAT values based on user-defined characteristics.,"Sponsor-defined controlled terminology. This is most commonly either a heading or a preprinted category value on the CRF, not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as ""Subcategory"" can be included in the column heading. SRSCAT can only be used if there is an SRCAT, and it must be a subcategorization of SRCAT.",Skin Response Subcategory for Test,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRSCAT,9,[Skin Response Subcategory]; NULL,What was the subcategory of the skin response?,Char,
978,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"A sponsor-defined identifier. In CDASH, this is typically used for preprinted or auto-generated numbers on the CRF, or any other type of identifier that does not already have a defined CDASH identifier field.","Because SPID is a sponsor-defined identifier, conformance to Question Text or Item Prompt is not applicable. Typically used as an identifier in a data query to communicate clearly to the site the specific record in question or to reconcile data. May be used to record preprinted number (e.g., line number, record number) on the CRF. This field may be populated by the sponsor's data collection system.",Skin Response Sponsor-Defined Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. May be used to create RELREC to link this record with a record in another domain.,SRSPID,10,[Sponsor defined],[Sponsor-defined question],Char,
979,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,A description of the object or focal point of the findings observation that is represented by SRTEST.,,Skin Response Object of the Observation,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SROBJ,11,[Intervention] Performed,What intervention was performed to elicit the skin response?,Char,
980,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The date of the reference time point, represented in an unambiguous date format (e.g., DD-MON-YYYY).","A complete date is expected. If the date of administration is collected on a separate CRF (e.g., VISDAT), then it should not be collected on the SR CRF.",SR Date of Reference Time Point,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable SRRFTDTC in ISO 8601 format.",SRRFTDAT,12,[Intervention] Administration Date,What was the date of the [intervention] performed to elicit the skin response?,Char,
981,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The time of the reference time point, represented in an unambiguous time format (e.g., hh:mm:ss).","Collect time if it is relevant for the analysis of the skin response (e.g., multiple [intervention] administrations).",SR Time of Reference Time Point,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable SRRFTDTC in ISO 8601 format.",SRRFTTIM,13,[Intervention] Administration Time,What was the time of the [intervention] performed to elicit the skin response?,Char,
982,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"A description of the anatomical location of the subject, relevant to the collection of skin response test.","Collected or preprinted when the sponsor needs to identify the specific anatomical location (e.g., arm for skin response). Sponsors may collect the data using a subset list of controlled terminology on the CRF. LAT, DIR, and PORTOT are used to further describe the anatomical location.",SR Location Used for Measurement,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRLOC,14,Anatomical Location,What was the anatomical location of the skin response measurement?,Char,['LOC']
983,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"Qualifier for anatomical location, further detailing the side of the body.",May be preprinted or collected when the sponsor needs to identify the specific side of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Skin Response Laterality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRLAT,15,Side,What was the side of the anatomical location of the skin response measurement?,Char,['LAT']
984,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,Descriptive name of the test or examination used to obtain the measurement or finding.,"Required to identify which test the result is for. It is recommended that the test names be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Test"" can be included in the column heading.",Skin Response Test or Examination Name,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. SRTESTCD may be determined from the value collected in SRTEST. The SDTMIG variables SRTESTCD and SRTEST are required in SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.,SRTEST,16,[Skin Response Test Name],What was the skin response test name?,Char,['SRTEST']
985,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,A text description of planned time point when measurements should be taken as defined in the protocol.,"Planned time points are needed to differentiate multiple sequential assessments. It is recommended that time points be preprinted on the CRF rather than collected in a free-text field. If the form is laid out as a grid, then words such as ""Planned Time Point"" can be included in the column heading.",Skin Response Planned Time Point Name,"Maps directly to the SDTMIG variable listed in the SDTMIG Target column. See the SDTMIG for additional information on representing time points. Time-point anchors SRTPTREF (text description) and SRRFTDTC (date/time) may be needed, as well as SDTMIG variables SRTPTNUM, SRELTM.",SRTPT,17,[Planned Time Point Name],What was the planned time point for skin response measurement?,Char,
986,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The date of the measurements, represented in an unambiguous date format (e.g., DD-MON-YYYY).","The date of measurement can be determined from a collected date of the visit (VISDAT); in such cases, a separate measurement date field is not required.",Skin Response Observation Date,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable SRDTC in ISO 8601 format.",SRDAT,18,Date,What was the date of the skin response measurement?,Char,
987,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,"The time of measurement, represented in an unambiguous time format (e.g., hh:mm:ss).","The time of measurement (if required) can be determined from a collected time of the visit (VISTIM); in such cases, a separate measurement date field is not required.",Skin Response Observation Time,"This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH DATE and TIME components and populate the SDTMIG variable SRDTC in ISO 8601 format.",SRTIM,19,Time,What was the time of the skin response measurement?,Char,
988,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,"Qualifier further detailing the position of the anatomical location, relative to the center of the body, organ, or specimen.",May be preprinted or collected when the sponsor needs to identify the directionality of the anatomical location. Sponsors may collect the data using a subset list of controlled terminology on the CRF.,Skin Response Directionality,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRDIR,20,Directionality,What was the directionality of the anatomical location of the skin response measurement?,Char,['DIR']
989,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,The role of the person who provided the evaluation.,"Used only for results that are subjective (e.g., assigned by a person or a group). May be a preprinted or collected. Sponsors may collect the data using a subset list of controlled terminology on the CRF.",Skin Response Evaluator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SREVAL,21,[Evaluator/Reporter],Who was the evaluator?,Char,['EVAL']
990,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,Used to distinguish multiple evaluators with the same role recorded in SREVAL.,If EVALID needs to be collected for each test on the horizontal record the CDASH variable [SRTESTCD]_ EVALID can be used.,Skin Response Evaluator Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SREVALID,22,[Evaluator/Reporter] Identifier,What was the identifier of the evaluator providing the skin response information?,Char,['MEDEVAL']
991,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",HR,Result of the skin response test as originally received or collected.,,SR Results or Findings in Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRORRES,23,(Result),What was the result of the skin response measurement?,Char,
992,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",R/C,The unit of the result as originally received or collected.,"Should be preprinted on the CRF with the associated test when possible, rather than collected in a free-text field.",SR Original Units,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRORRESU,24,Unit,What was the unit of the skin response measurement?,Char,['UNIT']
993,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An indication or description about how the value compares to the normal range or reference range.,The category of the value within the respective reference range. Ranges may be defined by SRORNRLO and SRORNRHI or other objective criteria. Reference Range Indicator may be included if not derived or determined programmatically after data collection. Should not be used to indicate clinical significance.,Skin Response Reference Range Indicator,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SRNRIND,25,Comparison to [Reference/Expected/Normal] Range,How [did/do] the reported values compare within the [reference/normal/expected] range?,Char,['NRIND']
994,Findings About Events or Interventions,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",SR,Skin Response,"This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. (Source: CDISC Controlled Terminology, GNRLOBSC, C135396, 2023-06-30)",O,An indication of whether the skin response result was clinically significant.,"If this level of information is needed, it may be added to the CRF.",Skin Response Clinical Significance,"This does not map directly to an SDTMIG variable. This information could be submitted in a SUPPSR dataset as the value of SUPPSR.QVAL where SUPPSR.QNAM =""SRCLSIG"" and SUPPSR.QLABEL=""Clinically Significant"". Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables in SDTM domains.",SRCLSIG,26,Clinically Significant,Was the result clinically significant?,Char,['NY']
995,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",CO,Comments,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
996,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",CO,Comments,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on CRFs that are shipped to each site. \n EDC: This should be pre-populated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
997,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",CO,Comments,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. \n EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
998,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",CO,Comments,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",O,A free-text comment.,"If an additional free-text field is needed to provide more information about a particular record, use the COVAL variable to collect the free text, and associate the free text (comment) with the original record using RDOMAIN, IDVAR, IDVARVAL.",Comment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. RDOMAIN contains the domain to which the comment is related.,COVAL,4,[Abbreviated version of the protocol-specified targeted question],[Protocol-specified targeted question],Char,
999,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",DM,Demographics,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",HR,A unique identifier for a study.,"Although this field is not typically captured on a CRF, it should be displayed clearly on the CRF and/or the EDC system. This field can be included in the database or populated during SDTM-based dataset creation before submission.",Study Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,STUDYID,1,[Protocol/Study],What is the study identifier?,Char,
1000,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",DM,Demographics,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",HR,A unique identifier for a site within a study.,"Paper: This is typically preprinted in the header of each CRF page for single-site studies. For studies with multiple sites, this field may be left blank so that the number can be recorded by the site, or it may be preprinted on CRFs that are shipped to each site. \n EDC: This should be pre-populated.",Study Site Identifier,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SITEID,2,Site (Identifier),What is the site identifier?,Char,
1001,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",DM,Demographics,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",HR,A unique subject identifier within a site and a study.,"Paper: This is typically recorded in the header of each CRF page. \n EDC: The subject identifiers may be system-generated. This CDASH variable is typically collected in all CDASH domains. However, this CDASH variable is populated only in the SDTMIG DM domain. For more information, refer to the SDTMIG.",Subject Identifier for the Study,Maps directly to the SDTMIG variable listed in the SDTMIG Target column.,SUBJID,3,[Subject/Participant] (Identifier),What [is/was] the (study) [subject/participant] identifier?,Char,
1002,Special-Purpose,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",DM,Demographics,"This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. (Source: CDISC Controlled Terminology, GNRLOBSC, C103377, 2023-06-30)",O,A free-text comment.,"If an additional free-text field is needed to provide more information about a particular record, use the COVAL variable to collect the free text, and associate the free text (comment) with the original record using RDOMAIN, IDVAR, IDVARVAL.",Comment,Maps directly to the SDTMIG variable listed in the SDTMIG Target column. RDOMAIN contains the domain to which the comment is related.,COVAL,4,[Abbreviated version of the protocol-specified targeted question],[Protocol-specified targeted question],Char,
